Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Paolo Antonio Ascierto
Based on 240 articles published since 2010
(Why 240 articles?)
||||
Expertise Level
The expertise of Paolo Antonio Ascierto ranks in the
  • Top 0.0016%
  • ... of 122,002 published authors worldwide on Melanoma
  • ... from 2010 through 2020
  • ... based on contributions to 240 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Ascierto, Paolo   ·   Ascierto, P A   ·   Ascierto, P   ·   Ascierto, Paolo Antonio   ·   Ascierto, Paolo A
Work Locations
Details
Most likely:    Istituto Nazionale Tumori IRCCS Fondazione Pascale      
2020
  • Department of Dermatology, University Hospital Essen, University of Duisburg-Essen & German Cancer Consortium Heidelberg, Germany. Electronic address: · Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Translational Skin Cancer Research, German Consortium of Translational Cancer Research (DKTK), Essen, & German Cancer Research Center (DKFZ), Heidelberg, Germany. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Dermatology, Timone Hospital and Aix-Marseille University, Marseille, France. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Department of Dermatology, University Hospital Essen, University of Duisburg-Essen & German Cancer Consortium Heidelberg, Germany. · Melanoma Institute Australia, The University of Sydney, And Royal North Shore Hospital, Sydney, NSW, Australia. · University of Manchester / the Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia and University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · Pubmed 32179447
  • Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", 80131 Naples, Italy. · Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy. · IRCCS, Istituto Nazionale Tumori "Regina Elena", Via Elio Chianesi 53, 00144 Rome, Italy. · Department of Molecular and Clinical Medicine, University of Roma "Sapienza", 00185 Rome, Italy. · Pubmed 32178301
  • Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy. · Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy. · Istituto Nazionale Tumori Regina Elena, IRCCS, Rome, Italy. · Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084, Fisciano, SA, Italy. · Department of Medicine and Surgery, University of Parma, Parma, Italy. · PhD Program in Drug Discovery and Development, Department of Pharmacy, University of Salerno, Fisciano, Italy. · Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084, Fisciano, SA, Italy. · Pubmed 32160899
  • Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy. · Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy. Electronic address: · Pubmed 32122547
  • Melanoma Unit, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy. Electronic address: · Department of Medicine, University of Colorado Comprehensive Cancer Center, Aurora, Colorado, USA. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy. · Department of Biotherapy, N. N. Blokhin Russian Cancer Research Center, Ministry of Health, Moscow, Russia. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine. · Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK. · Department of Cancer Immunology, Poznan University of Medical Sciences, Med-POLONIA, Poznan, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland. · Melanoma Translational Research Group, Melanoma Institute Australia, Wollstonecraft, New South Wales, Australia. · Product Development Oncology, Genentech, Inc., South San Francisco, California, USA. · Oncology Biostatistics, Genentech, Inc., South San Francisco, California, USA. · Clinical Development Department, Roche Products Ltd., Welwyn Garden City, UK. · Oncology Biomarker Development, Genentech, Inc., South San Francisco, California, USA. · Safety Science Oncology, Genentech, Inc., South San Francisco, California, USA. · Department of Dermatology, Essen University Hospital, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Pubmed 31912791
  • Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. Electronic address: · Department of Dermatology, University Hospital Zürich Skin Cancer Center and University Zürich, Zürich, Switzerland. · Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece. · Cancer Center, Massachusetts General Hospital, Boston, MA, USA. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Department of Dermatology, National Institute of Oncology, Budapest, Hungary. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Department of Dermato-oncology, University Hospital Prague and Charles University First Medical Faculty, Prague, Czech Republic. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · Department of Medical Oncology, Isala, Zwolle, Netherlands. · Department of Dermatology, University Medical Center Mainz, Mainz, Germany. · Pfizer Inc., Boulder, CO, USA. · Service of Dermatology, Department of Medicine and Paris-Sud University, Gustave Roussy, Villejuif, France. · Pubmed 31901705
  • Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15232, USA. · Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia. · Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Dermatology and Skin Cancers, Hôpital de la Timone, Aix-Marseille Université, Marseille, France. · Department of Dermatological Oncology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Medical Oncology, Mater Hospital, North Sydney, NSW, Australia. · Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia. · Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany. · Dermatology Unit, Department of Oncology, Gustave Roussy Cancer Centre, Villejuif, France. · Department of Medicine, Université Paris-Sud, Orsay, France. · Department of Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Surgical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Internal Medicine, VCU Massey Cancer Center, Richmond, VA 23298, USA. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland. · Department of Clinical Oncology, Merck & Co., Inc., Kenilworth, NJ 07033, USA. · Department of Medical Oncology, Gustave Roussy Cancer Institute & Université Paris-Saclay, Paris, France. · Pubmed 31870188
  • University Hospital Schleswig-Holstein, Kiel, Germany. Electronic address: · Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale," Naples, Italy. · University Hospital of Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Aix-Marseille University, Marseille, France. · UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Hôpital Saint-André, Bordeaux, France. · N.N. Blokhin Russian Cancer Research Center, Moscow, Russia. · APHP Dermatology and CIC Department, Hôpital Saint-Louis, INSERM U976, University Paris Diderot, Paris, France. · Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Hannover Medical School, Hannover, Germany. · University of Western Australia, Sir Charles Gairdner Hospital, Perth, WA, Australia. · Westmead Hospital and Macquarie University, Sydney, NSW, Australia. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 31864178
2019
  • Unit Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Ospedale Santa Maria Annunziata and University of Florence, Florence, Italy. · Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Unit Melanoma and Rare Tumors, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy. · Oncologia Medica B Policlinico Umberto I di Roma, Rome, Italy. · Surgical Oncology Unit, IOV-IRCCS of Padova and Dept. Surgery Oncology Gastroenterology, University of Padova, Padua, Italy. · Unit of Cancer Genetics, ICB-CNR, Sassari, Italy. · Research Director CNR, Italian Melanoma Intergroup (IMI), Unit of Cancer Genetics, Head Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Sassari, Italy. · IRCCS Fondazione Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Turin, Italy. · Skin Cancer Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, FC, Italy. · University of Parma, Parma, Italy. · Pubmed 31412885
  • Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Via Mariano Semmola snc, Naples, Italy. · Department of Medicine (DAME), University Hospital of Udine, Udine, Italy. · Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Via Mariano Semmola snc, Naples, Italy. · Pubmed 31359162
  • 1 New York University Perlmutter Cancer Center, New York, NY. · 2 University of Michigan Rogel Cancer Center, Ann Arbor, MI. · 3 From the Instituto Nazionale Tumori, Instituto di Ricovero e Cura a Carrattere Scientifico, Fondazione G. Pascale, Naples, Italy. · 4 Massachusetts General Hospital Cancer Center, Boston, MA. · Pubmed 31099689
  • Department of Clinical Medicine and Surgery, Oncology Unit, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131, Naples, Italy. · Department of Clinical Medicine and Surgery, Oncology Unit, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131, Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 30747264
  • a Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics , Istituto Nazionale Tumori IRCCS Fondazione G. Pascale , Napoli , Italy. · Pubmed 30652516
  • a IRCCS , Regina Elena National Cancer Institute , Rome , Italy. · b Department of Molecular and Clinical Medicine , University of Roma "Sapienza" , Rome , Italy. · c IRCCS , National Cancer Institute of Naples "Fondazione G. Pascale" , Naples , Italy. · Pubmed 30507327
  • Department of Dermatology, University Medical Center, Tübingen, Germany. · Division of Thoracic Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy. · Istituto Nazionale Tumori, IRCCS Fondazione Pascale, Naples, Italy. · Ospedali Riuniti Ancona, Ancona, Italy. · Università di Modena e Reggio Emilia, Modena, Italy. · Medical University of Graz, Graz, Austria. · Translational Skin Cancer Research, Deutsches Konsortium für Translationale Krebsforschung (DKTK) Partner Site Essen, Essen, Germany. · Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany. · University Hospital Schleswig-Holstein (UKSK), Campus Kiel, Kiel, Germany. · Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. · Azienda Ospedaliero-Universitaria Senese, Siena, Italy. · University Hospital Zurich and University Zurich, Zurich, Switzerland. · Charité, Berlin, Germany. · Dermatologikum Berlin, Berlin, Germany. · Philochem AG, Libernstrasse 3, 8112, Otelfingen, Switzerland. · Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Building HCI G396.4, Wolfgang-Pauli-Strasse 10, 8093, Zurich, Switzerland. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Sektion Dermatologische Onkologie, Universität Tübingen Hautklinik, Liebermeisterstraße 25, 72076, Tübingen, Germany. · Pubmed 31482307
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · European Institute of Oncology IRCCS, Milan, Italy. · Auckland City Hospital, Auckland, New Zealand. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Brisbane, Queensland, Australia. · Aarhus University Hospital, Aarhus, Denmark. · Ella Lemelbaum Institute for Melanoma, Sheba Medical Center at Tel HaShomer, Cancer Center (Oncology Institute), Ramat Gan, Israel. · IRCCS San Martino-IST, Genova, Italy. · Melanoma Institute Australia and the University of Sydney, Mater and Royal North Shore Hospitals, Sydney, New South Wales, Australia. · Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Sharett Institute of Oncology, Hadassah Hebrew Medical Center, Jerusalem, Israel. · Rambam Health Care Campus, Haifa, Israel. · Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec, Québec, Canada. · Novartis, East Hanover, NJ, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · University of California Los Angeles and the Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Pubmed 31171878
  • 1 Saint-Louis Hospital, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Paris, France. · 2 Université Paul Sabatier-Toulouse III, Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche 1037-CRCT, Toulouse, France. · 3 Université de Lille, Institut National de la Santé et de la Recherche Médicale U1189, Lille, France. · 4 Hospital General Universitario Gregorio Marañón, Madrid, Spain. · 5 Gustave Roussy, Institut National de la Santé et de la Recherche Médicale U981, Paris, France. · 6 Maria Skłodowska-Curie Institute-Oncology Center, Warsaw, Poland. · 7 Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia. · 8 University Hospital Tübingen, Tübingen, Germany. · 9 Istituto Nazionale Tumori-Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples, Italy. · 10 Cross Cancer Institute, Edmonton, Alberta, Canada. · 11 University Hospital, Essen, Germany. · 12 German Cancer Consortium, Heidelberg, Germany. · 13 St George's University Hospitals National Health Service Foundation Trust, Tooting, London, United Kingdom. · 14 Herlev Hospital, University of Copenhagen, Herlev, Denmark. · 15 University of Colorado, Denver, CO. · 16 Bristol-Myers Squibb, Princeton, NJ. · 17 Veneto Institute of Oncology-Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy. · Pubmed 30811280
  • Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Department of Medical Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia. · Department of Medicine, Institute Gustave Roussy, Villejuif, France. · Medical Oncology and Haematology, Cabrini Health, Melbourne, Victoria, Australia. · Dermatology Service, University Hospital of Bordeaux, Bordeaux, France. · UOC Oncological Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Clinique de Dermatologie, Unité d'Onco-Dermatologie, Institut National de la Santé et de la Recherche Médicale (INSERM) U1189, Centre Hospitalier Régional Universitaire de Lille, Lille, France. · Department of Dermatology, University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland. · Chris O'Brien Lifehouse, Melanoma Institute Australia, Camperdown, New South Wales. · Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Polish Mother's Memorial Hospital Research Institute, Lodz, Poland. · Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Assistance Publique-Hôpitaux de Paris Dermatology and Centre d'Investigation Clinique, University Paris Diderot INSERM U976, Saint Louis Hospital, Paris, France. · Institute for Advanced Biosciences, Université Grenoble Alpes/INSERM U1209/CNRS UMR 5309 Joint Research Center, Grenoble, France. · Dermatology Department, Grenoble Alpes University Hospital, Grenoble, France. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Melanoma Cancer Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy. · Department of Dermatology, University Hospital Cologne, Cologne, Germany. · Division of Oncology, Regina Elena Institute, Rome, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Center for Cancer Immune Therapy, Herlev Hospital, Herlev, Denmark. · Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium, Heidelberg, Germany. · First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece. · Global Biometric Sciences, Bristol-Myers Squibb, Princeton, New Jersey. · Oncology Clinical Development, Bristol-Myers Squibb, Princeton, New Jersey. · Princess Alexandra Hospital, University of Queensland, Woolloongabba, Queensland, Australia. · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, Queensland, Australia. · Pubmed 30422243
  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Cancer Immunotherapy and Innovative Therapy Unit, Naples. Italy. · Centro di Riferimento Oncologico, Department of Medical Oncology, Aviano (PN). Italy. · Research Branch, Sidra Medical and Research Centre, Doha. Qatar. · Pubmed 31804158
  • Department of Dermatology, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany; The German Cancer Consortium, Heidelberg, Germany. Electronic address: · Division of Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Banchi di Sotto, 55, 53100, Siena, SI, Italy. · N. N. Blokhin Russian Cancer Research Center, Ministry of Health, Russian Academy of Medical Sciences, Kashirskoye Shosse 24, 115478, Moscow, Russian Federation. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Centro Ospedaliero, 24129, Bergamo, BG, Italy. · Dnipropetrovsk State Medical Academy, Volodymyra Vernadskoho St, 9, Dnipropetrovsk, 49044, Ukraine. · Melanoma Unit, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori, IRCCS Fondazione Pascale, Via Mariano Semmola, 53, 80131, Napoli, NA, Italy. · Bristol Haematology and Oncology Centre, Horfield Rd, Avon, Bristol, BS2 8ED, United Kingdom. · Department of Cancer Immunology, Poznan University for Medical Sciences, Med-POLONIA, Collegium Maius, Fredry 10, 61-701, Poznań, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Wawelska 15 B, 00-001, Warsaw, Poland. · Melanoma Translational Research Group, Melanoma Institute Australia, 40 Rocklands Rd, Wollstonecraft NSW, 2065, New South Wales, Australia. · Genentech, Inc., 410 Allerton Ave, South San Francisco, CA, 94080, USA. · University of Colorado Comprehensive Cancer Center, 1665 Aurora Court Anschutz Cancer Pavilion, Aurora, CO 80045, USA. · Pubmed 31704549
  • Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Department of Medical, Surgical and Experimental Sciences, University of Sassari, Viale S., 07100 Sassari, Italy. · Anatomia Patologica, Azienda Ospedaliero Universitaria (AOU), 07100 Sassari, Italy. · Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico (CRO), 33081 Pordenone, Italy. · Department of Medical Oncology, Centro di Riferimento Oncologico (CRO), 33081 Pordenone, Italy. · Istituto Nazionale Tumori "Fondazione Pascale", 80131 Naples, Italy. · Istituto Nazionale Tumori "Fondazione Pascale", 80131 Naples, Italy. · Istituto Nazionale Tumori "Fondazione Pascale", 80131 Naples, Italy. · Oncologia Medica, Ospedale Civile, 07041 Sassari, Italy. · Anatomia Patologica, Azienda Ospedaliera Cannizzaro, Via Messina 829, 95126 Catania, Italy. · Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Anatomia Patologica, Azienda Ospedaliero Universitaria (AOU), 07100 Sassari, Italy. · Anatomia Patologica, Azienda Ospedaliero Universitaria (AOU), 07100 Sassari, Italy. · Anatomia Patologica, Azienda Ospedaliero Universitaria (AOU), 07100 Sassari, Italy. · Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Pubmed 31581559
  • Department of Dermatology, University Hospital Essen, Essen, German Cancer Consortium, Heidelberg, Germany. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain. · N.N. Blokhin Russian Cancer Research Centre, Ministry of Health, Moscow, Russia. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · Department of Medical Oncology, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Institute of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · First Department of Medicine, National and Kapodistrian University of Athens School of Medicine, Laiko General Hospital, Athens, Greece. · Division of Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. · Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy. · Department of Dermatology, Medical University of Vienna, Vienna, Austria. · Department of Dermatology, University of Lübeck, Lübeck, Germany. · Department of Dermatology, Hannover Medical School, Skin Cancer Centre Hannover, Hannover, Germany. · Department of Oncology, Oslo University Hospital, Oslo, Norway. · Department of Oncology, Metropolitan Hospital, Athens, Greece. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute, Oncology Center, Warsaw, Poland. · Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, United Kingdom. · Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Dermatology, SRH Wald Clinics, University Hospital, Gera, Germany. · Unit of Medical Oncology, Department of Oncology & Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Medical Oncology Department, General University Hospital, Gregorio Marañón and CIBERONC, Madrid, Spain. · Medical Oncology, Vall D'Hebron University, Barcelona, Spain. · Department of Dermatology, Universitats Spital, Zürich, Switzerland. · Oncology Clinical Development, Bristol-Myers Squibb, Princeton, NJ, USA. · Global Biometric Sciences, Bristol-Myers Squibb, Princeton, NJ, USA. · Department of Medical Oncology, Mount Vernon Cancer Centre, London, United Kingdom. · Pubmed 31581055
  • Department of Oncology, University Hospital Lausanne, Lausanne, Switzerland. · Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Napoli, Italy. · Department of Dermatology, Skin Cancer Centre, University Hospital Zürich, Zürich, Switzerland. · Charité Comprehensive Cancer Centre, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Pubmed 31566661
  • Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy. · Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy. · Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy. · Department of Molecular and Clinical Medicine, Laboratory Affiliated to Istituto Pasteur Italia Fondazione Cenci Bolognetti, University of Rome "Sapienza", 00161 Rome, Italy. · Department of Melanoma, Oncologic Immunotherapy and Innovative Therapies Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", 80131 Naples, Italy. · Department of Melanoma, Oncologic Immunotherapy and Innovative Therapies Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", 80131 Naples, Italy. · Department of Melanoma, Oncologic Immunotherapy and Innovative Therapies Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", 80131 Naples, Italy. · Department of Molecular and Clinical Medicine, University of Rome "Sapienza", 00161 Rome, Italy. · Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy. · Department of Melanoma, Oncologic Immunotherapy and Innovative Therapies Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", 80131 Naples, Italy. · Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA. · Department of Dermatology, Miller School of Medicine, Miami, FL 33136, USA. · Department of Melanoma, Oncologic Immunotherapy and Innovative Therapies Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", 80131 Naples, Italy. · Department of Molecular and Clinical Medicine, University of Rome "Sapienza", 00161 Rome, Italy. · Scientific Directorate, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy. · Pubmed 31557826
  • Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Traversa La Crucca 3, 07100, Sassari, Italy. · Department of Medical, Surgical, and Experimental Sciences, University of Sassari, Viale San Pietro 43, 07100, Sassari, Italy. · Istituto Nazionale Tumori "Fondazione Pascale", Via Mariano Semmola, 53, 80131, Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Traversa La Crucca 3, 07100, Sassari, Italy. · Pubmed 31455347
  • Department of Medical Oncology, Mount Vernon Cancer Centre, London, United Kingdom. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medical Oncology, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain. · N.N. Blokhin Russian Cancer Research Centre, Ministry of Health, Moscow, Russia. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · Department of Medical Oncology, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Institute of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · First Department of Medicine, National and Kapodistrian University of Athens School of Medicine, Laiko General Hospital, Athens, Greece. · Division of Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. · Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy. · Department of Dermatology, Medical University of Vienna, Vienna, Austria. · Department of Dermatology, University of Lübeck, Lübeck, Germany. · Department of Dermatology, Hannover Medical School, Skin Cancer Centre Hannover, Hannover, Germany. · Department of Oncology, Oslo University Hospital, Oslo, Norway. · Department of Oncology, Metropolitan Hospital, Athens, Greece. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute, Oncology Center, Warsaw, Poland. · Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, United Kingdom. · Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Dermatology, SRH Wald Clinics, University Hospital, Gera, Germany. · Unit of Medical Oncology, Department of Oncology & Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Medical Oncology Department, General University Hospital Gregorio Marañón and CIBERONC, Madrid, Spain. · Medical Oncology, Vall D'Hebron University, Barcelona, Spain. · Department of Dermatology, Universitats Spital, Zürich, Switzerland. · Oncology Clinical Development, Bristol-Myers Squibb, Princeton, NJ, USA. · Global Biometric Sciences, Bristol-Myers Squibb, Princeton, NJ, USA. · Department of Dermatology, University Hospital Essen, Essen, and the German Cancer Consortium, Heidelberg, Germany. · Pubmed 31445199
  • Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece. Electronic address: · Cancer Center, Massachusetts General Hospital, Boston, MA, USA. · Department of Dermatology, University Hospital Zürich Skin Cancer Center and University Zürich, Zürich, Switzerland. · Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Department of Dermatology, National Institute of Oncology, Budapest, Hungary. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Dermatology, University Hospital Essen, Essen, Germany, and German Cancer Consortium, Heidelberg, Germany. · Department of Dermato-oncology, University Hospital Prague and Charles University First Medical Faculty, Prague, Czech Republic. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · Melanoma Cancer Unit, Oncology Institute of Veneto IRCCS, Padua, Italy. · Department of Oncologic Dermatology, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux, France. · Department of Medical Oncology, Isala, Zwolle, Netherlands. · Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan. · Department of Dermatology, University Medical Center Mainz, Mainz, Germany. · Array BioPharma Inc., Boulder, CO, USA. · Service of Dermatology, Department of Medicine and Paris-Sud University, Gustave Roussy, Villejuif, France. · Pubmed 31437754
  • Gustave Roussy Cancer Insitute and University Paris-Sud, France. Electronic address: · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · AIX-Marseille University, Marseille, France. · University of Zurich Hospital, Zurich, Switzerland. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Melanoma Department, Gustave Roussy Institute and Univerity Paris-Sud, France. · Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy. · Oncology Specialists, SC, Park Ridge, IL, USA. · Dermatology and CIC Department, AP-HP, Saint-Louis Hospital, Université de Paris, INSERM U976, Paris, France. · Regina Elena National Cancer Institute, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · New York University Perlmutter Cancer Center, New York, NY, USA. · Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. · Bristol-Myers Squibb, Lawrenceville, NJ, USA. · Bristol-Myers Squibb, Braine-L'alleud, Belgium. · EORTC Headquarters, Brussels, Belgium. · Formerly at European Institute of Oncology, Milan, Italy. · Pubmed 31400634
  • Unit of Cancer Genetics, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Traversa La Crucca 3, Baldinca Li Punti, 07100, Sassari, Italy. · Department of Medical, Surgical, and Experimental Sciences, University of Sassari, Sassari, Italy. · National Tumor Institute "Fondazione G. Pascale", Napoli, Italy. · Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. · Department of Dermatology, University of Parma, Parma, Italy. · Unit of Medical Oncology, "Papa Giovanni XXIII" Hospital of Bergamo, Bergamo, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Traversa La Crucca 3, Baldinca Li Punti, 07100, Sassari, Italy. · Pubmed 31382929
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Medical Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Experimental Pharmacology Unit, Department of Translational Research, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA. · Department of Pathology and Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · The Angeles Clinic, Experimental Therapeutics Cedars Sinai Foundation, Los Angeles, CA, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · University of Chicago Medical Center, Chicago, IL, USA. · Oncology Department, UNIL-CHUV, Lausanne, Switzerland. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Institut de Cancérologie, Gustave Roussy Cancer Campus, Villejuif, Paris, France. · Refuge Biotechnologies, Menlo Park, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, 9609 Medical Center Drive, Bethesda, MD, 20892-7420, USA. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Pubmed 31331337
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands. · Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy. · Melanoma Institute Australia, The University of Sydney, and Mater and Royal North Shore Hospitals, Sydney, NSW, Australia. · Princess Alexandra Hospital, Brisbane, QLD, Australia. · Hospices Civils de Lyon Cancer Institute, Lyon, France. · Alfred Hospital, Melbourne, VIC, Australia. · Russian Oncology Scientific Centre, Moscow, Russia. · Fiona Stanley Hospital/University of Western Australia, Perth, WA, Australia. · Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Royal Marsden Hospital, London, United Kingdom. · Hospital Clinic Universitari de Barcelona, Barcelona, Spain. · Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy. · Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland. · Universitaetsklinikum - University Essen, Essen, Germany. · Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands. · Washington University School of Medicine, St. Louis, MO, USA. · Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. · Amsterdam University Medical Center, Location VUMC, Amsterdam, the Netherlands. · Aix Marseille University, Hôpital de la Timone, Marseille, France. · Skin Cancer Center, Hannover Medical School, Hannover, Germany. · Centre Hospitalier de l'Université de Montréal (CHUM), Centre de recherche du CHUM, Montreal, QC, Canada. · Christie NHS Foundation Trust, Manchester, United Kingdom. · Merck & Co., Inc., Kenilworth, NJ, United States. · EORTC Headquarters, Brussels, Belgium. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Pubmed 31200321
  • University of Colorado Comprehensive Cancer Center, Aurora, CO, USA. Electronic address: · University Hospital Schleswig-Holstein, Kiel, Germany. · The Royal Marsden NHS Foundation Trust, London, UK. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA. · Massachusetts General Hospital, Boston, MA, USA. · Peter MacCallum Cancer Centre, East Melbourne, VIC, and University of Melbourne, Parkville, VIC, Australia. · Nantes University, Nantes, France. · Genentech, Inc., South San Francisco, CA, USA. · Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy. · Pubmed 31173962
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Clinical Epidemiology Unit, University Hospital "San Martino", Genoa, Italy. · Institut Gustave Roussy Villejuif, Paris-Sud, VilleJuif, Paris, France. · Clinical Research and Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Melanoma Clinical Research & Early Drug Development, Melanoma Medical Oncology, Investigational Cancer Therapeutics, UT MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL), Amsterdam, The Netherlands. · Surgical Group, EORTC Melanoma Group, Brussels, Belgium. · Department Melanoma, Soft Tissue, Muscle-Skeletal and Head-Neck, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Clinical Trials Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Pubmed 31077205
  • Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Medical Oncology and Hematology, St. Luke's University Health Network, Bethlehem, PA, USA. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Hospital of Munich (LMU), Munich, Germany. · Department of Oncology, Highlands Oncology Group, Fayetteville, AR, USA. · Department of Dermatology, University Hospital Essen, Essen, Germany. · Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands. · Department of Medical Oncology, IRCCS San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medicine, Veterans Administration Portland Health Care System and Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA. · Biostatistics, Novartis Healthcare Private Limited, Hyderabad, India. · Department of Translational Oncology, Novartis Institutes for BioMedical Research, Cambridge, MA, USA. · Department of Translational Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Pubmed 30956763
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, 80131, Naples, Italy. · Biodesix Inc, Boulder, CO, USA. · Biodesix Inc, Boulder, CO, USA. · Pubmed 30925943
  • Department of Dermatology, University Hospital Würzburg, Würzburg, Germany. · Department of Dermatology, University Medical Center Tübingen, Liebermeisterstr. 25, 72076, Tübingen, Germany. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Dermatology, University Hospital Hamburg-Eppendorf (UKE), Hamburg, Germany. · Department of Dermatology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. · Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. · Department of Dermatology, Skin Cancer Center, Hannover Medical School, Hannover, Germany. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, West German Cancer Center, University Hospital, University Duisburg-Essen, Essen, Germany. · First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Dermatology, University Hospital of Zürich, Zurich, Switzerland. · Department of Dermatology, University Medical Center Tübingen, Liebermeisterstr. 25, 72076, Tübingen, Germany. · Pubmed 30806748
  • The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Cancer Clinical Trials Unit, Royal Adelaide Hospital, Centre for Cancer Biology, SA Pathology, University of South Australia, Adelaide, Australia; Discipline of Medicine, University of Adelaide, Adelaide, SA 5000, Australia. · Department of Medical Oncology, Hospital Clinic Barcelona, Barcelona, Spain. · Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany. · UOC Oncologia Medica, Istituto di Ricerca e Cura a Carattere Scientifico, San Martino-IST, Genova, Italy. · Department of Medical Oncology, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Dermatovenerologická klinika, University Hospital Prague, Charles University, First Medical Faculty, Prague, Czech Republic. · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. · Afdelingshoofd, Medische Oncologie, Brussels, Belgium. · Department of Dermatology, University Medical Center, Tuebingen, Germany. · Istituto Oncologico Veneto, Padua, Italy. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · University of Athens, Athens, Greece. · Hospital La Paz, Madrid, Spain. · University Medical Centre Groningen, Groningen, the Netherlands. · Christie NHS Foundation Trust, Manchester, UK. · Oslo University Hospital, Oslo, Norway. · Melanoma Institute Australia, Royal North Shore Hospital, University of Sydney, Sydney, Australia. · Department of Dermatooncology, National Institute of Oncology, Budapest, Hungary. · Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland. · McGill University, Segal Cancer Centre, Montreal, Quebec, Canada. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: · Pubmed 30580112
  • Unit of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy. · Unit of Clinical Epidemiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Unit of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy. · Department of Internal Medicine, University of Genoa, Genoa, Italy. · Department of Health Sciences, University of Genoa, Genoa, Italy. · Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy. · iTeos Therapeutics, Gosselies, Belgium. · Department of Medical Oncology and Molecular Genetics Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy. · Sapienza University of Rome, Rome, Italy. · Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy. · Department of Medical Sciences, Section of Surgical Pathology, University of Turin, Turin, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione'G. Pascale', Naples, Italy. · Pubmed 30311027
2018
  • Service de Dermatologie et Cancérologie Cutanée, Aix-Marseille University and APHM University Hospital, Marseille, France. Electronic address: · Department of Dermatology, University Medical Center, Tuebingen, Germany. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy. · The Royal Marsden NHS Foundation Trust, London, UK. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Department of Dermatology and Comprehensive Cancer Centre, University Hospital Essen, Essen, Germany. · Pubmed 30507438
  • From the Istituto Nazionale Tumori "Fondazione G. Pascale," Naples, Italy; Massachusetts General Hospital Cancer Center, Boston, MA; Center for Cancer Research, National Cancer Institute, Bethesda, MD. · Pubmed 30231371
  • Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS Fondazione "G. Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. · Pubmed 30228935
  • Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. Electronic address: · Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. · Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Department of Dermatology, National Institute of Oncology, Budapest, Hungary. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Department of Dermato-oncology, University Hospital Prague and Charles University First Medical Faculty, Prague, Czech Republic. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · Melanoma Cancer Unit, Oncology Institute of Veneto IRCCS, Padua, Italy. · Department of Oncologic Dermatology, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux Cédex, France. · Department of Medical Oncology, Isala, Zwolle, Netherlands. · Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan. · Department of Dermatology, University Medical Center Mainz, Mainz, Germany. · Translational Clinical Oncology, Novartis Pharma AG, Basel, Switzerland. · Array BioPharma, Boulder, CO, USA. · Service of Dermatology, Department of Medicine and Paris-Sud University, Gustave Roussy, Villejuif Cedex, France. · Cancer Center, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 30219628
  • Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. Electronic address: · Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. · Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Department of Dermatology, National Institute of Oncology, Budapest, Hungary. · Department of Dermatology, University Hospital Tüebingen, Tüebingen, Germany. · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Department of Dermato-oncology, University Hospital Prague, Charles University First Medical Faculty, Prague, Czech Republic. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · Melanoma Cancer Unit, Oncology Institute of Veneto IRCCS, Padua, Italy. · Department of Oncologic Dermatology, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux, France. · Department of Medical Oncology, Isala, Zwolle, Netherlands. · Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan. · Department of Dermatology, University Medical Center Mainz, Mainz, Germany. · Translational Clinical Oncology, Novartis Pharma AG, Basel, Switzerland. · Array BioPharma, Boulder, CO, USA. · Service of Dermatology, Department of Medicine, Paris-Sud University, Gustave Roussy, Villejuif, France. · Cancer Center, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 29573941
  • Division of Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. Electronic address: · University of Colorado Comprehensive Cancer Center, Aurora, CO, USA. · N N Blokhin Russian Cancer Research Center, Ministry of Health, Moscow, Russia. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine. · Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Bristol Haematology and Oncology Centre, Bristol, UK. · Department of Cancer Immunology, Poznan University for Medical Sciences, Med-POLONIA, Poznan, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland. · Melanoma Translational Research Group, Melanoma Institute Australia, Wollstonecraft, NSW, Australia. · Genentech, Inc, South San Francisco, CA, USA. · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Pubmed 29477665
  • Department of Dermato Cancerology, Nantes University, Nantes 44093, France. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples 80131, Italy. · Princess Alexandra Hospital, Woolloongabba, QLD 4102, Australia. · National Institute of Oncology, Budapest 1122, Hungary. · Azienda Ospedaliera Universitaria Senese, Siena 53100, Italy. · Department of Oncology and Haematology, Papa Giovanni XXIII Hospital, Bergamo 24127, Italy. · N. N. Blokhin Russian Cancer Research Center, Moscow 115478, Russia. · Moscow City Oncology Hospital 62, Krasnogorsk 14301, Russia. · Service de Dermatologie, Centre Hospitalier Lyon Sud, Pierre-Bénite 69495, France. · Hospital Universitario Virgen Macarena, Seville 41009, Spain. · Hôpital Saint André, Bordeaux 33075, France. · Department of Dermatology, University of Tübingen, Tübingen 72074, Germany. · Genentech, Inc., South San Francisco, CA 94080, USA. · The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. · University of Melbourne, Parkville, VIC 3052, Australia. · Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA 90095, USA. · Pubmed 29438370
  • Genentech, Inc., South San Francisco, CA, USA. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA. · Nantes University, Nantes, France. · Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy. · Peter MacCallum Cancer Centre, East Melbourne, VIC., Australia. · University of Melbourne, Parkville, VIC., Australia. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · The Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 29156488
  • Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00161, Rome, Italy. · Present Address: High Resolution NMR Unit, Core Facilities, Istituto Superiore di Sanità, 00161, Rome, Italy. · Division of Medical Oncology 2, IRCSS Regina Elena National Cancer Institute, 00144, Rome, Italy. · Preclinical Models and New Therapeutics Agents Unit, IRCSS Regina Elena National Cancer Institute, 00144, Rome, Italy. · Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100, Catanzaro, Italy. · Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics research, San Gallicano Dermatologic Institute, IRCSS, 00144, Rome, Italy. · Department of Plastic and Reconstructive Surgery, San Gallicano Dermatologic Institute, IRCSS, 00144, Rome, Italy. · Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia. · Pathology Research laboratory, Sapienza University, Sant'Andrea Hospital, 00189, Rome, Italy. · Cellular Diagnostics Unit, Sapienza University, Sant'Andrea Hospital, 00189, Rome, Italy. · Istituto Cantonale di Patologia, Servizio di Citologia Clinica, 6600, Locarno, Switzerland. · Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", 80131, Naples, Italy. · Scientific Directorate, Istituto Nazionale Tumori IRCSS Regina Elena, 00128, Rome, Italy. · Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00161, Rome, Italy. · Pubmed 30558661
  • Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Cancer Biology, Oregon Health & Science University, Portland, OR, USA. · Department of Pathology, Providence Portland Medical Center, Portland, OR, USA. · Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy. · Melanoma and Sarcoma Surgery Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Unit of Pathology, IRCCS, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, USA. · Pubmed 30524879
  • Melanoma Institute Australia, Sydney, Australia. Electronic address: · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York, USA. · MD Anderson Cancer Center, Houston, USA. · University of Duisburg-Essen Hospital, Heidelberg, Germany. · Peter MacCallum Cancer Centre, Melbourne, Australia. · Crown Princess Mary Cancer Centre, Sydney, Australia; Westmead Hospital, Sydney, Australia. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK; Francis Crick Institute, London, UK. · St Vincents Hospital, Sydney, Australia. · The Canberra Hospital, Canberra, Australia; ANU Medical School, Australian National University, Canberra, Australia. · University Hospital Zurich, Zurich, Switzerland. · Massachusetts General Hospital, Boston, USA. · Sir Charles Gairdner Hospital, Perth, Australia. · Princess Alexandra Hospital, Brisbane, Australia. · Liverpool Hospital, Sydney, Australia; Garvan Institute, Sydney, Australia. · Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy. · University of Tubingen, Tubingen, Germany. · Hannover Medical School, Hannover, Germany. · Vanderbilt Ingram Cancer Center, Nashville, USA. · Melanoma Institute Australia, Sydney, Australia; St Vincents Hospital, Sydney, Australia; University of New South Wales, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia; The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia. · Pubmed 30347289
  • University Hospital Schleswig-Holstein, Kiel, Germany. · The Royal Marsden NHS Foundation Trust, London, England. · The Jonsson Comprehensive Cancer Center at University of California, Los Angeles. · Nantes University, Nantes, France. · Massachusetts General Hospital, Boston. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · University of Colorado Comprehensive Cancer Center, Aurora. · Genentech Inc, South San Francisco, California. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · University of Melbourne, Parkville, Victoria, Australia. · Pubmed 30073321
  • Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Statistical Unit, Regina Elena National Cancer Institute, Rome, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, CNR, I-07100, Sassari, Italy. · Department of Diagnostic Pathology and Laboratory, Istituto Nazionale Tumori- IRCCS -Fondazione G. Pascale, Napoli, Italy. · Melanoma and Skin Cancers Surgery Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Napoli, Italy. · Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 30012216
  • Veneto Institute of Oncology IOVIRCCS, Padua, Italy. Electronic address: · Carol Davila University of Medicine and Pharmacy, Bucharest, Elias University Hospital, Bucharest, Romania. · Malta National Cancer Registry, Malta. · Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Department of Surgery Leiden University Medical Center, Leiden, The Netherlands. · Department of Plastic and Reconstructive Surgery, Tuscan Cancer Institute, Italy. · Cyprus Cancer Registry, Nicosia, Cyprus. · University Hospital Tuebingen, Tuebingen, Germany. · Cancer Registry Republic of Srpska, Banja Luka, Republika Srpska, Bosnia and Herzegovina. · Institute of Oncology, Ljubljana, Slovenia. · Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia. · The Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway. · Netherlands Comprehensive Cancer Organisation, The Netherlands. · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · Registro Tumori del Veneto, Padua, Italy. · Veneto Institute of Oncology IOVIRCCS, Padua, Italy. · Pubmed 30001892
  • Istituto Nazionale Tumori -IRCCS- 'Fondazione G. Pascale', 80131 Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, 07100 Sassari, Italy. · Pubmed 29956724
  • Istituto Nazionale Tumori Fondazione G. Pascale, Naples. · Odense University Hospital, Odense, Denmark. · European Institute of Oncology, Milan, Italy. · Karolinska Institutet, Stockholm, Sweden. · Hospital General Universitario Gregorio Marañon, Madrid, Spain. · Oxford University Hospitals NHS Foundation Trust, Oxford. · Gustave-Roussy and Paris-Sud University, Villejuif. · Lyon 1 University, Lyon Cancer Research Center, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · German Cancer Research Center (DKFZ) and Heidelberg University, Mannheim, Germany. · CHR Verviers East Belgium, Verviers, Belgium. · PRMA Consulting Ltd, Fleet, UK. · Pubmed 29750751
  • Department of Medical Sciences, University of Turin, Turin, Italy. · Italian Institute for Genomic Medicine, Turin, Italy. · Department of Agricultural, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy. · Statistics Unit Methodology for Clinical research Laboratory, Oncology Department, IRCCS, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapies O.U., Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Napoli, Italy. · Laboratory of Molecular Oncology, Istituto Dermopatico dell'Immacolata-IRCCS, Rome, Italy. · Department of Oncology and Dermatological Oncology, Istituto Dermopatico dell'Immacolata-IRCCS, Rome, Italy. · Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Pubmed 29721178
  • Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, NA, Italy. · Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori-Fondazione "G. Pascale", Naples, Italy. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The Angeles Clinic and Research Institute, Cedars Sinai Medical Care Foundation, Los Angeles, CA, USA. · Center for Melanoma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Pubmed 29665799
  • Department of Medical Oncology, IRCCS AOU San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Department of Plastic and Reconstructive Surgery, IRCCS AOU San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Department of Epidemiology, Biostatistics and Clinical Trials, IRCCS AOU San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italy. · Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy. · Pubmed 29552321
  • Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Department of Health Sciences, University of Genova, Genova, Italy. · Unit of Cellular Biology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Intergruppo Melanoma Italiano (IMI) and Department of Internal Medicine, University of Genova, Genova, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy. · Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. · Department of Medical Oncology, Molecular Genetics Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II,"Bari, Italy. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy. · Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy. · Pubmed 29531523
  • Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Surgical, Microsurgical and Medical Sciences, University of Sassari, Sassari, Italy. · Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy. · Istituto Nazionale Tumori, Fondazione Pascale, Napoli, Italy. · Pubmed 29492214
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G Pascale", 80131 Napoli, Italy. Electronic address: · Cancer Institute Gustave Roussy, University Paris-Sud, 98400 Villejuif/Paris-Sud, France. · Pubmed 29361473
  • The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK; CRUK Manchester Institute, Manchester, UK. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Westmead and Blacktown Hospitals, Westmead, Australia. · University Hospital of Zurich, Zurich, Switzerland. · Massachusetts General Hospital, Cancer Center, Boston, MA, USA. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia. · University Hospital Essen, Essen and German Cancer Consortium, Germany. · Schleswig-Holstein University Hospital, Kiel, Germany. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Australia. · Hospital Clínic de Barcelona, Barcelona, Spain. · Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Naples, Italy. · Medical Oncology and Immunotherapy University Hospital of Siena, Siena, Italy. · IRCCS - IRST (Istituto Scientifico Romagnolo per Lo Studio e La Cura Dei Tumori), Meldola, Italy. · The Royal Marsden NHS Foundation Trust, London, UK. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK. Electronic address: · Pubmed 29360604
  • Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, 'G. Pascale Tumor National Institute' - Naples, Naples, Italy. · Department of basic Medical Sciences, Neuroscience and Sense Organs, University of Bari 'Aldo Moro', Bari, Italy. · Pubmed 29308314
  • Perlmutter Cancer Center, NYU-Langone Medical Center New York, New York. · Smilow Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Biodesix Inc, Boulder, Colorado. · Pubmed 29208646
  • Elbe-Klinikum Buxtehude, Buxtehude, Germany. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Hospital Clinic Barcelona, Barcelona, Spain. · Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · University of Melbourne, Parkville, Vic., Australia. · Mapi, Stockholm, Sweden. · MSD SHARP & DOHME GMBH, Haar, Germany. · Merck & Co. Inc., Kenilworth, NJ, USA. · Pubmed 29044660
  • Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Via Mariano Semmola snc, 80131, Naples, NA, Italy. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Medical Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, OR, USA. · Istituto Nazionale Tumori-Fondazione "G. Pascale", Naples, Italy. · Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori-Fondazione "G.Pascale", Naples, Italy. · "Regina Elena" National Cancer Institute, Rome, Italy. · Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · Massachusetts General Hospital, Boston, MA, USA. · Department of Pathology and Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · The University of Chicago Medicine, Chicago, IL, USA. · Refuge Biotechnologies, Menlo Park, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Developmental Therapeutics Program, Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Weill Cornell Medical College, New York, NY, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Immune Oncology Discovery and System Biology, AbbVie, Redwood City, CA, USA. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA. · Pubmed 30031393
  • Department of Medical Oncology, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Tumor Epigenetics, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Tumor Epigenetics, Ospedale Policlinico San Martino, Genova, Italy; Department of Health Sciences, University of Genova, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy; Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. · Department of Medical Oncology and Molecular Genetics Laboratory, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy. · Section of Surgical Pathology, Department of Medical Sciences, University of Turin, Turin, Italy. · Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy. · Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Italy. · Unit of Tumor Epigenetics, Ospedale Policlinico San Martino, Genova, Italy. Electronic address: · Pubmed 29743138
  • New York University Perlmutter Cancer Center, New York, NY · Bristol-Myers Squibb, Princeton, NJ · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy · Pubmed 29446288
  • Aix Marseille University and APHM University-Hospital Marseille France, France. Electronic address: · University of Essen and German Cancer Consortium, Heidelberg, Germany. · University of Manchester, Christie National Foundation Trust Manchester, UK. · Istituto Nazionale Tumori - Fondazione "G. Pascale", Napoli, Italy. · Royal Marsden Hospital, London, UK. · Mount Vernon Cancer Centre, UK. · Gustave Roussy and Paris-Sud University, Paris, France. · Universitätsklinikum Schleswig-Holstein, Kiel, Germany. · Laura and Isaac Perlmutter Cancer Center Professor of Medicine NYU, New-York, USA. · University of California, San Francisco, San Francisco, CA, USA. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · University of Zurich, Zurich, Switzerland. · Karolinska University Hospital Solna, Stockholm Sweden. · Medical University of Vienna, Austria. · The Ella Lemelbaum Institute for Immuno-Oncology Division of Oncology Sheba Medical Center Tel Hashomer, Israel. · Netherlands Cancer Institute, The Netherlands. · University Hospital Tuebingen, Germany. · Pubmed 29224903
2017
  • Melanoma, Cancer Immunotherapy & Innovative Therapy Department at National Cancer Institute of Naples, Naples 80131, Italy. · Pubmed 30190923
  • Paolo A. Ascierto: Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Napoli, Italy. · Pubmed 29340009
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Pubmed 28789707
  • Melanoma, Cancer Immunotherapy and Innovative Therapies Unit - Istituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy. · Pubmed 29296516
  • Department of Medical Oncology, San Gerardo Hospital, via G. B. Pergolesi, 20052 Monza, Italy. · Pathology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", via M. Semmola, 80131 Naples, Italy. · Hematology Unit, Department of Clinical and Surgical Medicine, University of Naples Federico II, via S. Pansini, 80131 Naples, Italy. · Oncology Unit, Department of Medicine, Surgery and Dentistry, University of Salerno, via Allende, 84081 Baronissi (Salerno), Italy. · Pharmacology Unit, Department of Medicine, Surgery and Dentistry, University of Salerno, via Allende, 84081 Baronissi (Salerno), Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", via M. Semmola, 80131 Naples, Italy. · Pubmed 29290886
  • Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: · Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Department of Dermatology, Timone Hospital and Aix-Marseille University, Marseille, France. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia, The University of Sydney, and Royal North Shore Hospital, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia and University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University of Tuebingen, Tuebingen, Germany. · Pubmed 28756137
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28537004
  • Department Melanoma, Soft Tissues, Musculoskeletal and Head & Neck, Italian National Cancer Institute - IRCCS Pascale Foundation, Naples, Italy. Electronic address: · Department of Otorhinolaryngology, University of Brescia, Italy. · Department of Pathology and Cytopathology, Italian National Cancer Institute - IRCCS Pascale Foundation, Naples, Italy. · Department of Radiology, University of Brescia, Italy. · Particle Therapy Cancer Research Institute, CNAO Foundation, Milan, Italy. · Evaluative Epidemiology Unit, Fondazione IRCCS "Istituto Nazionale dei Tumori", Milan, Italy. · First Department of Medicine, Laiko General Hospital, Athens, Greece. · Department Melanoma, Soft Tissues, Musculoskeletal and Head & Neck, Italian National Cancer Institute - IRCCS Pascale Foundation, Naples, Italy. · Pubmed 28325255
  • Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Napoli, Italia. · CROM, Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Napoli, Italia. · Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Catanzaro "Magna Graecia", Catanzaro, Italia. · Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. · Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Roma, Italia. · IRCCS Istituto Nazionale Tumori "Regina Elena", Roma, Italy. · Pubmed 28118616
  • Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28058658
  • The Angeles Clinic and Research Institute, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · Ella Lemelbaum Institute of Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · University of California, San Francisco, San Francisco, CA, USA. · University Hospital Essen, Essen, Germany. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of Arizona Cancer Center, Tucson, AZ, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · City of Hope, Duarte, CA, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 28961465
  • The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, The Netherlands. Electronic address: · The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Department of Medical Oncology, Hospital Clínic Barcelona, Barcelona, Spain. Electronic address: · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. Electronic address: · IRCCS San Martino-IST, Genova, Italy. Electronic address: · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · General University Hospital, Dermatooncology U, Prague, Czech Republic. Electronic address: · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. Electronic address: · Afdelingshoofd, Medische Oncologie, Brussels, Belgium. Electronic address: · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. Electronic address: · Oncology Institute of Veneto-IRCCS, Padova, Italy. Electronic address: · Papa Giovanni XIII Hospital, Bergamo, Italy. Electronic address: · University of Athens, Athens, Greece. Electronic address: · Hospital La Paz, Madrid, Spain. Electronic address: · University Medical Centre Groningen, Groningen, The Netherlands. Electronic address: · McGill University, Segal Cancer Centre, Montreal, Quebec, Canada. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia; Discipline of Medicine, University of Adelaide, Adelaide, Australia. Electronic address: · Pubmed 28501764
  • Department of Dermato Cancerology, Nantes University, Nantes, France. · Department of Medicine, Hematology/Oncology, Jonsson Comprehensive Cancer Center, The University of California, Los Angeles, Los Angeles, USA. · Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, Centre Hospitalier Lyon Sud, Lyon 1 University, Lyons Cancer Research Center, France. · Dermatology and Cutaneous Oncology, Aix-Marseille University Hôpital de la Timone AP-HM, Marseille, France. · Department of Clinical Development, Genentech Inc., South San Francisco, USA. · Product Development Oncology, Genentech Inc., South San Francisco, USA. · Biostatistics, Genentech Inc., South San Francisco, USA. · Medical Affairs, Genentech, Inc., South San Francisco, USA. · Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28444112
  • Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · Medical Oncology, National Cancer Institute, Milan, Italy. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan Medical University, Poznan, Poland. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain. · AP-HP Dermatology CIC Departments, Saint-Louis Hospital, INSERM U976, Université Paris Diderot, Paris, France. · Odense University Hospital, Odense, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland. · Chris O'Brien Lifehouse and Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Eberhard Karls University, Tübingen, Germany. · University Medical Center, Mainz, Germany. · Department of Oncodermatology, INSERM Research Unit 892, Nantes University Hospital, Nantes, France. · Department of Dermatology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Hospital de la Timone, Marseille, France. · National Institute of Oncology, Budapest, Hungary. · Oslo University Hospital, Oslo, Norway. · Medizinische Hochschule Hannover, Hannover, Germany. · Wojewodzkie Centrum Oncologii, Gdańsk, Poland. · Department of Dermatology, Reims University Hospital, Reims, France. · Medical University of Vienna, Vienna, Austria. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · University Hospital Essen, Essen, Germany. · Hôspital Claude Huriez, Lille, France. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Bristol-Myers Squibb, Princeton, NJ, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 28359784
  • Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. Electronic address: · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione Pascale, Via Mariano Semmola, Naples, Italy. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Department of Oncologic Dermatology, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux, France. · Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Bracci, Siena, Italy. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian, Milan, Italy. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Department of Dermatology, Centre Hospitalier Lyon Sud, Lyons Cancer Research Center, Lyon 1 University, Pierre Bénite, France. · N N Blokhin Russian Cancer Research Center, Ministry of Health, Moscow, Russian Federation. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Medicine, University Health Network/Princess Margaret Hospital, Toronto, ON, Canada. · Department of Dermatology, National Institute of Oncology, Budapest, Hungary. · Department of Medical Oncology, Institute for Cancer Research, IRCCS San Martino, Largo Rosanna Benzi, Genova, Italy. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, USA. · Novartis Pharma AG, Basel, Switzerland. · Array BioPharma, Boulder, CO, USA. · Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. · Department of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 28284557
  • EORTC Headquarters, Brussels, Belgium. Electronic address: · EORTC Headquarters, Brussels, Belgium. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hôpital de la Timone, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Oncology Specialists S C, Park Ridge, IL, USA. · Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Paris. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 28162999
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Clinica Universidad de Navarra, Pamplona, Spain. · The Angeles Clinic and Research Institute, Los Angeles, California. · Aarhus University Hospital, Aarhus, Denmark. · Gustave Roussy and Paris-Sud University Villejuif, Villejuif, France. · Istituto Oncologico Veneto, Padua, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy. · University Hospital of Siena, Siena, Italy. · Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania. · Bristol-Myers Squibb, Princeton, New Jersey. · Stanford University School of Medicine, Stanford, California. · Yale Comprehensive Cancer Center, New Haven, Connecticut. · Stanford University School of Medicine, Stanford, California. · Pubmed 27756788
  • IRCCS Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy. · University of Campania "Luigi Vanvitelli", Naples, Italy. · Peptipharma, Viale Città D'Europa 679, 00144, Rome, Italy. · Institute of Genetics and Biophysics, National Research Council, Naples, Italy. · IRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy. · IRCCS Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy. · University 'Parthenope', Via Acton 38, 80133, Naples, Italy. · Pubmed 29216889
  • Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084, Fisciano, SA, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapies O.U, National Cancer Institute "G. Pascale", Naples, Italy. · Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084, Fisciano, SA, Italy. · PhD Program in Drug Discovery and Development, University of Salerno, Fisciano, SA, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Pubmed 29202855
  • Institute of Genetics and Biophysics (IGB), A. Buzzati-Traverso, CNR, I-80131 Naples, Italy. · Istituto Nazionale Tumori Fondazione G. Pascale, I-80131 Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, CNR, I-07100 Sassari, Italy. · Unit of Pathology, Hospital-University Health Unit (AOU), I-07100 Sassari, Italy. · Department of Biomedical and Biotechnological Sciences-BIOMETEC, University of Catania, I-95100 Catania, Italy. · Pubmed 29048639
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Institut Gustave Roussy and Paris Sud University, Paris, France. · Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medicine, Hematology and Oncology, Jonsson Comprehensive Cancer Center at the University of California Los Angeles, Los Angeles, USA. · Division of Medical Oncology and Hematology, Princess Margaret Hospital and University Health Network, Toronto, Canada. · The Angeles Clinic and Research Institute, Melanoma Therapeutics, Los Angeles, USA. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples. · Melanoma and Sarcoma, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Oncology, University of Manchester, Manchester, UK. · Department of Dermatology, University of Zurich, Zurich, Switzerland. · Department of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Biostatistics in Product Development, Biometrics. · Clinical Department. · Product Development, Oncology, Genentech Inc., South San Francisco, USA. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne. · Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 28961848
  • Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Aix-Marseille University, Hôpital de la Timone, Marseille, France. · Ospedale Monaldi, Naples, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK. · Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Genentech, Inc., South San Francisco, CA, USA. · Nantes University, Nantes, France. · Pubmed 28646893
  • Genentech, Inc., South San Francisco, California. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, and University of Melbourne, Parkville, Victoria, Australia. · Nantes University, Nantes, France. · The Royal Marsden NHS Foundation Trust, London, United Kingdom. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · HistoGeneX, Antwerp, Belgium. · Genentech, Inc., South San Francisco, California. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, California. · Pubmed 28536307
  • Peter MacCallum Cancer Centre, East Melbourne, Australia. · Elbe-Klinikum Buxtehude, Buxtehude, Germany. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Hospital Clinic Barcelona, Barcelona, Spain. · Mapi, Stockholm, Sweden. · MSD Sharp & Dohme GmbH, Haar, Germany. · Universitäts-Hautklinik Kiel, Kiel, Germany. · Merck & Co., Inc., Kenilworth, New Jersey, USA. · Merck & Co., Inc., Kenilworth, New Jersey, USA · Pubmed 28526721
  • Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Department of Health Sciences, University of Genova, Genova, Italy. · Unit of Cellular Biology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Intergruppo Melanoma Italiano (IMI) and Department of Internal Medicine, University of Genova, Genova, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. · Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. · Department of Medical Oncology and Molecular Genetics Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy. · Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy. · Pubmed 28446908
  • Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Pansini, 5, 80131, Naples, Italy. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · CEINGE Biotecnologie Avanzate, Naples, Italy. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Pansini, 5, 80131, Naples, Italy. · Pubmed 28434031
  • Melanoma, Cancer Immunotherapy and Innovative Therapies O.U., Istituto Nazionale Tumori Fondazione "G. Pascale" , Napoli, Italy. · Regina Elena National Cancer Institute , Rome, Italy. · Unit of Melanoma and Sarcoma Surgery, Istituto Nazionale Tumori Fondazione , Napoli, Italy. · Pubmed 28405510
  • Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Campus - Germaneto , Catanzaro, Italy. · Department of Microbiology, Cell and Tumorbiology (MTC), Karolinska Institutet , Stockholm, Sweden. · Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Campus - Germaneto, Catanzaro, Italy; Department of Microbiology, Cell and Tumorbiology (MTC), Karolinska Institutet, Stockholm, Sweden. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale ," Napoli, Italy. · Department of Oncology and Pathology, Karolinska Institutet , Stockholm, Sweden. · Karolinska Institutet Statistical Core Facility, Karolinska Institutet , Stockholm, Sweden. · Department of Health Sciences, University "Magna Græcia" of Catanzaro, Campus - Germaneto , Catanzaro, Italy. · Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Experimental Oncology and Molecular Medicine , Milan, Italy. · Department of Obstetrics and Gynecology, University of Cambridge Clinical School , Cambridge, UK. · Scientific Directorate, IRCCS Istituto Nazionale Tumori Fondazione "G. Pascale ," Napoli, Italy. · Pubmed 28344869
  • Dipartimento di Patologia Diagnostica e di Laboratorio: SC di Anatomia Patologica e Citopatologia, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Struttura Complessa di Oncologia Medica e Terapie Innovative, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Genomica Funzionale, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Pharmacy, University of Naples "Federico II", 80131, Naples, Italy. · Melanoma and Sarcoma Surgery Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, 07100, Sassari, Italy. · Department of Medicine and Surgery, University of Salerno, Baronissi, 84081, Salerno, Italy. · Department of Medicine and Surgery, University of Salerno, Baronissi, 84081, Salerno, Italy. · Dipartimento di Patologia Diagnostica e di Laboratorio: SC di Anatomia Patologica e Citopatologia, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28231855
  • Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. Electronic address: · Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Oncology, Immunotherapy Unit, INSERM U932, Institut Curie, Paris, France. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany; School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London, UK. · Pubmed 28167454
  • Pathology Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italy. · Department of Psychiatry, Pathology Unit, University of Naples SUN, Naples, Italy. · Pubmed 28067428
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy. · Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Oncology & Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS "Regina Elena" National Cancer Institute, Rome, Italy. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York City, NY, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · INSERM (National Institute of Health and Medical Research), Institut Gustave Roussy, Villejuif, France. · Massachusetts General Hospital, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York City, NY, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA. · Georgia Cancer Center, Augusta University, Augusta, GA, USA. · Department of Hematology/Oncology, University of Chicago Comprehensive Cancer Center, Chicago, IL, USA. · CNRS (National Center for Scientific Research, France), University Paris-Saclay, Gustave Roussy, Villejuif, France. · Division of Cancer Medicine, Department of Melanoma Medical Oncology-Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. · Pediatrics, Human Oncology and Genetics, University of Wisconsin, Madison, WI, USA. · UW Carbone Cancer Center, Madison, WI, USA. · Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Center for Cancer Immune Therapy (CCIT), Department of Hematology, University Hospital Herlev, Herlev, Denmark. · Department of Immunology and Microbiology, University of Copenhagen, Herlev, Denmark. · Clinical Center, National Institutes of Health, Bethesda, MD, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medicine, Immunology and Dermatology Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA. · Pubmed 29145885
  • INSERM (National Institute of Health and Medical Research), Paris, France. · Institute of Pathology, University of Bern, Bern, Switzerland. · Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, OR, USA. · Laboratory of Immunology, Hopital Européen Georges Pompidou, Paris, France. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · AbbVie Medical Corporation, Redwood City, CA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 29058595
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Medical Oncology Unit, G. Rummo Hospital, Benevento, Italy. · UT Southwestern, Medical Center, Dallas, TX, USA. · McGill Department of Oncology, McGill University, Montreal, Canada. · Medical Oncology, Yale School of Medicine, New Haven, CT, USA. · Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Section of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA. · Department of Urology and Gynecology, Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy. · Pubmed 29020960
  • Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital. · Departments of Allogeneic Stem Cell Transplantation and Hematology, Karolinska University Hospital. · Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. · Melanoma Unit, Royal Marsden NHS Foundation Trust, London. · Royal Marsden Hospital, London, UK. · Westmead Hospital, Melanoma Institute Australia and Macquarie University, Sydney, Australia. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Naples, Italy. · Pubmed 28407116
2016
  • Department of Dermatology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. · Department of Oncology, Lausanne University Hospital, Champ de l'Air, Rue du Bugnon 21, 1011, Lausanne, Switzerland. · Ludwig Centre and Swiss Institute of Bioinformatics, Génopode Building, 1015, Lausanne, Switzerland. · Istituto Nazionale Tumori, Fondazione 'G. Pascale', Via Mariano Semmola, 52, 80131, Naples, Italy. · Clinical Development, Amgen Europe GmbH, Dammstrasse 23, 6300, Zug, Switzerland. · Division of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands. · Pubmed 27372293
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia. · Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131 Napoli, Italy. Electronic address: · Pubmed 26765776
  • Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. Electronic address: · 28355 Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Dermatology Department, Timone Hospital and Aix-Marseille University, Marseille, France. · University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University Tuebingen, 72074 Tuebingen, Germany. · Pubmed 26707829
  • a Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy , Istituto Nazionale Tumori Fondazione G. Pascale , Napoli , Italy. · b Sidra Medical and Research Centre , Doha , Qatar. · Pubmed 26642234
  • Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 27604993
  • Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. Electronic address: · Nantes University, Nantes, France. · Princess Alexandra Hospital, Woolloongabba, QLD, Australia. · National Institute of Oncology, Budapest, Hungary. · Azienda Ospedaliera Universitaria Senese, Siena, Italy. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · N N Blokhin Russian Cancer Research Center, Moscow, Russia. · Moscow City Oncology Hospital 62, Krasnogorsk, Russia. · Centre Hospitalier Lyon Sud, Lyon 1 University, Lyon, France; Lyons Cancer Research Center, Lyon, France. · Hospital Universitario Virgen Macarena, Seville, Spain. · Hôpital Saint André, Bordeaux, France. · University of Tübingen, Tübingen, Germany. · Genentech Inc, South San Francisco, CA, USA. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, Los Angeles, CA, USA. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 27480103
  • Melanoma Institute Australia, The University of Sydney, and Mater Hospital, Sydney, Australia · Gallipoli Medical Research Foundation and Princess Alexandra Hospital, Greenslopes, Australia. · Istituto Nazionale Tumori Fondazione Pascale, Napoli, Italy. · Gustave-Roussy, Paris, France. · University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany. · Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · BC Cancer Agency, University of British Columbia, Vancouver, Canada. · Adelphi Values, Boston, MA, USA. · Bristol-Myers Squibb, Princeton, NJ, USA. · Duke Clinical Research Institute, Durham, NC, USA. · Pubmed 27405322
  • Skin Cancer Center Hannover , Hannover Medical School , Hannover , Germany. · Unit of Immunotherapy of Human Tumors , Fondazione RCCS Istituto Nazionale dei Tumori , Milan , Italy. · Petrov Research Institute of Oncology , St. Petersburg , Russia. · Istituto Europeo Di Oncologia , Milano , Italy. · Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit , Istituto Nazionale Tumori Fondazione Pascale , Naples , Italy. · Cancer Research Center , Moscow , Russia. · Aix Marseille University Hôpital de la Timone, Service de Dermatologie , Marseille , France. · Immunotherapy Unit , Romagna Cancer Institute IRST- IRCCS , Meldola , Italy. · Department of Dermatology , University Hospital Essen , Essen , Germany. · Istituto Nazionale per la Ricerca sul Cancro Oncologia Medica , Genova , Italy. · Humanitas Cancer Center, Istituto Clinico Humanitas IRCCS , Rozzano , Italy. · Department of Dermatology , University of Mainz , Mainz , Germany. · Dermatology Clinic , Hôpital Hôtel-Dieu, CHU Nantes , Nantes , France. · Department of Dermatology , Skin Cancer Center, Schleswig-Holstein University Hospital , Kiel , Germany. · Department of Dermatology , Paracelsus Medical University, Klinikum Nuremberg , Nuremberg , Germany. · Département d'Oncologie Médicale , Centre Eugène Marquis , Rennes , France. · GSK Vaccines , Rixensart , Belgium. · GSK Vaccines, Rixensart, Belgium; Celyad, Mont-Saint-Guibert, Rixensart, Belgium. · GSK Vaccines, Rixensart, Belgium; Vianova-Biosciences, Lasne, Belgium. · Pubmed 27843625
  • Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione 'G. Pascale', Via Mariano Semmola, 80131 Napoli, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 27711085
  • Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Naples 80131, Italy; · Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Rome 00161, Italy; · Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210; · Department of Genetics, Genomic Sciences Icahn School of Medicine at Mount Sinai, New York, NY 10029; · Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Catanzaro "Magna Graecia", Catanzaro 88100, Italy; · Istituto Cantonale di Patologia, Servizio di Citologia Clinica, 6600 Locarno, Switzerland. · Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210; · Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Naples 80131, Italy; · Pubmed 27503895
  • Cancer Biology and Epigenomics Program, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. · Cancer Biology and Epigenomics Program, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA. · Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. · Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, 80131 Napoli, Italy. · Department of Pathology, Istituto Nazionale Tumori Fondazione Pascale, 80131 Napoli, Italy. · Cancer Biology and Epigenomics Program, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. · Pubmed 27446436
  • Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy. Electronic address: · European Institute of Oncology (IEO), Milano, Italy. · Department of Dermatology and Plastic Surgery, University of Rome ''La Sapienza'', Roma, Italy. · Department of Biomedical Sciences and Human Oncology, University of Torino, Torino, Italy. · Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy. · Department of Surgery and Advanced Cancer Therapies, Morgagni-Pierantoni Hospital, Forlì, Italy. · Plastic Surgery Unit, Tuscan Tumor Institute (ITT), Santa Maria Annunziata Hospital, Firenze, Italy. · National Cancer Institute, Fondazione Pascale, Naples, Italy. · Medical Oncology Unit, Giovanni Paolo II Cancer Institute, Bari, Italy. · Plastic Surgery Unit, San Gallicano Dermatology Institute, Roma, Italy. · Clinical Trials and Biostatistics Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy. · Pubmed 27424789
  • Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. Electronic address: · Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Department of Oncology, Immunotherapy Unit, INSERM U932, Institut Curie, Paris, France. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Research Group on Geriatrics, Charité - Universitaetsmedizin, Berlin, Germany; Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, Germany. · Research Group on Geriatrics, Charité - Universitaetsmedizin, Berlin, Germany. · Singapore Immunology Network, Agency for Science, Technology and Research, Singapore. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany; School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London, UK. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Pubmed 27400322
  • Melanoma, Cancer Immunotherapy, and Innovative Therapy, Istituto nazionale Tumori Fondazione "G Pascale", Napoli, 80131, Italy. Electronic address: · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospital, Sydney, Australia. · Pubmed 27324281
  • Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Department of Immunology, University of Tübingen, Tübingen, Germany. · Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Dermatology, University Hospital of Munich, Munich, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Dermatology, University of Zürich, Zürich, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy. · Department of Dermatology and Venereology, University Hospital of Cologne, Cologne, Germany. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Hospital Erlangen, Erlangen, Germany. · Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover, Germany. · Department of Dermatology and Allergology, University Hospital of Marburg, Marburg, Germany. · Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Dermatology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. · Department of Oncology, Service of Medical Oncology, Institut Curie, Paris, France. · Department of Dermatology, University Medical Center Dresden, Dresden, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27185375
  • Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, United Kingdom. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Pubmed 27169993
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan I-20146, Italy. · Department of Epidemiology, National Cancer Institute 'G. Pascale' Foundation, Naples I-80131, Italy. · Unit of Medical Oncology and Innovative Therapies, National Cancer Institute 'G. Pascale' Foundation, Naples I-80131, Italy. · Department of Surgical Oncological and Gastroenterological Sciences, Padua University, Padua I-35122, Italy; Melanoma and Sarcoma Unit, Veneto Oncological Institute for Research and Treatment, Padua I-35128, Italy. · Melanoma and Sarcoma Unit, Veneto Oncological Institute for Research and Treatment, Padua I-35128, Italy. · Department of Dermatology, Society of Clinical Oncology Santa Maria Degli Angeli Oncological Hospital, Pordenone I-33170, Italy. · Department of Dermatology, Tuscan Orthopaedic Institute Hospital 'Palagi', University of Florence, Florence I-50125, Italy. · Department of Medical Oncology, Company University Hospital San Martino, National Institute for Cancer Research, Genova I-16132, Italy. · Plastic Surgery Unit, St. Orsola-Malpighi Hospital, Bologna I-40138, Italy. · Department of Plastic and Reconstructive Surgery, University of Bari, Bari I-70121, Italy. · Dermatalogical Clinic, Institute for Research and Treatment San Matteo Hospital, Pavia I-27100, Italy. · Oncological Unit, Vito Fazzi Hospital, Lecce I-73100, Italy. · Dermatological Institute, Catholic University of America, Rome I-00153, Italy. · Melanoma Unit, European Institute of Oncology, Milan I-20146, Italy. · Dermatalogical Clinic, Maggiore Hospital, Trieste I-34125, Italy. · Department of Plastic and Reconstructive Surgery, Company University Hospital San Martino, National Institute for Cancer Research, Genova I-16132, Italy. · Pubmed 27073541
  • Istituto Nazionale Tumori Fondazione "G. Pascale" , Naples , Italy. · Pubmed 27047798
  • Oncology of Melanoma Unit, European Institute of Oncology, Milan. · Medical Oncology and Immunotherapy, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples. · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan. · Istituto Toscano Tumori, University Hospital of Siena, Siena. · IV Oncology Division, Istituto Dermopatico dell'Immacolata IRCCS, Rome. · Immunotherapy and Somatic Cell Therapy Unit, Scientific Institute of Romagna, Meldola. · Department of Medical Oncology, National Institute for Cancer Research, IRCCS San Martino, Genoa. · Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Statistical Unit, Regina Elena National Cancer Institute, Rome, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan · Pubmed 26802161
  • Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Memorial Sloan Kettering Cancer Center, New York, New York. · Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. · Department of Oncology, Service of Medical Oncology, Research Unit 932, Institut Curie, Paris, France. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Immunology, University of Tübingen, Tübingen, Germany. · Pubmed 26787752
  • Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy; Genetics of Rare Cancers, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy; Genetics of Rare Cancers, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. Electronic address: · Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy. · Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy; Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, Istituto Oncologico Veneto (IOV)-IRCCS, Padua, Italy. · Section of Oncology and Immunology, Department of Surgery, Oncology, and Gastroenterology, University of Padua, Padua, Italy. · Melanoma and Soft Tissue Sarcoma Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy. · Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Melanoma and Sarcoma Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Medical Genetics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Department of Dermatology, University of Florence, Florence, Italy. · Unit of Medical Genetics, Department of Biomedical Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Plastic Surgery Unit, Regional Melanoma Referral Center, Santa Maria Annunziata Hospital, Florence, Italy. · Division of Dermatoncological Surgery, European Institute of Oncology, Milan, Italy. · Medical Oncology Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Dermatology Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Department of Medical Sciences, Dermatology Section, University of Turin, Turin, Italy. · Dermatoncological Surgery Unit, Presidio Sanitario Gradenigo, Turin, Italy. · Anatomopathology Unit, Università dell'Insubria, Ospedale di Circolo, Varese, Italy. · Dermatology Unit, Ospedale di Circolo, Varese, Italy. · Cancer Genetics Unit, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Melanoma, National Cancer Institute Pascale Foundation, Naples, Italy. · Dermatology Unit, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Plastic and Reconstructive Surgery, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliera Universitaria (AOU) San Martino-Istituto Nazionale dei Tumori (IST) Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Pubmed 26775776
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
  • Laboratory of Integrative Cancer Immunology, INSERM UMRS1138 Cordeliers Research Center, University Pierre et Marie Curie, Paris 6, 15 Rue de l'Ecole de Medecine, 75006, Paris, France. · University Paris Descartes, 45 Rue Saints Pères, 75006, Paris, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, 97213, USA. · Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, 97239, USA. · Department of Pathology, Providence Portland Medical Center, Portland, OR, 97213, USA. · Department of Oncology-Pathology, The Karolinska Hospital, Stockholm, Sweden. · Institute of Pathology, University of Bern, Bern, Switzerland. · Unit of Pathology, IRCCS, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Sidra Medical and Research Center, Doha, Qatar. · IRCCS, Istituto Nazionale Tumori, Fondazione "G. Pascale",Scentific Directorate, Naples, Italy. · Laboratory of Integrative Cancer Immunology, INSERM UMRS1138, Cordeliers Research Center, 15 Rue de l'Ecole de Medecine, 75006, Paris, France. · Centre de Recherche des Cordeliers, University Pierre et Marie Curie, Paris 6, 15 Rue de l'Ecole de Medecine, 75006, Paris, France. · Immunomonitoring Platform, Laboratory of Immunology, Georges Pompidou European Hospital, 20-40 Rue Leblanc, 75015, Paris, France. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Pubmed 27650038
  • Istituto di Chimica Biomolecolare, CNR, Sassari, Italy. · Istituto Nazionale Tumori, Napoli, Italy. · Dipartimento di Chirurgia, Microchirurgia e Scienze Mediche, Università di Sassari, Sassari, Italy. · Istituto di Chimica Biomolecolare, CNR, Sassari, Italy. Electronic address: · Pubmed 27265006
2015
  • Institute of Biomolecular Chemistry, National Research Council (CNR), Sassari, Italy. · Department of Pathology, Hospital-University Health Unit (AOU), Sassari, Italy. · Skin Cancer Unit, Istituto Scientifico Romagnolo Tumori (IRST), Meldola, Italy. · Istituto Nazionale Tumori (INT), Fondazione G. Pascale, Naples, Italy. · Pubmed 30190844
  • Melanoma, Cancer Immunotherapy & Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italy. · Pubmed 30190830
  • Unità di Genetica dei Tumori, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche , Sassari , Italy. · Istituto di Scienze dell'Alimentazione, Consiglio Nazionale delle Ricerche , Avellino , Italy. · Dipartimento di Scienze Chirurgiche, Microchirurgiche e Mediche, Università di Sassari , Sassari , Italy. · Istituto Nazionale Tumori "Fondazione Pascale" , Naples , Italy. · Pubmed 26322273
  • Department of Oncology, Johns Hopkins University , Baltimore, MD , USA. · Department of Oncology, Centro de Investigación Médica Aplicada (CIMA), Clinica Universidad de Navarra , Pamplona , Spain. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale" , Napoli , Italy. · Pubmed 26217587
  • Istituto Nazionale Tumori, Fondazione "G. Pascale", Napoli, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Pubmed 26137543
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Oncology Division, Department of Clinical Medicine, University "Federico II" of Naples, Italy. Electronic address: · Oncology Division, Department of Clinical Medicine, University "Federico II" of Naples, Italy. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Pubmed 25511547
  • University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · University Hospital Essen, Essen, Germany. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sheba Medical Center, Tel Hashomer, Israel. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. · University Medical Center, Mainz, Germany. · Universitätsklinikum Tübingen, Tübingen, Germany. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. · St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. · University of North Carolina, Chapel Hill, NC, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Merck & Co, Kenilworth, NJ, USA. · University of California, San Francisco, San Francisco, CA, USA. · Pubmed 26115796
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Aix-Marseille University, Hôpital de La Timone APHM, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Oncology Specialists SC, Park Ridge, IL, USA. · Assistance Publique Hôpitaux de Paris, Dermatology and CIC Departments, Hôpital Saint Louis, University Paris 7, INSERM U976, France. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, Alberta, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · EORTC Headquarters, Brussels, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 25840693
  • Moffitt Cancer Center, Tampa, FL, USA. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · California Pacific Center for Melanoma Research, San Francisco, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Medizinische Hochschule Hannover, Hannover, Germany. · Universitair Ziekenhuis Brussel, Brussels, Belgium. · Medical University of Vienna, Vienna, Austria. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada. · University of Michigan, Ann Arbor, MI, USA. · Washington University, St Louis, MO, USA. · Centre Hospitalier Universitaire de Lyon, Lyon, France. · Christie Hospital, Manchester, UK. · Huntsman Cancer Institute, Salt Lake City, UT, USA. · German Cancer Research Centre University Hospital, Heidelberg, Germany. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Yale Cancer Center, New Haven, CT, USA. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Elbe Kliniken Buxtehude, Buxtehude, Germany. · Department of Medicine, University of California, Los Angeles, CA, USA. · Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA. · Department of Oncology, Herlev Hospital, Copenhagen, Denmark. · Aix-Marseille University, Hopital de la Timone, Marseille, France. · Technische Universität München School of Medicine, II Medical Department, Munich, Germany. · Bristol-Myers Squibb, Princeton, NJ, USA. · Bristol-Myers Squibb, Braine-I'Alleud, Belgium. · Royal Marsden Hospital, London, UK. · Pubmed 25795410
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena. · Medical Oncology and Innovative Therapies, Fondazione 'G. Pascale', National Cancer Institute, Naples. · Medical Oncology 2, IRCCS, AOU San Martino, Genoa. · Melanoma Unit, San Raffaele Scientific Institute, Milan. · Immunotherapy and Somatic Cell Therapy Unit, Scientific Institute of Romagna, Meldola. · Melanoma and Sarcoma Unit, National Institute for Cancer Research, Milan. · Dermatoncological Division, Istituto Europeo di Oncologia, Milan. · Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan. · Statistical Unit, Regina Elena National Cancer Institute, Rome. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena · Pubmed 25538176
  • Melanoma Department, Istituto Nazionale Tumori 'Fondazione Pascale' Napoli, Italy. · Division of Pathology, Istituto Nazionale Tumori 'Fondazione Pascale' Napoli, Italy. · Division of Anesthesiology, Istituto Nazionale Tumori 'Fondazione Pascale' Napoli, Italy. · Pubmed 30190842
  • Christie NHS Foundation Trust, Manchester, UK. · Istituto Nazionale Tumori, Fondazione G Pascale, Napoli, Italy. · Karolinska Institutet, Stockholm, Sweden. · Clinica Universitaria de Navarra, Pamplona, Spain. · Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Institute of Cancer Sciences, Manchester M20 4BX, UK. Electronic address: · Pubmed 26433815
  • Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Naples, Italy. · Dipartimento di Chirurgia "P. Valdoni", Sapienza Università di Roma, Rome, Italy. · Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Catanzaro "Magna Graecia", Catanzaro, Italy. · Takis S.r.l., Rome, Italy. · Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Rome, Italy. · Istituto Pasteur Fondazione Cenci Bolognetti, Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Rome, Italy. · Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Azienda Ospedaliera S. Andrea, Rome, Italy. · Pubmed 26208478
  • Melanoma and Sarcoma Surgery Unit; Istituto Nazionale Tumori Fondazione "G. Pascale" ; Naples, Italy. · Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione "G. Pascale" ; Naples, Italy. · Statistical Unit; Regina Elena National Cancer Institute ; Rome, Italy. · Scientific Direction; Istituto Nazionale Tumori Fondazione "G. Pascale" ; Naples, Italy. · Pubmed 26155423
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Oncology and Medicine, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, 3970 Reservoir Rd NW, Washington, DC, 20057, USA. · Pubmed 26141621
  • Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Naples, Italy. · Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy. · Melanoma Unit, National Cancer Institute 'G. Pascale Foundation', Naples, Italy. · Dermatology Section, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy. · Department of Biological Science, University of Portsmouth, Portsmouth, UK. · Pubmed 25895097
  • European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy. · Istituto Oncologico Veneto, Padova, Italy. · Istituto Nazionale dei Tumori di Napoli, Italy. · Federazione Italiana delle Associazioni di Volontariato in Oncologia, Italy. · Pubmed 25729424
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori - Fondazione 'G. Pascale', Via Mariano Semmola, 80131, Naples, Italy, · Pubmed 25549844
  • Institute of Genetics and Biophysics -I.G.B. A. Buzzati-Traverso- CNR, Naples I-80131, Italy; Dipartimento di Scienze Biomediche, Università degli Studi di Catania, Catania I-95124, Italy. Electronic address: · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine (DTM), Clinical Center (CC), Center for Human Immunology (CHI), National Institutes of Health (NIH), Bethesda, MD, United States; Sidra Medical and Research Center, Doha, Qatar. · Institute of Genetics and Biophysics -I.G.B. A. Buzzati-Traverso- CNR, Naples I-80131, Italy. · Institute of Genetics and Biophysics -I.G.B. A. Buzzati-Traverso- CNR, Naples I-80131, Italy; Institute of Biosciences and BioResources-IBB, CNR, Naples I-8013, Italy. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine (DTM), Clinical Center (CC), Center for Human Immunology (CHI), National Institutes of Health (NIH), Bethesda, MD, United States. · Dipartimento di Scienze Biomediche, Università degli Studi di Catania, Catania I-95124, Italy. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples I-80131, Italy. · Pubmed 25444926
  • Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Department of Genetic Medicine, Weill Cornell Medical College in Qatar, PO Box 24144, Doha, Qatar; Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar. Electronic address: · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Department of Biochemistry, Biocenter, University of Wuerzburg, Wuerzburg 97074, Germany; Genelux Corporation, San Diego Science Center, San Diego 92109, USA. · Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Center of Excellence for Biomedical Research (CEBR), University of Genoa, Italy. · Department of Biology, Northern Michigan University, Marquette, MI, USA. · Department of Genetic Medicine, Weill Cornell Medical College in Qatar, PO Box 24144, Doha, Qatar. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Institute of Infectious and Tropical Diseases, University of Milan, L. Sacco Hospital, Milan, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale", Via G. Semmola, Naples, Italy. · Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Pubmed 25174651
  • Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Translational Molecular Pathology, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Departments of Pathology and Laboratory Medicine and Surgery, David Geffen School of Medicine at University of California Los Angeles (UCLA), John Wayne Cancer Institute, Santa Monica, CA, USA. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · University of Manchester/Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre and University of Melbourne, Victoria, Australia. · Department of Oncology-Pathology, The Karolinska Hospital, Stockholm, Sweden. · Centro de Investigación Médica Aplicada, and Clinica Universidad de Navarra, Pamplona, Navarra, Spain. · Department of Dermatology, Harvard Medical School, Boston, MA, USA. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Division of Molecular Oncology, Unit of Bio-Immunotherapy of Solid Tumors, San Raffaele Institute, Milan, Italy. · Vanderbilt University Medical Center, Nashville, TN, USA. · Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Essen, Germany. · Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Centre, Doha, Qatar. · INSERM, UMRS1138, Laboratory of Integrative Cancer Immunology, Université Paris Descartes, Sorbonne Paris Cité, Centre de Recherche des Cordeliers, Paris, France. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 26619946
2014
  • Department of Melanoma and Soft Tissue, Istituto Nazionale Tumori Fondazione "G, Pascale", Via Mariano Semmola, 80131 Naples, Italy. · Pubmed 25015684
  • Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Pubmed 24577788
  • From Royal Marsden Hospital, London (J.L.) · Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Azienda Ospedaliera Universitaria Senese, Siena (M. Maio), and Papa Giovanni XXIII Hospital, Bergamo (M. Mandalà) - all in Italy · Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite (L.T.), and Hôpital Saint André, Bordeaux (C.D.) - all in France · Princess Alexandra Hospital, Woolloongabba, QLD (V.A.), and Peter MacCallum Cancer Centre, Melbourne, VIC (G.A.M.) - both in Australia · National Institute of Oncology, Budapest, Hungary (G.L.) · N.N. Blokhin Russian Cancer Research Center, Moscow (L.D.), and Moscow City Oncology Hospital 62, Krasnogorsk (D.S.) - both in Russia · Hospital Universitario Virgen Macarena, Seville, Spain (L.C.-M.) · University of Tübingen, Tübingen, Germany (C.G.) · Genentech, South San Francisco, CA (M.A.S., I.C., N.C., S.P.H.) · and Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles (A.R.). · Pubmed 25265494
  • Melanoma Cancer Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata, 64, 35128 Padua, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G Pascale', Via Cappella dei Cangiani, 1, 80131 Naples, Italy. · Medical Oncology and Immunotherapy Unit, University Hospital of Siena, Istituto Toscano Tumori, Strada delle Scotte, 14, 53100 Siena, Italy. · 1] Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy [2] Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035-39, 00189 Rome, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy. · Divisione Melanoma, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141 Milan, Italy. · Oncology of Melanoma Unit, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141 Milan, Italy. · Department of Medical Oncology A, San Martino Hospital, National Institute for Cancer Research, L.go R. Benzi, 10, 16132 Genoa, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Torino, San Giovanni Battista di Torino, Via Cherasco, 23, 10126 Turin, Italy. · Division of Medical Oncology, Institute for Cancer Research and Treatment, IRCC, Piedmont Oncology Foundation, Strada Provinciale, 142, 10060 Candiolo, Italy. · Unit of Medical Oncology, Papa Giovanni XXIII Hospital, Piazza OMS-Organizzazione Mondiale della Sanità, 1, 24127 Bergamo, Italy. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133 Milan, Italy. · Pubmed 24619072
  • Royal Marsden Hospital NHS Foundation Trust, London, UK. Electronic address: · Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Dermatooncology Department, General University Hospital, Prague, Czech Republic. · Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · Universitair Ziekenhuis Brussel, Brussels, Belgium. · Service of Oncology-Hospital La Paz, Madrid, Spain. · Universität Tübingen-Hautklinik, Tübingen, Germany. · Melanoma Oncology Unit, Veneto Oncology Institute, Gattamelata, Padova, Italy. · Medical Oncology, University of Athens, Greece. · Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands. · Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · IRCCS San Martino Hospital-IST, Genoa, Italy. · University Hospital Schleswig-Holstein, Department of Dermatology, Kiel, Germany. · Cancer Clinical Trials Unit, Royal Adelaide Hospital, and Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia. · F Hoffmann-La Roche, Basel, Switzerland. · Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. Electronic address: · Pubmed 24582505
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione "G. Pascale"; Naples, Italy. · Statistical Unit; Regina Elena National Cancer Institute; Rome, Italy. · Radiotherapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale"; Naples, Italy. · Radiology Unit; Istituto Nazionale Tumori Fondazione "G. Pascale"; Naples, Italy. · National Research Council; Sassari, Italy. · Scientific Direction; Istituto Nazionale Tumori Fondazione "G. Pascale"; Naples, Italy. · Melanoma and Sarcoma Surgery Unit; Istituto Nazionale Tumori Fondazione "G. Pascale"; Naples, Italy. · Pubmed 25083318
  • European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy. · Istituto Nazionale dei Tumori di Napoli, Italy. · Istituto Oncologico Veneto, Padova, Italy. · Federazione Italiana delle Associazioni di Volontariato in Oncologia, Italy. · Pubmed 25075214
  • Istituto Nazionale Tumori Fondazione 'G, Pascale', Napoli, Italy. · Pubmed 24885479
  • UOS Epigenetica dei Tumori, IRCCS A.O.U. San Martino-IST, Genova, Italy. · UOS Epigenetica dei Tumori, IRCCS A.O.U. San Martino-IST, Genova, Italy; Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università degli Studi di Genova, Genova, Italy. · UOC Biologia cellulare, IRCCS A.O.U. San Martino-IST, Genova, Italy. · UOC Epidemiologia Clinica, IRCCS A.O.U. San Martino-IST, Genova, Italy. · Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università degli Studi di Genova, Genova, Italy. · Unità di Oncologia Medica e Terapie Innovative, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · UOC Oncologia Medica 2, IRCCS A.O.U. San Martino-IST, Genova, Italy. · UOS Epigenetica dei Tumori, IRCCS A.O.U. San Martino-IST, Genova, Italy. Electronic address: · Pubmed 24801647
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
  • Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy,1. · Pubmed 24484235
  • Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Melanoma Cancer Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy. · "Paolo Giaccone" Polyclinic University Hospital, Palermo, Italy. · Divisione Melanoma e Sarcomi Muscolo-Cutanei, Istituto Europeo di Oncologia IEO-IRCCS, Milan, Italy. · Unità di Ricerca Traslazionale sul Melanoma, Divisione di Oncologia Medica del Melanoma, Istituto Europeo di Oncologia IEO-IRCCS, Milan, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy; Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy. · San Martino Hospital, National Institute for Cancer Research, Genoa, Italy. · University Hospital Pisa, "Gathered Hospitals of Santa Chiara", Pisa, Italy. · Department of Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 24100024
2013
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale," Naples, Italy. · Pubmed 22874771
  • Alexander M.M. Eggermont, Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, and Université Paris-Sud, Kremlin Bicêtre, Paris, France · Stefan Suciu, Larissa Polders, and Michel Praet, European Organisation for Research and Treatment of Cancer, Brussels, Belgium · Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland · Jeremy Marsden, University Hospital Birmingham, Birmingham · Philippa Corrie, Addenbrookes Hospital, Cambridge · Poulam M. Patel, University of Nottingham, Nottingham · Neville Davidson, Broomfield Hospital, Broomfield, United Kingdom · Mario Santinami, Istituto Nazionale dei Tumori, Milan · Paolo A. Ascierto, Istituto Nazionale Tumori Fondazione Pascale, Napoli · Lorenzo Borgognoni, Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence · Maria Grazia Bernengo, University Hospital Turin, Turin, Italy · Steinar Aamdal, Oslo University Hospital and Radium Hospital, Oslo, Norway · Wim H. Kruit, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands · Lars Bastholt, Odense University Hospital, Odense, Denmark · and Alan Spatz, McGill University and Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Pubmed 24019551
  • Paolo A. Ascierto, Ester Simeone, Instituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy · David Minor, California Pacific Center for Melanoma Research and Treatment, San Francisco · Antoni Ribas, Jonsson Comprehensive Cancer Center, University of California, Los Angeles · Omid Hamid, Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA · Anne O'Hagan, Niki Arya, Mary Guckert, Anne-Marie Martin, Jolly Mazumdar, Vicki L. Goodman, GlaxoSmithKline Oncology, Collegeville · Ravi Amaravadi, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA · Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX · Celeste Lebbe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris, Université Paris Diderot, Paris · Jean-Jacques Grob, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France · Dirk Schadendorf, University Hospital Essen, Essen · Tabea Wilhelm, Uwe Trefzer, Charité-Universitätsmedizin, Berlin, Germany · Richard F. Kefford, Georgina V. Long, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia. · Pubmed 23918947
  • National Tumor Institute, Foundation G Pascale, Naples, Italy. · Pubmed 23414587
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Department of Melanoma, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Pubmed 23497384
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione G Pascale, Napoli, Italy. · Pubmed 23460532
  • Istituto Nazionale Tumori, Fondazione "G, Pascale", Naples, Italy. · Pubmed 23731854
2012
  • Department of Melanoma, Istituto Nazionale Tumori Fondazione G, Pascale, Naples, Italy. · Pubmed 22554099
  • Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G, Pascale, Naples, Italy. · Pubmed 22640478
  • Department of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 22551296
2011
  • Department of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 21439082
2010
  • Unit of Medical Oncology and Innovative Therapy, National Tumor Institute, Naples, Italy. · Pubmed 20406483
  • Unit of Medical Oncology and Innovative Therapy and Melanoma Cooperative Group, National Tumor Institute, Naples, Italy. · Pubmed 20712892
  • National Cancer Institute, Naples, Italy. · Pubmed 20707921
2019
  • From the Royal Marsden NHS Foundation Trust, London (J.L.), and the College of Medicine, Swansea University, Swansea (J.W.) - both in the United Kingdom · the Oncology Institute of Veneto IRCCS, Padua (V.C.-S.), the European Institute of Oncology, IRCCS, Milan (P.F.F.), Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and the Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital, Siena (M.M.) - all in Italy · the University of Colorado Cancer Center, Aurora (R.G.) · Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille Hôpital Timone, Marseille (J.-J.G.), and Université de Paris, INSERM Unité 976, Assistance Publique-Hôpitaux de Paris Dermatology and Centres d'Investigation Clinique, Saint Louis Hospital, Paris (C.L.) - both in France · the Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · the University of Michigan, Ann Arbor (C.D.L.) · Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.) · the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.) · Universitäts Spital, Zurich, Switzerland (R.D.) · Cross Cancer Institute, Edmonton, AB (M.S.), and the Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada · Tasman Oncology Research, Southport, QLD (A.H.), the Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney, Sydney, NSW (M.S.C., G.V.L.), and the Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and the Peter MacCallum Cancer Centre, Melbourne, VIC (G.M.) - all in Australia · General University Hospital Gregorio Marañon and Centro de Investigación Biomédica en Red de Oncología, Madrid (I.M.-R.) · the Netherlands Cancer Institute, Amsterdam (J.H.) · the Leuven Cancer Institute, Department of General Medical Oncology, University Hospital Leuven, Leuven, Belgium (P.S.) · University of California San Diego Health-La Jolla Moores Cancer Center, La Jolla (G.A.D.) · the Department of Oncology, Odense University Hospital, Odense, Denmark (L.B.) · Bristol-Myers Squibb, Princeton, NJ (J.I.R., A.B., A.M.) · Dana-Farber Cancer Institute, Boston (F.S.H.) · and the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W.). · Pubmed 31562797
2018
  • From the Gustave Roussy Cancer Campus Grand Paris and University Paris-Saclay, Villejuif (A.M.M.E., C.R.), Hospices Civils de Lyon Cancer Institute, Cancer Research Center of Lyon, Lyon University, Lyon (S.D.), and Aix-Marseille University, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille (J.-J.G.) - all in France · Netherlands Cancer Institute-Antoni van Leeuwenhoek (C.U.B., A.C.J.A.) and VU University Medical Center (A.J.M.E.), Amsterdam, and Radboud University Medical Center Nijmegen, Nijmegen (R.K.) - all in the Netherlands · Azienda Ospedaliera Papa Giovanni XXIII, Bergamo (M. Mandala), Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples (P.A.A.), and Universita Degli Studi Di Siena-Policlinico le Scotte, Siena (M. Maio) - all in Italy · Melanoma Institute Australia, the University of Sydney, and Mater and Royal North Shore Hospitals (G.V.L.) and Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney (M.S.C.), Sydney, Princess Alexandra Hospital, University of Queensland, Brisbane (V.A.), Alfred Hospital (A.H.) and Peter MacCallum Cancer Centre (S. Sandhu), Melbourne, VIC, and Fiona Stanley Hospital-University of Western Australia-Edith Cowan University Perth, Perth (A.K.) - all in Australia · Cancer Research Center, Moscow (M.L.) · Royal Marsden Hospital, London (J.L.) · Hospital Clinic Universitari de Barcelona, Barcelona (S.P.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · University Hospital Essen, Essen and German Cancer Consortium, Heidelberg (D.S.), and the Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover (R.G.) - all in Germany · Washington University School of Medicine, St. Louis (L.H.-A.) · Centre Hospitalier de l'Université de Montréal (CHUM), Centre de Recherche du CHUM, Montreal (R.J.) · Christie NHS Foundation Trust, Manchester, United Kingdom (P.L.) · Merck, Kenilworth, NJ (N.I.) · and the European Organization for the Research and Treatment of Cancer Headquarters, Brussels (S.M., S. Suciu). · Pubmed 29658430
2017
  • From New York University Perlmutter Cancer Center, New York (J.W.) · Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M. Mandala), Medical Oncology, National Cancer Institute, Milan (M.D.V.), Oncology Institute of Veneto Istituti di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M. Maio), Ospedale Policlinico San Martino, Genoa (P.Q.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · National and Kapodistrian University of Athens, Athens (H.J.G.) · Hospital Clinic de Barcelona, Barcelona (A.M.A.), and General University Hospital Gregorio Marañón, Madrid (I.M.-R.) - both in Spain · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · Hospices Civils de Lyon, Pierre Bénite (S.D.), Aix-Marseille University, Hospital de la Timone, Marseille (J.-J.G.), Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse (N.M.), Université Lille, INSERM Unité 1189, CHU Lille, Lille (L.M.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint Louis, Université Paris Diderot, Paris (C.L.) - all in France · Oncology Center Sf. Nectarie, Craiova, Romania (M. Schenker) · Princess Margaret Cancer Centre, University of Toronto, Toronto (M.O.B.), and Cross Cancer Institute, Edmonton, AB (M. Smylie) - both in Canada · the Department of Oncology, University of Oxford, Oxford (M.R.M.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · Gallipoli Medical Research Foundation and University of Queensland, Queensland, VIC (V.A.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.) - all in Australia · University of Colorado, Denver (R.G.) · Winship Cancer Institute, Emory University School of Medicine, Atlanta (R.R.K.) · Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.) · University of Washington, Seattle (S.B.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Nagoya University Graduate School of Medicine, Nagoya (K.Y.), and the National Cancer Center Hospital, Tokyo (N.Y.) - both in Japan · Seoul National University Hospital, Seoul, South Korea (T.M.K.) · and Bristol-Myers Squibb, Princeton, NJ (V.P, J.S., A.Q.). · Pubmed 28891423
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.) · Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · University of Colorado, Denver (R.G.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · University of Michigan, Ann Arbor (C.D.L.) · the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.) · Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada · Universitäts Spital, Zurich, Switzerland (R.D.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia · Netherlands Cancer Institute, Amsterdam (J.H.) · University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.) · General University Hospital Gregorio Marañón, Madrid (I.M.-R.) · Northwestern University, Chicago (J.S.) · Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.) · and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
  • aDepartment of Medical Oncology, Royal North Shore Hospital bDepartment of Medical Oncology Melanoma Institute Australia cDepartment of Medical Oncology, The University of Sydney, Sydney, New South Wales, Australia dDepartment of Medical Oncology, Istituto Nazionale Tumori 'Fondazione Pascale', Naples, Campania, Italy. · Pubmed 28230715
2016
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France · the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy · University of Zurich Hospital, Zurich, Switzerland (R.D.) · Memorial Sloan Kettering Cancer Center, New York (J.D.W.) · Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark · the Angeles Clinic and Research Institute, Los Angeles (O.H.) · Oncology Specialists, Park Ridge, IL (J.M.R.) · Cross Cancer Institute, Edmonton, AB, Canada (M.S.) · H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.) · Broomfield Hospital, Chelmsford, United Kingdom (S.T.) · Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany · Dana-Farber Cancer Institute, Boston (F.S.H.) · Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.) · and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
2015
  • aDepartment of Dermatology, University Hospital Zürich, Zürich, Switzerland bDepartment of Dermatology, University Hospital Essen, Essen cDepartment of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany dIstituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy eRoyal Marsden NHS Foundation Trust, London, UK fAPHP Oncodermatology Unit, University Paris 7 Diderot U976, Paris, France. · Pubmed 26426764
  • O.U. Melanoma, Cancer Immunotherapy and Innovative Therapies, National Cancer Institute of Naples "G. Pascale" Foundation, Naples, Italy. · Pubmed 26175403
  • 1First Department of Medicine, Athens University Medical School, Athens, Greece; 2Division of Medical Oncology, Baskent University School of Medicine, Adana, Turkey; 3Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy; 4Department of Biotherapy, Blokhin Cancer Center, Moscow, Russia; 5Department of Dermatology, Medical University of Vienna, Vienna, Austria; 6Department of Dermatology, Institute Gustave Roussy, Villejuif Cedex, France; 7Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel; 8Department of Dermatologie, University of Kiel, Kiel, Germany; and 9Oncology Service, Hospital La Paz, Madrid, Spain. · Pubmed 24176884
  • From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.) · Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France · Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.) · Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.) · Department of Dermatology, University of Essen, Essen, Germany (D.S.) · University of Zürich Hospital, Zurich, Switzerland (R.D.) · Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie) · Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia · Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.) · Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.) · Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York · Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.) · Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc · Pubmed 26027431
  • aDivision of Melanoma, Cancer Immunotherapy and Innovative Therapies bDivision of Melanoma and Skin Cancer cDepartment of Diagnostic Imaging, Radiant and Metabolic Therapy, Division of Radiology dDivision of Radiotherapy, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 25622086
2014
  • Istituto Nazionale Tunori Fondazione 'G. Pascale', Naples, Italy. · Pubmed 24419498
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Pubmed 24258976
  • Unit of Melanoma, Immunotherapy and Innovative Therapies, Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G. Pascale, Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24114495
  • Pathology Unit, Istituto Nazionale Tumori Fondazione, "G. Pascale", via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24993904
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24695951
2013
  • National Cancer Institute-Fondazione Pascale, Naples, Italy. · Pubmed 23036080
  • Department of Melanoma, Istituto Nazionale Tumori Fondazione Pascale, Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 23402397
  • Unit of Surgery "Melanoma - Soft Tissues - Head & Neck - Skin Cancers", Istituto Nazionale per lo Studio e la cura dei tumori "Fondazione G,Pascale" IRCCS, Naples, Italy. · Pubmed 24289268
  • Department Melanoma, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 23317446
2012
  • Unit of Medical Oncology and Innovative Therapy, G Pascale Institute of National Tumor Foundation, Naples, Italy. · Pubmed 22993335
  • Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Pubmed 22524673
  • Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione, G, Pascale, Napoli, Italy. · Pubmed 22433222
  • Department of Surgery, National Cancer Institute, Via Mariano Semmola, Naples, Italy. · Pubmed 22800396
  • Pathology Unit, Istituto Nazionale Tumori Fondazione G, Pascale, via Mariano Semmola, 80131, Naples, Italy. · Pubmed 22583695
2011
  • Division of Cardiology, National Cancer Institute, Sen. Pascale Foundation, via Mariano Semmola, 80131 Naples, Italy. · Pubmed 21705351
Probable:    National Institutes of Health      
2018
  • From the Istituto Nazionale Tumori "Fondazione G. Pascale," Naples, Italy; Massachusetts General Hospital Cancer Center, Boston, MA; Center for Cancer Research, National Cancer Institute, Bethesda, MD. · Pubmed 30231371
Probable:    Harvard University Boston   Contact    
2018
  • From the Istituto Nazionale Tumori "Fondazione G. Pascale," Naples, Italy; Massachusetts General Hospital Cancer Center, Boston, MA; Center for Cancer Research, National Cancer Institute, Bethesda, MD. · Pubmed 30231371
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 240 total) written by Paolo Antonio Ascierto about Melanoma:

  • Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019. 2020
  • In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma. 2020
  • Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients. 2020
  • Multiplex immunohistochemistry assay to evaluate the melanoma tumor microenvironment. 2020
  • Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAF 2020
  • Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma. 2020
  • KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma. 2020
  • Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials. 2020
  • New paradigm for stage III melanoma: from surgery to adjuvant treatment. 2019
  • The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era. 2019
Show List of Full Article Records
Google Searches

Learn more about Paolo Antonio Ascierto using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Istituto Nazionale Tumori IRCCS Fondazione Pascale
National Institutes of Health
Harvard University Boston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Istituto Nazionale Tumori IRCCS Fondazione Pascale
2020
  • Department of Dermatology, University Hospital Essen, University of Duisburg-Essen & German Cancer Consortium Heidelberg, Germany. Electronic address: · Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Translational Skin Cancer Research, German Consortium of Translational Cancer Research (DKTK), Essen, & German Cancer Research Center (DKFZ), Heidelberg, Germany. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Dermatology, Timone Hospital and Aix-Marseille University, Marseille, France. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Department of Dermatology, University Hospital Essen, University of Duisburg-Essen & German Cancer Consortium Heidelberg, Germany. · Melanoma Institute Australia, The University of Sydney, And Royal North Shore Hospital, Sydney, NSW, Australia. · University of Manchester / the Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia and University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · Pubmed 32179447
  • Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", 80131 Naples, Italy. · Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy. · IRCCS, Istituto Nazionale Tumori "Regina Elena", Via Elio Chianesi 53, 00144 Rome, Italy. · Department of Molecular and Clinical Medicine, University of Roma "Sapienza", 00185 Rome, Italy. · Pubmed 32178301
  • Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy. · Istituto Nazionale Tumori - IRCCS - Fondazione "G. Pascale", Naples, Italy. · Istituto Nazionale Tumori Regina Elena, IRCCS, Rome, Italy. · Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084, Fisciano, SA, Italy. · Department of Medicine and Surgery, University of Parma, Parma, Italy. · PhD Program in Drug Discovery and Development, Department of Pharmacy, University of Salerno, Fisciano, Italy. · Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084, Fisciano, SA, Italy. · Pubmed 32160899
  • Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy. · Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy. Electronic address: · Pubmed 32122547
  • Melanoma Unit, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy. Electronic address: · Department of Medicine, University of Colorado Comprehensive Cancer Center, Aurora, Colorado, USA. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy. · Department of Biotherapy, N. N. Blokhin Russian Cancer Research Center, Ministry of Health, Moscow, Russia. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine. · Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK. · Department of Cancer Immunology, Poznan University of Medical Sciences, Med-POLONIA, Poznan, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland. · Melanoma Translational Research Group, Melanoma Institute Australia, Wollstonecraft, New South Wales, Australia. · Product Development Oncology, Genentech, Inc., South San Francisco, California, USA. · Oncology Biostatistics, Genentech, Inc., South San Francisco, California, USA. · Clinical Development Department, Roche Products Ltd., Welwyn Garden City, UK. · Oncology Biomarker Development, Genentech, Inc., South San Francisco, California, USA. · Safety Science Oncology, Genentech, Inc., South San Francisco, California, USA. · Department of Dermatology, Essen University Hospital, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Pubmed 31912791
  • Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. Electronic address: · Department of Dermatology, University Hospital Zürich Skin Cancer Center and University Zürich, Zürich, Switzerland. · Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece. · Cancer Center, Massachusetts General Hospital, Boston, MA, USA. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Department of Dermatology, National Institute of Oncology, Budapest, Hungary. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Department of Dermato-oncology, University Hospital Prague and Charles University First Medical Faculty, Prague, Czech Republic. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · Department of Medical Oncology, Isala, Zwolle, Netherlands. · Department of Dermatology, University Medical Center Mainz, Mainz, Germany. · Pfizer Inc., Boulder, CO, USA. · Service of Dermatology, Department of Medicine and Paris-Sud University, Gustave Roussy, Villejuif, France. · Pubmed 31901705
  • Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15232, USA. · Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia. · Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Dermatology and Skin Cancers, Hôpital de la Timone, Aix-Marseille Université, Marseille, France. · Department of Dermatological Oncology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Medical Oncology, Mater Hospital, North Sydney, NSW, Australia. · Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia. · Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany. · Dermatology Unit, Department of Oncology, Gustave Roussy Cancer Centre, Villejuif, France. · Department of Medicine, Université Paris-Sud, Orsay, France. · Department of Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Surgical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Internal Medicine, VCU Massey Cancer Center, Richmond, VA 23298, USA. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland. · Department of Clinical Oncology, Merck & Co., Inc., Kenilworth, NJ 07033, USA. · Department of Medical Oncology, Gustave Roussy Cancer Institute & Université Paris-Saclay, Paris, France. · Pubmed 31870188
  • University Hospital Schleswig-Holstein, Kiel, Germany. Electronic address: · Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale," Naples, Italy. · University Hospital of Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Aix-Marseille University, Marseille, France. · UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Hôpital Saint-André, Bordeaux, France. · N.N. Blokhin Russian Cancer Research Center, Moscow, Russia. · APHP Dermatology and CIC Department, Hôpital Saint-Louis, INSERM U976, University Paris Diderot, Paris, France. · Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Hannover Medical School, Hannover, Germany. · University of Western Australia, Sir Charles Gairdner Hospital, Perth, WA, Australia. · Westmead Hospital and Macquarie University, Sydney, NSW, Australia. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 31864178
2019
  • Unit Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Ospedale Santa Maria Annunziata and University of Florence, Florence, Italy. · Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Unit Melanoma and Rare Tumors, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy. · Oncologia Medica B Policlinico Umberto I di Roma, Rome, Italy. · Surgical Oncology Unit, IOV-IRCCS of Padova and Dept. Surgery Oncology Gastroenterology, University of Padova, Padua, Italy. · Unit of Cancer Genetics, ICB-CNR, Sassari, Italy. · Research Director CNR, Italian Melanoma Intergroup (IMI), Unit of Cancer Genetics, Head Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Sassari, Italy. · IRCCS Fondazione Istituto Nazionale dei Tumori di Milano, Milan, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Turin, Italy. · Skin Cancer Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, FC, Italy. · University of Parma, Parma, Italy. · Pubmed 31412885
  • Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Via Mariano Semmola snc, Naples, Italy. · Department of Medicine (DAME), University Hospital of Udine, Udine, Italy. · Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Via Mariano Semmola snc, Naples, Italy. · Pubmed 31359162
  • 1 New York University Perlmutter Cancer Center, New York, NY. · 2 University of Michigan Rogel Cancer Center, Ann Arbor, MI. · 3 From the Instituto Nazionale Tumori, Instituto di Ricovero e Cura a Carrattere Scientifico, Fondazione G. Pascale, Naples, Italy. · 4 Massachusetts General Hospital Cancer Center, Boston, MA. · Pubmed 31099689
  • Department of Clinical Medicine and Surgery, Oncology Unit, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131, Naples, Italy. · Department of Clinical Medicine and Surgery, Oncology Unit, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131, Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 30747264
  • a Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics , Istituto Nazionale Tumori IRCCS Fondazione G. Pascale , Napoli , Italy. · Pubmed 30652516
  • a IRCCS , Regina Elena National Cancer Institute , Rome , Italy. · b Department of Molecular and Clinical Medicine , University of Roma "Sapienza" , Rome , Italy. · c IRCCS , National Cancer Institute of Naples "Fondazione G. Pascale" , Naples , Italy. · Pubmed 30507327
  • Department of Dermatology, University Medical Center, Tübingen, Germany. · Division of Thoracic Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy. · Istituto Nazionale Tumori, IRCCS Fondazione Pascale, Naples, Italy. · Ospedali Riuniti Ancona, Ancona, Italy. · Università di Modena e Reggio Emilia, Modena, Italy. · Medical University of Graz, Graz, Austria. · Translational Skin Cancer Research, Deutsches Konsortium für Translationale Krebsforschung (DKTK) Partner Site Essen, Essen, Germany. · Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany. · University Hospital Schleswig-Holstein (UKSK), Campus Kiel, Kiel, Germany. · Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. · Azienda Ospedaliero-Universitaria Senese, Siena, Italy. · University Hospital Zurich and University Zurich, Zurich, Switzerland. · Charité, Berlin, Germany. · Dermatologikum Berlin, Berlin, Germany. · Philochem AG, Libernstrasse 3, 8112, Otelfingen, Switzerland. · Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Building HCI G396.4, Wolfgang-Pauli-Strasse 10, 8093, Zurich, Switzerland. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Sektion Dermatologische Onkologie, Universität Tübingen Hautklinik, Liebermeisterstraße 25, 72076, Tübingen, Germany. · Pubmed 31482307
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · European Institute of Oncology IRCCS, Milan, Italy. · Auckland City Hospital, Auckland, New Zealand. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Brisbane, Queensland, Australia. · Aarhus University Hospital, Aarhus, Denmark. · Ella Lemelbaum Institute for Melanoma, Sheba Medical Center at Tel HaShomer, Cancer Center (Oncology Institute), Ramat Gan, Israel. · IRCCS San Martino-IST, Genova, Italy. · Melanoma Institute Australia and the University of Sydney, Mater and Royal North Shore Hospitals, Sydney, New South Wales, Australia. · Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Sharett Institute of Oncology, Hadassah Hebrew Medical Center, Jerusalem, Israel. · Rambam Health Care Campus, Haifa, Israel. · Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec, Québec, Canada. · Novartis, East Hanover, NJ, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · University of California Los Angeles and the Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Pubmed 31171878
  • 1 Saint-Louis Hospital, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Paris, France. · 2 Université Paul Sabatier-Toulouse III, Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche 1037-CRCT, Toulouse, France. · 3 Université de Lille, Institut National de la Santé et de la Recherche Médicale U1189, Lille, France. · 4 Hospital General Universitario Gregorio Marañón, Madrid, Spain. · 5 Gustave Roussy, Institut National de la Santé et de la Recherche Médicale U981, Paris, France. · 6 Maria Skłodowska-Curie Institute-Oncology Center, Warsaw, Poland. · 7 Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia. · 8 University Hospital Tübingen, Tübingen, Germany. · 9 Istituto Nazionale Tumori-Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples, Italy. · 10 Cross Cancer Institute, Edmonton, Alberta, Canada. · 11 University Hospital, Essen, Germany. · 12 German Cancer Consortium, Heidelberg, Germany. · 13 St George's University Hospitals National Health Service Foundation Trust, Tooting, London, United Kingdom. · 14 Herlev Hospital, University of Copenhagen, Herlev, Denmark. · 15 University of Colorado, Denver, CO. · 16 Bristol-Myers Squibb, Princeton, NJ. · 17 Veneto Institute of Oncology-Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy. · Pubmed 30811280
  • Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Department of Medical Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia. · Department of Medicine, Institute Gustave Roussy, Villejuif, France. · Medical Oncology and Haematology, Cabrini Health, Melbourne, Victoria, Australia. · Dermatology Service, University Hospital of Bordeaux, Bordeaux, France. · UOC Oncological Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Clinique de Dermatologie, Unité d'Onco-Dermatologie, Institut National de la Santé et de la Recherche Médicale (INSERM) U1189, Centre Hospitalier Régional Universitaire de Lille, Lille, France. · Department of Dermatology, University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland. · Chris O'Brien Lifehouse, Melanoma Institute Australia, Camperdown, New South Wales. · Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Polish Mother's Memorial Hospital Research Institute, Lodz, Poland. · Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Assistance Publique-Hôpitaux de Paris Dermatology and Centre d'Investigation Clinique, University Paris Diderot INSERM U976, Saint Louis Hospital, Paris, France. · Institute for Advanced Biosciences, Université Grenoble Alpes/INSERM U1209/CNRS UMR 5309 Joint Research Center, Grenoble, France. · Dermatology Department, Grenoble Alpes University Hospital, Grenoble, France. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Melanoma Cancer Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy. · Department of Dermatology, University Hospital Cologne, Cologne, Germany. · Division of Oncology, Regina Elena Institute, Rome, Italy. · Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Center for Cancer Immune Therapy, Herlev Hospital, Herlev, Denmark. · Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium, Heidelberg, Germany. · First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece. · Global Biometric Sciences, Bristol-Myers Squibb, Princeton, New Jersey. · Oncology Clinical Development, Bristol-Myers Squibb, Princeton, New Jersey. · Princess Alexandra Hospital, University of Queensland, Woolloongabba, Queensland, Australia. · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, Queensland, Australia. · Pubmed 30422243
  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Cancer Immunotherapy and Innovative Therapy Unit, Naples. Italy. · Centro di Riferimento Oncologico, Department of Medical Oncology, Aviano (PN). Italy. · Research Branch, Sidra Medical and Research Centre, Doha. Qatar. · Pubmed 31804158
  • Department of Dermatology, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany; The German Cancer Consortium, Heidelberg, Germany. Electronic address: · Division of Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Banchi di Sotto, 55, 53100, Siena, SI, Italy. · N. N. Blokhin Russian Cancer Research Center, Ministry of Health, Russian Academy of Medical Sciences, Kashirskoye Shosse 24, 115478, Moscow, Russian Federation. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Centro Ospedaliero, 24129, Bergamo, BG, Italy. · Dnipropetrovsk State Medical Academy, Volodymyra Vernadskoho St, 9, Dnipropetrovsk, 49044, Ukraine. · Melanoma Unit, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori, IRCCS Fondazione Pascale, Via Mariano Semmola, 53, 80131, Napoli, NA, Italy. · Bristol Haematology and Oncology Centre, Horfield Rd, Avon, Bristol, BS2 8ED, United Kingdom. · Department of Cancer Immunology, Poznan University for Medical Sciences, Med-POLONIA, Collegium Maius, Fredry 10, 61-701, Poznań, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Wawelska 15 B, 00-001, Warsaw, Poland. · Melanoma Translational Research Group, Melanoma Institute Australia, 40 Rocklands Rd, Wollstonecraft NSW, 2065, New South Wales, Australia. · Genentech, Inc., 410 Allerton Ave, South San Francisco, CA, 94080, USA. · University of Colorado Comprehensive Cancer Center, 1665 Aurora Court Anschutz Cancer Pavilion, Aurora, CO 80045, USA. · Pubmed 31704549
  • Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Department of Medical, Surgical and Experimental Sciences, University of Sassari, Viale S., 07100 Sassari, Italy. · Anatomia Patologica, Azienda Ospedaliero Universitaria (AOU), 07100 Sassari, Italy. · Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico (CRO), 33081 Pordenone, Italy. · Department of Medical Oncology, Centro di Riferimento Oncologico (CRO), 33081 Pordenone, Italy. · Istituto Nazionale Tumori "Fondazione Pascale", 80131 Naples, Italy. · Istituto Nazionale Tumori "Fondazione Pascale", 80131 Naples, Italy. · Istituto Nazionale Tumori "Fondazione Pascale", 80131 Naples, Italy. · Oncologia Medica, Ospedale Civile, 07041 Sassari, Italy. · Anatomia Patologica, Azienda Ospedaliera Cannizzaro, Via Messina 829, 95126 Catania, Italy. · Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Anatomia Patologica, Azienda Ospedaliero Universitaria (AOU), 07100 Sassari, Italy. · Anatomia Patologica, Azienda Ospedaliero Universitaria (AOU), 07100 Sassari, Italy. · Anatomia Patologica, Azienda Ospedaliero Universitaria (AOU), 07100 Sassari, Italy. · Institute of Biomolecular Chemistry, National Research Council (CNR), Traversa La Crucca 3, 07100 Sassari, Italy. · Pubmed 31581559
  • Department of Dermatology, University Hospital Essen, Essen, German Cancer Consortium, Heidelberg, Germany. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain. · N.N. Blokhin Russian Cancer Research Centre, Ministry of Health, Moscow, Russia. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · Department of Medical Oncology, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Institute of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · First Department of Medicine, National and Kapodistrian University of Athens School of Medicine, Laiko General Hospital, Athens, Greece. · Division of Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. · Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy. · Department of Dermatology, Medical University of Vienna, Vienna, Austria. · Department of Dermatology, University of Lübeck, Lübeck, Germany. · Department of Dermatology, Hannover Medical School, Skin Cancer Centre Hannover, Hannover, Germany. · Department of Oncology, Oslo University Hospital, Oslo, Norway. · Department of Oncology, Metropolitan Hospital, Athens, Greece. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute, Oncology Center, Warsaw, Poland. · Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, United Kingdom. · Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Dermatology, SRH Wald Clinics, University Hospital, Gera, Germany. · Unit of Medical Oncology, Department of Oncology & Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Medical Oncology Department, General University Hospital, Gregorio Marañón and CIBERONC, Madrid, Spain. · Medical Oncology, Vall D'Hebron University, Barcelona, Spain. · Department of Dermatology, Universitats Spital, Zürich, Switzerland. · Oncology Clinical Development, Bristol-Myers Squibb, Princeton, NJ, USA. · Global Biometric Sciences, Bristol-Myers Squibb, Princeton, NJ, USA. · Department of Medical Oncology, Mount Vernon Cancer Centre, London, United Kingdom. · Pubmed 31581055
  • Department of Oncology, University Hospital Lausanne, Lausanne, Switzerland. · Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Napoli, Italy. · Department of Dermatology, Skin Cancer Centre, University Hospital Zürich, Zürich, Switzerland. · Charité Comprehensive Cancer Centre, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Pubmed 31566661
  • Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy. · Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy. · Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy. · Department of Molecular and Clinical Medicine, Laboratory Affiliated to Istituto Pasteur Italia Fondazione Cenci Bolognetti, University of Rome "Sapienza", 00161 Rome, Italy. · Department of Melanoma, Oncologic Immunotherapy and Innovative Therapies Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", 80131 Naples, Italy. · Department of Melanoma, Oncologic Immunotherapy and Innovative Therapies Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", 80131 Naples, Italy. · Department of Melanoma, Oncologic Immunotherapy and Innovative Therapies Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", 80131 Naples, Italy. · Department of Molecular and Clinical Medicine, University of Rome "Sapienza", 00161 Rome, Italy. · Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy. · Department of Melanoma, Oncologic Immunotherapy and Innovative Therapies Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", 80131 Naples, Italy. · Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA. · Department of Dermatology, Miller School of Medicine, Miami, FL 33136, USA. · Department of Melanoma, Oncologic Immunotherapy and Innovative Therapies Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", 80131 Naples, Italy. · Department of Molecular and Clinical Medicine, University of Rome "Sapienza", 00161 Rome, Italy. · Scientific Directorate, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy. · Pubmed 31557826
  • Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Traversa La Crucca 3, 07100, Sassari, Italy. · Department of Medical, Surgical, and Experimental Sciences, University of Sassari, Viale San Pietro 43, 07100, Sassari, Italy. · Istituto Nazionale Tumori "Fondazione Pascale", Via Mariano Semmola, 53, 80131, Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Traversa La Crucca 3, 07100, Sassari, Italy. · Pubmed 31455347
  • Department of Medical Oncology, Mount Vernon Cancer Centre, London, United Kingdom. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medical Oncology, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain. · N.N. Blokhin Russian Cancer Research Centre, Ministry of Health, Moscow, Russia. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · Department of Medical Oncology, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Institute of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · First Department of Medicine, National and Kapodistrian University of Athens School of Medicine, Laiko General Hospital, Athens, Greece. · Division of Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. · Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy. · Department of Dermatology, Medical University of Vienna, Vienna, Austria. · Department of Dermatology, University of Lübeck, Lübeck, Germany. · Department of Dermatology, Hannover Medical School, Skin Cancer Centre Hannover, Hannover, Germany. · Department of Oncology, Oslo University Hospital, Oslo, Norway. · Department of Oncology, Metropolitan Hospital, Athens, Greece. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute, Oncology Center, Warsaw, Poland. · Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, United Kingdom. · Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Dermatology, SRH Wald Clinics, University Hospital, Gera, Germany. · Unit of Medical Oncology, Department of Oncology & Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Medical Oncology Department, General University Hospital Gregorio Marañón and CIBERONC, Madrid, Spain. · Medical Oncology, Vall D'Hebron University, Barcelona, Spain. · Department of Dermatology, Universitats Spital, Zürich, Switzerland. · Oncology Clinical Development, Bristol-Myers Squibb, Princeton, NJ, USA. · Global Biometric Sciences, Bristol-Myers Squibb, Princeton, NJ, USA. · Department of Dermatology, University Hospital Essen, Essen, and the German Cancer Consortium, Heidelberg, Germany. · Pubmed 31445199
  • Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece. Electronic address: · Cancer Center, Massachusetts General Hospital, Boston, MA, USA. · Department of Dermatology, University Hospital Zürich Skin Cancer Center and University Zürich, Zürich, Switzerland. · Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Department of Dermatology, National Institute of Oncology, Budapest, Hungary. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Dermatology, University Hospital Essen, Essen, Germany, and German Cancer Consortium, Heidelberg, Germany. · Department of Dermato-oncology, University Hospital Prague and Charles University First Medical Faculty, Prague, Czech Republic. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · Melanoma Cancer Unit, Oncology Institute of Veneto IRCCS, Padua, Italy. · Department of Oncologic Dermatology, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux, France. · Department of Medical Oncology, Isala, Zwolle, Netherlands. · Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan. · Department of Dermatology, University Medical Center Mainz, Mainz, Germany. · Array BioPharma Inc., Boulder, CO, USA. · Service of Dermatology, Department of Medicine and Paris-Sud University, Gustave Roussy, Villejuif, France. · Pubmed 31437754
  • Gustave Roussy Cancer Insitute and University Paris-Sud, France. Electronic address: · Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · AIX-Marseille University, Marseille, France. · University of Zurich Hospital, Zurich, Switzerland. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Melanoma Department, Gustave Roussy Institute and Univerity Paris-Sud, France. · Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy. · Oncology Specialists, SC, Park Ridge, IL, USA. · Dermatology and CIC Department, AP-HP, Saint-Louis Hospital, Université de Paris, INSERM U976, Paris, France. · Regina Elena National Cancer Institute, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · New York University Perlmutter Cancer Center, New York, NY, USA. · Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. · Bristol-Myers Squibb, Lawrenceville, NJ, USA. · Bristol-Myers Squibb, Braine-L'alleud, Belgium. · EORTC Headquarters, Brussels, Belgium. · Formerly at European Institute of Oncology, Milan, Italy. · Pubmed 31400634
  • Unit of Cancer Genetics, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Traversa La Crucca 3, Baldinca Li Punti, 07100, Sassari, Italy. · Department of Medical, Surgical, and Experimental Sciences, University of Sassari, Sassari, Italy. · National Tumor Institute "Fondazione G. Pascale", Napoli, Italy. · Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. · Department of Dermatology, University of Parma, Parma, Italy. · Unit of Medical Oncology, "Papa Giovanni XXIII" Hospital of Bergamo, Bergamo, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Traversa La Crucca 3, Baldinca Li Punti, 07100, Sassari, Italy. · Pubmed 31382929
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Medical Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Experimental Pharmacology Unit, Department of Translational Research, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA. · Department of Pathology and Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · The Angeles Clinic, Experimental Therapeutics Cedars Sinai Foundation, Los Angeles, CA, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · University of Chicago Medical Center, Chicago, IL, USA. · Oncology Department, UNIL-CHUV, Lausanne, Switzerland. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Institut de Cancérologie, Gustave Roussy Cancer Campus, Villejuif, Paris, France. · Refuge Biotechnologies, Menlo Park, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, 9609 Medical Center Drive, Bethesda, MD, 20892-7420, USA. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Pubmed 31331337
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands. · Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy. · Melanoma Institute Australia, The University of Sydney, and Mater and Royal North Shore Hospitals, Sydney, NSW, Australia. · Princess Alexandra Hospital, Brisbane, QLD, Australia. · Hospices Civils de Lyon Cancer Institute, Lyon, France. · Alfred Hospital, Melbourne, VIC, Australia. · Russian Oncology Scientific Centre, Moscow, Russia. · Fiona Stanley Hospital/University of Western Australia, Perth, WA, Australia. · Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Royal Marsden Hospital, London, United Kingdom. · Hospital Clinic Universitari de Barcelona, Barcelona, Spain. · Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy. · Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland. · Universitaetsklinikum - University Essen, Essen, Germany. · Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands. · Washington University School of Medicine, St. Louis, MO, USA. · Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. · Amsterdam University Medical Center, Location VUMC, Amsterdam, the Netherlands. · Aix Marseille University, Hôpital de la Timone, Marseille, France. · Skin Cancer Center, Hannover Medical School, Hannover, Germany. · Centre Hospitalier de l'Université de Montréal (CHUM), Centre de recherche du CHUM, Montreal, QC, Canada. · Christie NHS Foundation Trust, Manchester, United Kingdom. · Merck & Co., Inc., Kenilworth, NJ, United States. · EORTC Headquarters, Brussels, Belgium. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Pubmed 31200321
  • University of Colorado Comprehensive Cancer Center, Aurora, CO, USA. Electronic address: · University Hospital Schleswig-Holstein, Kiel, Germany. · The Royal Marsden NHS Foundation Trust, London, UK. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA. · Massachusetts General Hospital, Boston, MA, USA. · Peter MacCallum Cancer Centre, East Melbourne, VIC, and University of Melbourne, Parkville, VIC, Australia. · Nantes University, Nantes, France. · Genentech, Inc., South San Francisco, CA, USA. · Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy. · Pubmed 31173962
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Clinical Epidemiology Unit, University Hospital "San Martino", Genoa, Italy. · Institut Gustave Roussy Villejuif, Paris-Sud, VilleJuif, Paris, France. · Clinical Research and Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Melanoma Clinical Research & Early Drug Development, Melanoma Medical Oncology, Investigational Cancer Therapeutics, UT MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL), Amsterdam, The Netherlands. · Surgical Group, EORTC Melanoma Group, Brussels, Belgium. · Department Melanoma, Soft Tissue, Muscle-Skeletal and Head-Neck, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Clinical Trials Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Pubmed 31077205
  • Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Medical Oncology and Hematology, St. Luke's University Health Network, Bethlehem, PA, USA. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Hospital of Munich (LMU), Munich, Germany. · Department of Oncology, Highlands Oncology Group, Fayetteville, AR, USA. · Department of Dermatology, University Hospital Essen, Essen, Germany. · Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands. · Department of Medical Oncology, IRCCS San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medicine, Veterans Administration Portland Health Care System and Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA. · Biostatistics, Novartis Healthcare Private Limited, Hyderabad, India. · Department of Translational Oncology, Novartis Institutes for BioMedical Research, Cambridge, MA, USA. · Department of Translational Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Pubmed 30956763
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, 80131, Naples, Italy. · Biodesix Inc, Boulder, CO, USA. · Biodesix Inc, Boulder, CO, USA. · Pubmed 30925943
  • Department of Dermatology, University Hospital Würzburg, Würzburg, Germany. · Department of Dermatology, University Medical Center Tübingen, Liebermeisterstr. 25, 72076, Tübingen, Germany. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Dermatology, University Hospital Hamburg-Eppendorf (UKE), Hamburg, Germany. · Department of Dermatology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. · Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. · Department of Dermatology, Skin Cancer Center, Hannover Medical School, Hannover, Germany. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, West German Cancer Center, University Hospital, University Duisburg-Essen, Essen, Germany. · First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Dermatology, University Hospital of Zürich, Zurich, Switzerland. · Department of Dermatology, University Medical Center Tübingen, Liebermeisterstr. 25, 72076, Tübingen, Germany. · Pubmed 30806748
  • The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Cancer Clinical Trials Unit, Royal Adelaide Hospital, Centre for Cancer Biology, SA Pathology, University of South Australia, Adelaide, Australia; Discipline of Medicine, University of Adelaide, Adelaide, SA 5000, Australia. · Department of Medical Oncology, Hospital Clinic Barcelona, Barcelona, Spain. · Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany. · UOC Oncologia Medica, Istituto di Ricerca e Cura a Carattere Scientifico, San Martino-IST, Genova, Italy. · Department of Medical Oncology, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Dermatovenerologická klinika, University Hospital Prague, Charles University, First Medical Faculty, Prague, Czech Republic. · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. · Afdelingshoofd, Medische Oncologie, Brussels, Belgium. · Department of Dermatology, University Medical Center, Tuebingen, Germany. · Istituto Oncologico Veneto, Padua, Italy. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · University of Athens, Athens, Greece. · Hospital La Paz, Madrid, Spain. · University Medical Centre Groningen, Groningen, the Netherlands. · Christie NHS Foundation Trust, Manchester, UK. · Oslo University Hospital, Oslo, Norway. · Melanoma Institute Australia, Royal North Shore Hospital, University of Sydney, Sydney, Australia. · Department of Dermatooncology, National Institute of Oncology, Budapest, Hungary. · Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland. · McGill University, Segal Cancer Centre, Montreal, Quebec, Canada. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: · Pubmed 30580112
  • Unit of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy. · Unit of Clinical Epidemiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Unit of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy. · Department of Internal Medicine, University of Genoa, Genoa, Italy. · Department of Health Sciences, University of Genoa, Genoa, Italy. · Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy. · iTeos Therapeutics, Gosselies, Belgium. · Department of Medical Oncology and Molecular Genetics Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy. · Sapienza University of Rome, Rome, Italy. · Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy. · Department of Medical Sciences, Section of Surgical Pathology, University of Turin, Turin, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione'G. Pascale', Naples, Italy. · Pubmed 30311027
2018
  • Service de Dermatologie et Cancérologie Cutanée, Aix-Marseille University and APHM University Hospital, Marseille, France. Electronic address: · Department of Dermatology, University Medical Center, Tuebingen, Germany. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy. · The Royal Marsden NHS Foundation Trust, London, UK. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Department of Dermatology and Comprehensive Cancer Centre, University Hospital Essen, Essen, Germany. · Pubmed 30507438
  • From the Istituto Nazionale Tumori "Fondazione G. Pascale," Naples, Italy; Massachusetts General Hospital Cancer Center, Boston, MA; Center for Cancer Research, National Cancer Institute, Bethesda, MD. · Pubmed 30231371
  • Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori - IRCCS Fondazione "G. Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. · Pubmed 30228935
  • Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. Electronic address: · Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. · Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Department of Dermatology, National Institute of Oncology, Budapest, Hungary. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Department of Dermato-oncology, University Hospital Prague and Charles University First Medical Faculty, Prague, Czech Republic. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · Melanoma Cancer Unit, Oncology Institute of Veneto IRCCS, Padua, Italy. · Department of Oncologic Dermatology, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux Cédex, France. · Department of Medical Oncology, Isala, Zwolle, Netherlands. · Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan. · Department of Dermatology, University Medical Center Mainz, Mainz, Germany. · Translational Clinical Oncology, Novartis Pharma AG, Basel, Switzerland. · Array BioPharma, Boulder, CO, USA. · Service of Dermatology, Department of Medicine and Paris-Sud University, Gustave Roussy, Villejuif Cedex, France. · Cancer Center, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 30219628
  • Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. Electronic address: · Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. · Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Department of Dermatology, National Institute of Oncology, Budapest, Hungary. · Department of Dermatology, University Hospital Tüebingen, Tüebingen, Germany. · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Department of Dermato-oncology, University Hospital Prague, Charles University First Medical Faculty, Prague, Czech Republic. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · Melanoma Cancer Unit, Oncology Institute of Veneto IRCCS, Padua, Italy. · Department of Oncologic Dermatology, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux, France. · Department of Medical Oncology, Isala, Zwolle, Netherlands. · Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan. · Department of Dermatology, University Medical Center Mainz, Mainz, Germany. · Translational Clinical Oncology, Novartis Pharma AG, Basel, Switzerland. · Array BioPharma, Boulder, CO, USA. · Service of Dermatology, Department of Medicine, Paris-Sud University, Gustave Roussy, Villejuif, France. · Cancer Center, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 29573941
  • Division of Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. Electronic address: · University of Colorado Comprehensive Cancer Center, Aurora, CO, USA. · N N Blokhin Russian Cancer Research Center, Ministry of Health, Moscow, Russia. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine. · Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Bristol Haematology and Oncology Centre, Bristol, UK. · Department of Cancer Immunology, Poznan University for Medical Sciences, Med-POLONIA, Poznan, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland. · Melanoma Translational Research Group, Melanoma Institute Australia, Wollstonecraft, NSW, Australia. · Genentech, Inc, South San Francisco, CA, USA. · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Pubmed 29477665
  • Department of Dermato Cancerology, Nantes University, Nantes 44093, France. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples 80131, Italy. · Princess Alexandra Hospital, Woolloongabba, QLD 4102, Australia. · National Institute of Oncology, Budapest 1122, Hungary. · Azienda Ospedaliera Universitaria Senese, Siena 53100, Italy. · Department of Oncology and Haematology, Papa Giovanni XXIII Hospital, Bergamo 24127, Italy. · N. N. Blokhin Russian Cancer Research Center, Moscow 115478, Russia. · Moscow City Oncology Hospital 62, Krasnogorsk 14301, Russia. · Service de Dermatologie, Centre Hospitalier Lyon Sud, Pierre-Bénite 69495, France. · Hospital Universitario Virgen Macarena, Seville 41009, Spain. · Hôpital Saint André, Bordeaux 33075, France. · Department of Dermatology, University of Tübingen, Tübingen 72074, Germany. · Genentech, Inc., South San Francisco, CA 94080, USA. · The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. · University of Melbourne, Parkville, VIC 3052, Australia. · Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA 90095, USA. · Pubmed 29438370
  • Genentech, Inc., South San Francisco, CA, USA. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA. · Nantes University, Nantes, France. · Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy. · Peter MacCallum Cancer Centre, East Melbourne, VIC., Australia. · University of Melbourne, Parkville, VIC., Australia. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · The Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 29156488
  • Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00161, Rome, Italy. · Present Address: High Resolution NMR Unit, Core Facilities, Istituto Superiore di Sanità, 00161, Rome, Italy. · Division of Medical Oncology 2, IRCSS Regina Elena National Cancer Institute, 00144, Rome, Italy. · Preclinical Models and New Therapeutics Agents Unit, IRCSS Regina Elena National Cancer Institute, 00144, Rome, Italy. · Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100, Catanzaro, Italy. · Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics research, San Gallicano Dermatologic Institute, IRCSS, 00144, Rome, Italy. · Department of Plastic and Reconstructive Surgery, San Gallicano Dermatologic Institute, IRCSS, 00144, Rome, Italy. · Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia. · Pathology Research laboratory, Sapienza University, Sant'Andrea Hospital, 00189, Rome, Italy. · Cellular Diagnostics Unit, Sapienza University, Sant'Andrea Hospital, 00189, Rome, Italy. · Istituto Cantonale di Patologia, Servizio di Citologia Clinica, 6600, Locarno, Switzerland. · Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", 80131, Naples, Italy. · Scientific Directorate, Istituto Nazionale Tumori IRCSS Regina Elena, 00128, Rome, Italy. · Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00161, Rome, Italy. · Pubmed 30558661
  • Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Cancer Biology, Oregon Health & Science University, Portland, OR, USA. · Department of Pathology, Providence Portland Medical Center, Portland, OR, USA. · Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy. · Melanoma and Sarcoma Surgery Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Unit of Pathology, IRCCS, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, USA. · Pubmed 30524879
  • Melanoma Institute Australia, Sydney, Australia. Electronic address: · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York, USA. · MD Anderson Cancer Center, Houston, USA. · University of Duisburg-Essen Hospital, Heidelberg, Germany. · Peter MacCallum Cancer Centre, Melbourne, Australia. · Crown Princess Mary Cancer Centre, Sydney, Australia; Westmead Hospital, Sydney, Australia. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Skin and Renal Unit, The Royal Marsden NHS Foundation Trust, London, UK; Francis Crick Institute, London, UK. · St Vincents Hospital, Sydney, Australia. · The Canberra Hospital, Canberra, Australia; ANU Medical School, Australian National University, Canberra, Australia. · University Hospital Zurich, Zurich, Switzerland. · Massachusetts General Hospital, Boston, USA. · Sir Charles Gairdner Hospital, Perth, Australia. · Princess Alexandra Hospital, Brisbane, Australia. · Liverpool Hospital, Sydney, Australia; Garvan Institute, Sydney, Australia. · Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy. · University of Tubingen, Tubingen, Germany. · Hannover Medical School, Hannover, Germany. · Vanderbilt Ingram Cancer Center, Nashville, USA. · Melanoma Institute Australia, Sydney, Australia; St Vincents Hospital, Sydney, Australia; University of New South Wales, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia; The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia. · Pubmed 30347289
  • University Hospital Schleswig-Holstein, Kiel, Germany. · The Royal Marsden NHS Foundation Trust, London, England. · The Jonsson Comprehensive Cancer Center at University of California, Los Angeles. · Nantes University, Nantes, France. · Massachusetts General Hospital, Boston. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · University of Colorado Comprehensive Cancer Center, Aurora. · Genentech Inc, South San Francisco, California. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · University of Melbourne, Parkville, Victoria, Australia. · Pubmed 30073321
  • Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Statistical Unit, Regina Elena National Cancer Institute, Rome, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, CNR, I-07100, Sassari, Italy. · Department of Diagnostic Pathology and Laboratory, Istituto Nazionale Tumori- IRCCS -Fondazione G. Pascale, Napoli, Italy. · Melanoma and Skin Cancers Surgery Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Napoli, Italy. · Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 30012216
  • Veneto Institute of Oncology IOVIRCCS, Padua, Italy. Electronic address: · Carol Davila University of Medicine and Pharmacy, Bucharest, Elias University Hospital, Bucharest, Romania. · Malta National Cancer Registry, Malta. · Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Department of Surgery Leiden University Medical Center, Leiden, The Netherlands. · Department of Plastic and Reconstructive Surgery, Tuscan Cancer Institute, Italy. · Cyprus Cancer Registry, Nicosia, Cyprus. · University Hospital Tuebingen, Tuebingen, Germany. · Cancer Registry Republic of Srpska, Banja Luka, Republika Srpska, Bosnia and Herzegovina. · Institute of Oncology, Ljubljana, Slovenia. · Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia. · The Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway. · Netherlands Comprehensive Cancer Organisation, The Netherlands. · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · Registro Tumori del Veneto, Padua, Italy. · Veneto Institute of Oncology IOVIRCCS, Padua, Italy. · Pubmed 30001892
  • Istituto Nazionale Tumori -IRCCS- 'Fondazione G. Pascale', 80131 Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, 07100 Sassari, Italy. · Pubmed 29956724
  • Istituto Nazionale Tumori Fondazione G. Pascale, Naples. · Odense University Hospital, Odense, Denmark. · European Institute of Oncology, Milan, Italy. · Karolinska Institutet, Stockholm, Sweden. · Hospital General Universitario Gregorio Marañon, Madrid, Spain. · Oxford University Hospitals NHS Foundation Trust, Oxford. · Gustave-Roussy and Paris-Sud University, Villejuif. · Lyon 1 University, Lyon Cancer Research Center, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · German Cancer Research Center (DKFZ) and Heidelberg University, Mannheim, Germany. · CHR Verviers East Belgium, Verviers, Belgium. · PRMA Consulting Ltd, Fleet, UK. · Pubmed 29750751
  • Department of Medical Sciences, University of Turin, Turin, Italy. · Italian Institute for Genomic Medicine, Turin, Italy. · Department of Agricultural, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy. · Statistics Unit Methodology for Clinical research Laboratory, Oncology Department, IRCCS, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapies O.U., Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Napoli, Italy. · Laboratory of Molecular Oncology, Istituto Dermopatico dell'Immacolata-IRCCS, Rome, Italy. · Department of Oncology and Dermatological Oncology, Istituto Dermopatico dell'Immacolata-IRCCS, Rome, Italy. · Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Pubmed 29721178
  • Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, NA, Italy. · Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori-Fondazione "G. Pascale", Naples, Italy. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The Angeles Clinic and Research Institute, Cedars Sinai Medical Care Foundation, Los Angeles, CA, USA. · Center for Melanoma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Pubmed 29665799
  • Department of Medical Oncology, IRCCS AOU San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Department of Plastic and Reconstructive Surgery, IRCCS AOU San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Department of Epidemiology, Biostatistics and Clinical Trials, IRCCS AOU San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italy. · Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy. · Pubmed 29552321
  • Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Department of Health Sciences, University of Genova, Genova, Italy. · Unit of Cellular Biology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Intergruppo Melanoma Italiano (IMI) and Department of Internal Medicine, University of Genova, Genova, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy. · Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. · Department of Medical Oncology, Molecular Genetics Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II,"Bari, Italy. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy. · Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy. · Pubmed 29531523
  • Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Surgical, Microsurgical and Medical Sciences, University of Sassari, Sassari, Italy. · Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy. · Istituto Nazionale Tumori, Fondazione Pascale, Napoli, Italy. · Pubmed 29492214
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G Pascale", 80131 Napoli, Italy. Electronic address: · Cancer Institute Gustave Roussy, University Paris-Sud, 98400 Villejuif/Paris-Sud, France. · Pubmed 29361473
  • The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK; CRUK Manchester Institute, Manchester, UK. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Westmead and Blacktown Hospitals, Westmead, Australia. · University Hospital of Zurich, Zurich, Switzerland. · Massachusetts General Hospital, Cancer Center, Boston, MA, USA. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia. · University Hospital Essen, Essen and German Cancer Consortium, Germany. · Schleswig-Holstein University Hospital, Kiel, Germany. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Australia. · Hospital Clínic de Barcelona, Barcelona, Spain. · Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Naples, Italy. · Medical Oncology and Immunotherapy University Hospital of Siena, Siena, Italy. · IRCCS - IRST (Istituto Scientifico Romagnolo per Lo Studio e La Cura Dei Tumori), Meldola, Italy. · The Royal Marsden NHS Foundation Trust, London, UK. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK. Electronic address: · Pubmed 29360604
  • Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, 'G. Pascale Tumor National Institute' - Naples, Naples, Italy. · Department of basic Medical Sciences, Neuroscience and Sense Organs, University of Bari 'Aldo Moro', Bari, Italy. · Pubmed 29308314
  • Perlmutter Cancer Center, NYU-Langone Medical Center New York, New York. · Smilow Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Biodesix Inc, Boulder, Colorado. · Pubmed 29208646
  • Elbe-Klinikum Buxtehude, Buxtehude, Germany. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Hospital Clinic Barcelona, Barcelona, Spain. · Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · University of Melbourne, Parkville, Vic., Australia. · Mapi, Stockholm, Sweden. · MSD SHARP & DOHME GMBH, Haar, Germany. · Merck & Co. Inc., Kenilworth, NJ, USA. · Pubmed 29044660
  • Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Via Mariano Semmola snc, 80131, Naples, NA, Italy. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Medical Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, OR, USA. · Istituto Nazionale Tumori-Fondazione "G. Pascale", Naples, Italy. · Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori-Fondazione "G.Pascale", Naples, Italy. · "Regina Elena" National Cancer Institute, Rome, Italy. · Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · Massachusetts General Hospital, Boston, MA, USA. · Department of Pathology and Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · The University of Chicago Medicine, Chicago, IL, USA. · Refuge Biotechnologies, Menlo Park, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Developmental Therapeutics Program, Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Weill Cornell Medical College, New York, NY, USA. · La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. · Immune Oncology Discovery and System Biology, AbbVie, Redwood City, CA, USA. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA. · Pubmed 30031393
  • Department of Medical Oncology, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Tumor Epigenetics, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Tumor Epigenetics, Ospedale Policlinico San Martino, Genova, Italy; Department of Health Sciences, University of Genova, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy; Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. · Department of Medical Oncology and Molecular Genetics Laboratory, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy. · Section of Surgical Pathology, Department of Medical Sciences, University of Turin, Turin, Italy. · Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy. · Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Italy. · Unit of Tumor Epigenetics, Ospedale Policlinico San Martino, Genova, Italy. Electronic address: · Pubmed 29743138
  • New York University Perlmutter Cancer Center, New York, NY · Bristol-Myers Squibb, Princeton, NJ · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy · Pubmed 29446288
  • Aix Marseille University and APHM University-Hospital Marseille France, France. Electronic address: · University of Essen and German Cancer Consortium, Heidelberg, Germany. · University of Manchester, Christie National Foundation Trust Manchester, UK. · Istituto Nazionale Tumori - Fondazione "G. Pascale", Napoli, Italy. · Royal Marsden Hospital, London, UK. · Mount Vernon Cancer Centre, UK. · Gustave Roussy and Paris-Sud University, Paris, France. · Universitätsklinikum Schleswig-Holstein, Kiel, Germany. · Laura and Isaac Perlmutter Cancer Center Professor of Medicine NYU, New-York, USA. · University of California, San Francisco, San Francisco, CA, USA. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · University of Zurich, Zurich, Switzerland. · Karolinska University Hospital Solna, Stockholm Sweden. · Medical University of Vienna, Austria. · The Ella Lemelbaum Institute for Immuno-Oncology Division of Oncology Sheba Medical Center Tel Hashomer, Israel. · Netherlands Cancer Institute, The Netherlands. · University Hospital Tuebingen, Germany. · Pubmed 29224903
2017
  • Melanoma, Cancer Immunotherapy & Innovative Therapy Department at National Cancer Institute of Naples, Naples 80131, Italy. · Pubmed 30190923
  • Paolo A. Ascierto: Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Napoli, Italy. · Pubmed 29340009
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Pubmed 28789707
  • Melanoma, Cancer Immunotherapy and Innovative Therapies Unit - Istituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy. · Pubmed 29296516
  • Department of Medical Oncology, San Gerardo Hospital, via G. B. Pergolesi, 20052 Monza, Italy. · Pathology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", via M. Semmola, 80131 Naples, Italy. · Hematology Unit, Department of Clinical and Surgical Medicine, University of Naples Federico II, via S. Pansini, 80131 Naples, Italy. · Oncology Unit, Department of Medicine, Surgery and Dentistry, University of Salerno, via Allende, 84081 Baronissi (Salerno), Italy. · Pharmacology Unit, Department of Medicine, Surgery and Dentistry, University of Salerno, via Allende, 84081 Baronissi (Salerno), Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", via M. Semmola, 80131 Naples, Italy. · Pubmed 29290886
  • Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: · Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Department of Dermatology, Timone Hospital and Aix-Marseille University, Marseille, France. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia, The University of Sydney, and Royal North Shore Hospital, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia and University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University of Tuebingen, Tuebingen, Germany. · Pubmed 28756137
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28537004
  • Department Melanoma, Soft Tissues, Musculoskeletal and Head & Neck, Italian National Cancer Institute - IRCCS Pascale Foundation, Naples, Italy. Electronic address: · Department of Otorhinolaryngology, University of Brescia, Italy. · Department of Pathology and Cytopathology, Italian National Cancer Institute - IRCCS Pascale Foundation, Naples, Italy. · Department of Radiology, University of Brescia, Italy. · Particle Therapy Cancer Research Institute, CNAO Foundation, Milan, Italy. · Evaluative Epidemiology Unit, Fondazione IRCCS "Istituto Nazionale dei Tumori", Milan, Italy. · First Department of Medicine, Laiko General Hospital, Athens, Greece. · Department Melanoma, Soft Tissues, Musculoskeletal and Head & Neck, Italian National Cancer Institute - IRCCS Pascale Foundation, Naples, Italy. · Pubmed 28325255
  • Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Napoli, Italia. · CROM, Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Napoli, Italia. · Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Catanzaro "Magna Graecia", Catanzaro, Italia. · Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. · Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Roma, Italia. · IRCCS Istituto Nazionale Tumori "Regina Elena", Roma, Italy. · Pubmed 28118616
  • Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28058658
  • The Angeles Clinic and Research Institute, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · Ella Lemelbaum Institute of Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · University of California, San Francisco, San Francisco, CA, USA. · University Hospital Essen, Essen, Germany. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of Arizona Cancer Center, Tucson, AZ, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · City of Hope, Duarte, CA, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 28961465
  • The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, The Netherlands. Electronic address: · The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Department of Medical Oncology, Hospital Clínic Barcelona, Barcelona, Spain. Electronic address: · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. Electronic address: · IRCCS San Martino-IST, Genova, Italy. Electronic address: · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · General University Hospital, Dermatooncology U, Prague, Czech Republic. Electronic address: · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. Electronic address: · Afdelingshoofd, Medische Oncologie, Brussels, Belgium. Electronic address: · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. Electronic address: · Oncology Institute of Veneto-IRCCS, Padova, Italy. Electronic address: · Papa Giovanni XIII Hospital, Bergamo, Italy. Electronic address: · University of Athens, Athens, Greece. Electronic address: · Hospital La Paz, Madrid, Spain. Electronic address: · University Medical Centre Groningen, Groningen, The Netherlands. Electronic address: · McGill University, Segal Cancer Centre, Montreal, Quebec, Canada. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia; Discipline of Medicine, University of Adelaide, Adelaide, Australia. Electronic address: · Pubmed 28501764
  • Department of Dermato Cancerology, Nantes University, Nantes, France. · Department of Medicine, Hematology/Oncology, Jonsson Comprehensive Cancer Center, The University of California, Los Angeles, Los Angeles, USA. · Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, Centre Hospitalier Lyon Sud, Lyon 1 University, Lyons Cancer Research Center, France. · Dermatology and Cutaneous Oncology, Aix-Marseille University Hôpital de la Timone AP-HM, Marseille, France. · Department of Clinical Development, Genentech Inc., South San Francisco, USA. · Product Development Oncology, Genentech Inc., South San Francisco, USA. · Biostatistics, Genentech Inc., South San Francisco, USA. · Medical Affairs, Genentech, Inc., South San Francisco, USA. · Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28444112
  • Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · Medical Oncology, National Cancer Institute, Milan, Italy. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan Medical University, Poznan, Poland. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain. · AP-HP Dermatology CIC Departments, Saint-Louis Hospital, INSERM U976, Université Paris Diderot, Paris, France. · Odense University Hospital, Odense, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland. · Chris O'Brien Lifehouse and Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia. · Eberhard Karls University, Tübingen, Germany. · University Medical Center, Mainz, Germany. · Department of Oncodermatology, INSERM Research Unit 892, Nantes University Hospital, Nantes, France. · Department of Dermatology, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Hospital de la Timone, Marseille, France. · National Institute of Oncology, Budapest, Hungary. · Oslo University Hospital, Oslo, Norway. · Medizinische Hochschule Hannover, Hannover, Germany. · Wojewodzkie Centrum Oncologii, Gdańsk, Poland. · Department of Dermatology, Reims University Hospital, Reims, France. · Medical University of Vienna, Vienna, Austria. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · University Hospital Essen, Essen, Germany. · Hôspital Claude Huriez, Lille, France. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Bristol-Myers Squibb, Princeton, NJ, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 28359784
  • Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. Electronic address: · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione Pascale, Via Mariano Semmola, Naples, Italy. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Department of Oncologic Dermatology, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux, France. · Medical Oncology and Immunotherapy, University Hospital of Siena, Viale Bracci, Siena, Italy. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian, Milan, Italy. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. · Department of Dermatology, Centre Hospitalier Lyon Sud, Lyons Cancer Research Center, Lyon 1 University, Pierre Bénite, France. · N N Blokhin Russian Cancer Research Center, Ministry of Health, Moscow, Russian Federation. · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. · Department of Medicine, University Health Network/Princess Margaret Hospital, Toronto, ON, Canada. · Department of Dermatology, National Institute of Oncology, Budapest, Hungary. · Department of Medical Oncology, Institute for Cancer Research, IRCCS San Martino, Largo Rosanna Benzi, Genova, Italy. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, USA. · Novartis Pharma AG, Basel, Switzerland. · Array BioPharma, Boulder, CO, USA. · Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. · Department of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 28284557
  • EORTC Headquarters, Brussels, Belgium. Electronic address: · EORTC Headquarters, Brussels, Belgium. · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Hôpital de la Timone, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Oncology Specialists S C, Park Ridge, IL, USA. · Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Paris. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, AB, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 28162999
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Clinica Universidad de Navarra, Pamplona, Spain. · The Angeles Clinic and Research Institute, Los Angeles, California. · Aarhus University Hospital, Aarhus, Denmark. · Gustave Roussy and Paris-Sud University Villejuif, Villejuif, France. · Istituto Oncologico Veneto, Padua, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy. · University Hospital of Siena, Siena, Italy. · Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania. · Bristol-Myers Squibb, Princeton, New Jersey. · Stanford University School of Medicine, Stanford, California. · Yale Comprehensive Cancer Center, New Haven, Connecticut. · Stanford University School of Medicine, Stanford, California. · Pubmed 27756788
  • IRCCS Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy. · University of Campania "Luigi Vanvitelli", Naples, Italy. · Peptipharma, Viale Città D'Europa 679, 00144, Rome, Italy. · Institute of Genetics and Biophysics, National Research Council, Naples, Italy. · IRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy. · IRCCS Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy. · University 'Parthenope', Via Acton 38, 80133, Naples, Italy. · Pubmed 29216889
  • Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084, Fisciano, SA, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapies O.U, National Cancer Institute "G. Pascale", Naples, Italy. · Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084, Fisciano, SA, Italy. · PhD Program in Drug Discovery and Development, University of Salerno, Fisciano, SA, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Pubmed 29202855
  • Institute of Genetics and Biophysics (IGB), A. Buzzati-Traverso, CNR, I-80131 Naples, Italy. · Istituto Nazionale Tumori Fondazione G. Pascale, I-80131 Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, CNR, I-07100 Sassari, Italy. · Unit of Pathology, Hospital-University Health Unit (AOU), I-07100 Sassari, Italy. · Department of Biomedical and Biotechnological Sciences-BIOMETEC, University of Catania, I-95100 Catania, Italy. · Pubmed 29048639
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Institut Gustave Roussy and Paris Sud University, Paris, France. · Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medicine, Hematology and Oncology, Jonsson Comprehensive Cancer Center at the University of California Los Angeles, Los Angeles, USA. · Division of Medical Oncology and Hematology, Princess Margaret Hospital and University Health Network, Toronto, Canada. · The Angeles Clinic and Research Institute, Melanoma Therapeutics, Los Angeles, USA. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples. · Melanoma and Sarcoma, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Oncology, University of Manchester, Manchester, UK. · Department of Dermatology, University of Zurich, Zurich, Switzerland. · Department of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Biostatistics in Product Development, Biometrics. · Clinical Department. · Product Development, Oncology, Genentech Inc., South San Francisco, USA. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne. · Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 28961848
  • Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Aix-Marseille University, Hôpital de la Timone, Marseille, France. · Ospedale Monaldi, Naples, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · University of Melbourne, Parkville, VIC, Australia. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK. · Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani 3, 41071, Seville, Spain. · Genentech, Inc., South San Francisco, CA, USA. · Nantes University, Nantes, France. · Pubmed 28646893
  • Genentech, Inc., South San Francisco, California. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, and University of Melbourne, Parkville, Victoria, Australia. · Nantes University, Nantes, France. · The Royal Marsden NHS Foundation Trust, London, United Kingdom. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · HistoGeneX, Antwerp, Belgium. · Genentech, Inc., South San Francisco, California. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, California. · Pubmed 28536307
  • Peter MacCallum Cancer Centre, East Melbourne, Australia. · Elbe-Klinikum Buxtehude, Buxtehude, Germany. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Hospital Clinic Barcelona, Barcelona, Spain. · Mapi, Stockholm, Sweden. · MSD Sharp & Dohme GmbH, Haar, Germany. · Universitäts-Hautklinik Kiel, Kiel, Germany. · Merck & Co., Inc., Kenilworth, New Jersey, USA. · Merck & Co., Inc., Kenilworth, New Jersey, USA · Pubmed 28526721
  • Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Department of Health Sciences, University of Genova, Genova, Italy. · Unit of Cellular Biology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. · Intergruppo Melanoma Italiano (IMI) and Department of Internal Medicine, University of Genova, Genova, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy. · Istituto Dermopatico dell'Immacolata IDI-IRCCS, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. · Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. · Department of Medical Oncology and Molecular Genetics Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy. · Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy. · Pubmed 28446908
  • Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Pansini, 5, 80131, Naples, Italy. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · CEINGE Biotecnologie Avanzate, Naples, Italy. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Pansini, 5, 80131, Naples, Italy. · Pubmed 28434031
  • Melanoma, Cancer Immunotherapy and Innovative Therapies O.U., Istituto Nazionale Tumori Fondazione "G. Pascale" , Napoli, Italy. · Regina Elena National Cancer Institute , Rome, Italy. · Unit of Melanoma and Sarcoma Surgery, Istituto Nazionale Tumori Fondazione , Napoli, Italy. · Pubmed 28405510
  • Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Campus - Germaneto , Catanzaro, Italy. · Department of Microbiology, Cell and Tumorbiology (MTC), Karolinska Institutet , Stockholm, Sweden. · Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Campus - Germaneto, Catanzaro, Italy; Department of Microbiology, Cell and Tumorbiology (MTC), Karolinska Institutet, Stockholm, Sweden. · Melanoma Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale ," Napoli, Italy. · Department of Oncology and Pathology, Karolinska Institutet , Stockholm, Sweden. · Karolinska Institutet Statistical Core Facility, Karolinska Institutet , Stockholm, Sweden. · Department of Health Sciences, University "Magna Græcia" of Catanzaro, Campus - Germaneto , Catanzaro, Italy. · Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Experimental Oncology and Molecular Medicine , Milan, Italy. · Department of Obstetrics and Gynecology, University of Cambridge Clinical School , Cambridge, UK. · Scientific Directorate, IRCCS Istituto Nazionale Tumori Fondazione "G. Pascale ," Napoli, Italy. · Pubmed 28344869
  • Dipartimento di Patologia Diagnostica e di Laboratorio: SC di Anatomia Patologica e Citopatologia, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Struttura Complessa di Oncologia Medica e Terapie Innovative, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Genomica Funzionale, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Pharmacy, University of Naples "Federico II", 80131, Naples, Italy. · Melanoma and Sarcoma Surgery Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, 07100, Sassari, Italy. · Department of Medicine and Surgery, University of Salerno, Baronissi, 84081, Salerno, Italy. · Department of Medicine and Surgery, University of Salerno, Baronissi, 84081, Salerno, Italy. · Dipartimento di Patologia Diagnostica e di Laboratorio: SC di Anatomia Patologica e Citopatologia, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 28231855
  • Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. Electronic address: · Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Oncology, Immunotherapy Unit, INSERM U932, Institut Curie, Paris, France. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany; School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London, UK. · Pubmed 28167454
  • Pathology Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italy. · Department of Psychiatry, Pathology Unit, University of Naples SUN, Naples, Italy. · Pubmed 28067428
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy. · Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Oncology & Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS "Regina Elena" National Cancer Institute, Rome, Italy. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York City, NY, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · INSERM (National Institute of Health and Medical Research), Institut Gustave Roussy, Villejuif, France. · Massachusetts General Hospital, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York City, NY, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany. · Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA. · Georgia Cancer Center, Augusta University, Augusta, GA, USA. · Department of Hematology/Oncology, University of Chicago Comprehensive Cancer Center, Chicago, IL, USA. · CNRS (National Center for Scientific Research, France), University Paris-Saclay, Gustave Roussy, Villejuif, France. · Division of Cancer Medicine, Department of Melanoma Medical Oncology-Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. · Pediatrics, Human Oncology and Genetics, University of Wisconsin, Madison, WI, USA. · UW Carbone Cancer Center, Madison, WI, USA. · Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Center for Cancer Immune Therapy (CCIT), Department of Hematology, University Hospital Herlev, Herlev, Denmark. · Department of Immunology and Microbiology, University of Copenhagen, Herlev, Denmark. · Clinical Center, National Institutes of Health, Bethesda, MD, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medicine, Immunology and Dermatology Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA. · Pubmed 29145885
  • INSERM (National Institute of Health and Medical Research), Paris, France. · Institute of Pathology, University of Bern, Bern, Switzerland. · Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, OR, USA. · Laboratory of Immunology, Hopital Européen Georges Pompidou, Paris, France. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · AbbVie Medical Corporation, Redwood City, CA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 29058595
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Medical Oncology Unit, G. Rummo Hospital, Benevento, Italy. · UT Southwestern, Medical Center, Dallas, TX, USA. · McGill Department of Oncology, McGill University, Montreal, Canada. · Medical Oncology, Yale School of Medicine, New Haven, CT, USA. · Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Section of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA. · Department of Urology and Gynecology, Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy. · Pubmed 29020960
  • Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital. · Departments of Allogeneic Stem Cell Transplantation and Hematology, Karolinska University Hospital. · Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. · Melanoma Unit, Royal Marsden NHS Foundation Trust, London. · Royal Marsden Hospital, London, UK. · Westmead Hospital, Melanoma Institute Australia and Macquarie University, Sydney, Australia. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Naples, Italy. · Pubmed 28407116
2016
  • Department of Dermatology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. · Department of Oncology, Lausanne University Hospital, Champ de l'Air, Rue du Bugnon 21, 1011, Lausanne, Switzerland. · Ludwig Centre and Swiss Institute of Bioinformatics, Génopode Building, 1015, Lausanne, Switzerland. · Istituto Nazionale Tumori, Fondazione 'G. Pascale', Via Mariano Semmola, 52, 80131, Naples, Italy. · Clinical Development, Amgen Europe GmbH, Dammstrasse 23, 6300, Zug, Switzerland. · Division of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands. · Pubmed 27372293
  • Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia. · Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131 Napoli, Italy. Electronic address: · Pubmed 26765776
  • Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. Electronic address: · 28355 Bremen, Germany. · Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Massachusetts General Hospital, Boston, MA, USA. · Dermatology Department, Timone Hospital and Aix-Marseille University, Marseille, France. · University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany. · Royal Marsden Hospital NHS Foundation Trust, London, UK. · Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. · University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. · University of California, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France. · Department of Dermatology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany. · Center for Dermatooncology, Department of Dermatology, University Tuebingen, 72074 Tuebingen, Germany. · Pubmed 26707829
  • a Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy , Istituto Nazionale Tumori Fondazione G. Pascale , Napoli , Italy. · b Sidra Medical and Research Centre , Doha , Qatar. · Pubmed 26642234
  • Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 27604993
  • Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia. Electronic address: · Nantes University, Nantes, France. · Princess Alexandra Hospital, Woolloongabba, QLD, Australia. · National Institute of Oncology, Budapest, Hungary. · Azienda Ospedaliera Universitaria Senese, Siena, Italy. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · N N Blokhin Russian Cancer Research Center, Moscow, Russia. · Moscow City Oncology Hospital 62, Krasnogorsk, Russia. · Centre Hospitalier Lyon Sud, Lyon 1 University, Lyon, France; Lyons Cancer Research Center, Lyon, France. · Hospital Universitario Virgen Macarena, Seville, Spain. · Hôpital Saint André, Bordeaux, France. · University of Tübingen, Tübingen, Germany. · Genentech Inc, South San Francisco, CA, USA. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, Los Angeles, CA, USA. · Royal Marsden NHS Foundation Trust, London, UK. · Pubmed 27480103
  • Melanoma Institute Australia, The University of Sydney, and Mater Hospital, Sydney, Australia · Gallipoli Medical Research Foundation and Princess Alexandra Hospital, Greenslopes, Australia. · Istituto Nazionale Tumori Fondazione Pascale, Napoli, Italy. · Gustave-Roussy, Paris, France. · University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany. · Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · BC Cancer Agency, University of British Columbia, Vancouver, Canada. · Adelphi Values, Boston, MA, USA. · Bristol-Myers Squibb, Princeton, NJ, USA. · Duke Clinical Research Institute, Durham, NC, USA. · Pubmed 27405322
  • Skin Cancer Center Hannover , Hannover Medical School , Hannover , Germany. · Unit of Immunotherapy of Human Tumors , Fondazione RCCS Istituto Nazionale dei Tumori , Milan , Italy. · Petrov Research Institute of Oncology , St. Petersburg , Russia. · Istituto Europeo Di Oncologia , Milano , Italy. · Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit , Istituto Nazionale Tumori Fondazione Pascale , Naples , Italy. · Cancer Research Center , Moscow , Russia. · Aix Marseille University Hôpital de la Timone, Service de Dermatologie , Marseille , France. · Immunotherapy Unit , Romagna Cancer Institute IRST- IRCCS , Meldola , Italy. · Department of Dermatology , University Hospital Essen , Essen , Germany. · Istituto Nazionale per la Ricerca sul Cancro Oncologia Medica , Genova , Italy. · Humanitas Cancer Center, Istituto Clinico Humanitas IRCCS , Rozzano , Italy. · Department of Dermatology , University of Mainz , Mainz , Germany. · Dermatology Clinic , Hôpital Hôtel-Dieu, CHU Nantes , Nantes , France. · Department of Dermatology , Skin Cancer Center, Schleswig-Holstein University Hospital , Kiel , Germany. · Department of Dermatology , Paracelsus Medical University, Klinikum Nuremberg , Nuremberg , Germany. · Département d'Oncologie Médicale , Centre Eugène Marquis , Rennes , France. · GSK Vaccines , Rixensart , Belgium. · GSK Vaccines, Rixensart, Belgium; Celyad, Mont-Saint-Guibert, Rixensart, Belgium. · GSK Vaccines, Rixensart, Belgium; Vianova-Biosciences, Lasne, Belgium. · Pubmed 27843625
  • Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione 'G. Pascale', Via Mariano Semmola, 80131 Napoli, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 27711085
  • Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Naples 80131, Italy; · Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Rome 00161, Italy; · Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210; · Department of Genetics, Genomic Sciences Icahn School of Medicine at Mount Sinai, New York, NY 10029; · Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Catanzaro "Magna Graecia", Catanzaro 88100, Italy; · Istituto Cantonale di Patologia, Servizio di Citologia Clinica, 6600 Locarno, Switzerland. · Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210; · Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Naples 80131, Italy; · Pubmed 27503895
  • Cancer Biology and Epigenomics Program, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. · Cancer Biology and Epigenomics Program, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA. · Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. · Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, 80131 Napoli, Italy. · Department of Pathology, Istituto Nazionale Tumori Fondazione Pascale, 80131 Napoli, Italy. · Cancer Biology and Epigenomics Program, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. · Pubmed 27446436
  • Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy. Electronic address: · European Institute of Oncology (IEO), Milano, Italy. · Department of Dermatology and Plastic Surgery, University of Rome ''La Sapienza'', Roma, Italy. · Department of Biomedical Sciences and Human Oncology, University of Torino, Torino, Italy. · Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy. · Department of Surgery and Advanced Cancer Therapies, Morgagni-Pierantoni Hospital, Forlì, Italy. · Plastic Surgery Unit, Tuscan Tumor Institute (ITT), Santa Maria Annunziata Hospital, Firenze, Italy. · National Cancer Institute, Fondazione Pascale, Naples, Italy. · Medical Oncology Unit, Giovanni Paolo II Cancer Institute, Bari, Italy. · Plastic Surgery Unit, San Gallicano Dermatology Institute, Roma, Italy. · Clinical Trials and Biostatistics Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy. · Pubmed 27424789
  • Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. Electronic address: · Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Department of Oncology, Immunotherapy Unit, INSERM U932, Institut Curie, Paris, France. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Research Group on Geriatrics, Charité - Universitaetsmedizin, Berlin, Germany; Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, Germany. · Research Group on Geriatrics, Charité - Universitaetsmedizin, Berlin, Germany. · Singapore Immunology Network, Agency for Science, Technology and Research, Singapore. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany; School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London, UK. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Pubmed 27400322
  • Melanoma, Cancer Immunotherapy, and Innovative Therapy, Istituto nazionale Tumori Fondazione "G Pascale", Napoli, 80131, Italy. Electronic address: · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospital, Sydney, Australia. · Pubmed 27324281
  • Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Department of Immunology, University of Tübingen, Tübingen, Germany. · Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Dermatology, University Hospital of Munich, Munich, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Dermatology, University of Zürich, Zürich, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy. · Department of Dermatology and Venereology, University Hospital of Cologne, Cologne, Germany. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Hospital Erlangen, Erlangen, Germany. · Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover, Germany. · Department of Dermatology and Allergology, University Hospital of Marburg, Marburg, Germany. · Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Dermatology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. · Department of Oncology, Service of Medical Oncology, Institut Curie, Paris, France. · Department of Dermatology, University Medical Center Dresden, Dresden, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27185375
  • Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, United Kingdom. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Pubmed 27169993
  • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan I-20146, Italy. · Department of Epidemiology, National Cancer Institute 'G. Pascale' Foundation, Naples I-80131, Italy. · Unit of Medical Oncology and Innovative Therapies, National Cancer Institute 'G. Pascale' Foundation, Naples I-80131, Italy. · Department of Surgical Oncological and Gastroenterological Sciences, Padua University, Padua I-35122, Italy; Melanoma and Sarcoma Unit, Veneto Oncological Institute for Research and Treatment, Padua I-35128, Italy. · Melanoma and Sarcoma Unit, Veneto Oncological Institute for Research and Treatment, Padua I-35128, Italy. · Department of Dermatology, Society of Clinical Oncology Santa Maria Degli Angeli Oncological Hospital, Pordenone I-33170, Italy. · Department of Dermatology, Tuscan Orthopaedic Institute Hospital 'Palagi', University of Florence, Florence I-50125, Italy. · Department of Medical Oncology, Company University Hospital San Martino, National Institute for Cancer Research, Genova I-16132, Italy. · Plastic Surgery Unit, St. Orsola-Malpighi Hospital, Bologna I-40138, Italy. · Department of Plastic and Reconstructive Surgery, University of Bari, Bari I-70121, Italy. · Dermatalogical Clinic, Institute for Research and Treatment San Matteo Hospital, Pavia I-27100, Italy. · Oncological Unit, Vito Fazzi Hospital, Lecce I-73100, Italy. · Dermatological Institute, Catholic University of America, Rome I-00153, Italy. · Melanoma Unit, European Institute of Oncology, Milan I-20146, Italy. · Dermatalogical Clinic, Maggiore Hospital, Trieste I-34125, Italy. · Department of Plastic and Reconstructive Surgery, Company University Hospital San Martino, National Institute for Cancer Research, Genova I-16132, Italy. · Pubmed 27073541
  • Istituto Nazionale Tumori Fondazione "G. Pascale" , Naples , Italy. · Pubmed 27047798
  • Oncology of Melanoma Unit, European Institute of Oncology, Milan. · Medical Oncology and Immunotherapy, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples. · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan. · Istituto Toscano Tumori, University Hospital of Siena, Siena. · IV Oncology Division, Istituto Dermopatico dell'Immacolata IRCCS, Rome. · Immunotherapy and Somatic Cell Therapy Unit, Scientific Institute of Romagna, Meldola. · Department of Medical Oncology, National Institute for Cancer Research, IRCCS San Martino, Genoa. · Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin. · Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo. · Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Statistical Unit, Regina Elena National Cancer Institute, Rome, Italy. · Oncology of Melanoma Unit, European Institute of Oncology, Milan · Pubmed 26802161
  • Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Memorial Sloan Kettering Cancer Center, New York, New York. · Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. · Department of Oncology, Service of Medical Oncology, Research Unit 932, Institut Curie, Paris, France. · Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany. · German Cancer Consortium (DKTK), Heidelberg, Germany. Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. · Department of Dermatology, University Medical Center, Tübingen, Germany. · Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Internal Medicine II, University Medical Center, Tübingen, Germany. · Department of Dermatology, University Medical Center, Tübingen, Germany. Department of Immunology, University of Tübingen, Tübingen, Germany. · Pubmed 26787752
  • Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy; Genetics of Rare Cancers, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy; Genetics of Rare Cancers, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. Electronic address: · Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy. · Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy; Department of Internal Medicine, Medical Specialties and Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, Istituto Oncologico Veneto (IOV)-IRCCS, Padua, Italy. · Section of Oncology and Immunology, Department of Surgery, Oncology, and Gastroenterology, University of Padua, Padua, Italy. · Melanoma and Soft Tissue Sarcoma Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy. · Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Melanoma and Sarcoma Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Medical Genetics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Department of Dermatology, University of Florence, Florence, Italy. · Unit of Medical Genetics, Department of Biomedical Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Plastic Surgery Unit, Regional Melanoma Referral Center, Santa Maria Annunziata Hospital, Florence, Italy. · Division of Dermatoncological Surgery, European Institute of Oncology, Milan, Italy. · Medical Oncology Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Dermatology Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Department of Medical Sciences, Dermatology Section, University of Turin, Turin, Italy. · Dermatoncological Surgery Unit, Presidio Sanitario Gradenigo, Turin, Italy. · Anatomopathology Unit, Università dell'Insubria, Ospedale di Circolo, Varese, Italy. · Dermatology Unit, Ospedale di Circolo, Varese, Italy. · Cancer Genetics Unit, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Melanoma, National Cancer Institute Pascale Foundation, Naples, Italy. · Dermatology Unit, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Plastic and Reconstructive Surgery, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Department of Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliera Universitaria (AOU) San Martino-Istituto Nazionale dei Tumori (IST) Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Pubmed 26775776
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
  • Laboratory of Integrative Cancer Immunology, INSERM UMRS1138 Cordeliers Research Center, University Pierre et Marie Curie, Paris 6, 15 Rue de l'Ecole de Medecine, 75006, Paris, France. · University Paris Descartes, 45 Rue Saints Pères, 75006, Paris, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, 97213, USA. · Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, 97239, USA. · Department of Pathology, Providence Portland Medical Center, Portland, OR, 97213, USA. · Department of Oncology-Pathology, The Karolinska Hospital, Stockholm, Sweden. · Institute of Pathology, University of Bern, Bern, Switzerland. · Unit of Pathology, IRCCS, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Sidra Medical and Research Center, Doha, Qatar. · IRCCS, Istituto Nazionale Tumori, Fondazione "G. Pascale",Scentific Directorate, Naples, Italy. · Laboratory of Integrative Cancer Immunology, INSERM UMRS1138, Cordeliers Research Center, 15 Rue de l'Ecole de Medecine, 75006, Paris, France. · Centre de Recherche des Cordeliers, University Pierre et Marie Curie, Paris 6, 15 Rue de l'Ecole de Medecine, 75006, Paris, France. · Immunomonitoring Platform, Laboratory of Immunology, Georges Pompidou European Hospital, 20-40 Rue Leblanc, 75015, Paris, France. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Pubmed 27650038
  • Istituto di Chimica Biomolecolare, CNR, Sassari, Italy. · Istituto Nazionale Tumori, Napoli, Italy. · Dipartimento di Chirurgia, Microchirurgia e Scienze Mediche, Università di Sassari, Sassari, Italy. · Istituto di Chimica Biomolecolare, CNR, Sassari, Italy. Electronic address: · Pubmed 27265006
2015
  • Institute of Biomolecular Chemistry, National Research Council (CNR), Sassari, Italy. · Department of Pathology, Hospital-University Health Unit (AOU), Sassari, Italy. · Skin Cancer Unit, Istituto Scientifico Romagnolo Tumori (IRST), Meldola, Italy. · Istituto Nazionale Tumori (INT), Fondazione G. Pascale, Naples, Italy. · Pubmed 30190844
  • Melanoma, Cancer Immunotherapy & Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Napoli, Italy. · Pubmed 30190830
  • Unità di Genetica dei Tumori, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche , Sassari , Italy. · Istituto di Scienze dell'Alimentazione, Consiglio Nazionale delle Ricerche , Avellino , Italy. · Dipartimento di Scienze Chirurgiche, Microchirurgiche e Mediche, Università di Sassari , Sassari , Italy. · Istituto Nazionale Tumori "Fondazione Pascale" , Naples , Italy. · Pubmed 26322273
  • Department of Oncology, Johns Hopkins University , Baltimore, MD , USA. · Department of Oncology, Centro de Investigación Médica Aplicada (CIMA), Clinica Universidad de Navarra , Pamplona , Spain. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale" , Napoli , Italy. · Pubmed 26217587
  • Istituto Nazionale Tumori, Fondazione "G. Pascale", Napoli, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Pubmed 26137543
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Oncology Division, Department of Clinical Medicine, University "Federico II" of Naples, Italy. Electronic address: · Oncology Division, Department of Clinical Medicine, University "Federico II" of Naples, Italy. Electronic address: · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Electronic address: · Pubmed 25511547
  • University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · University Hospital Essen, Essen, Germany. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sheba Medical Center, Tel Hashomer, Israel. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. · University Medical Center, Mainz, Germany. · Universitätsklinikum Tübingen, Tübingen, Germany. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. · St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. · University of North Carolina, Chapel Hill, NC, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Merck & Co, Kenilworth, NJ, USA. · University of California, San Francisco, San Francisco, CA, USA. · Pubmed 26115796
  • Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. Electronic address: · IOV-IRCCS, Melanoma Oncology Unit, Padova, Italy. · Aix-Marseille University, Hôpital de La Timone APHM, Marseille, France. · University of Zürich Hospital, Zürich, Switzerland. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Aarhus University Hospital, Aarhus, Denmark. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Oncology Specialists SC, Park Ridge, IL, USA. · Assistance Publique Hôpitaux de Paris, Dermatology and CIC Departments, Hôpital Saint Louis, University Paris 7, INSERM U976, France. · Istituti Fisioterapici Ospitalieri, Rome, Italy. · Cross Cancer Institute, Edmonton, Alberta, Canada. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Bristol-Myers Squibb, Wallingford, CT, USA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · EORTC Headquarters, Brussels, Belgium. · European Institute of Oncology, Milan, Italy. · Pubmed 25840693
  • Moffitt Cancer Center, Tampa, FL, USA. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · California Pacific Center for Melanoma Research, San Francisco, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Medizinische Hochschule Hannover, Hannover, Germany. · Universitair Ziekenhuis Brussel, Brussels, Belgium. · Medical University of Vienna, Vienna, Austria. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada. · University of Michigan, Ann Arbor, MI, USA. · Washington University, St Louis, MO, USA. · Centre Hospitalier Universitaire de Lyon, Lyon, France. · Christie Hospital, Manchester, UK. · Huntsman Cancer Institute, Salt Lake City, UT, USA. · German Cancer Research Centre University Hospital, Heidelberg, Germany. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Yale Cancer Center, New Haven, CT, USA. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Elbe Kliniken Buxtehude, Buxtehude, Germany. · Department of Medicine, University of California, Los Angeles, CA, USA. · Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA. · Department of Oncology, Herlev Hospital, Copenhagen, Denmark. · Aix-Marseille University, Hopital de la Timone, Marseille, France. · Technische Universität München School of Medicine, II Medical Department, Munich, Germany. · Bristol-Myers Squibb, Princeton, NJ, USA. · Bristol-Myers Squibb, Braine-I'Alleud, Belgium. · Royal Marsden Hospital, London, UK. · Pubmed 25795410
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena. · Medical Oncology and Innovative Therapies, Fondazione 'G. Pascale', National Cancer Institute, Naples. · Medical Oncology 2, IRCCS, AOU San Martino, Genoa. · Melanoma Unit, San Raffaele Scientific Institute, Milan. · Immunotherapy and Somatic Cell Therapy Unit, Scientific Institute of Romagna, Meldola. · Melanoma and Sarcoma Unit, National Institute for Cancer Research, Milan. · Dermatoncological Division, Istituto Europeo di Oncologia, Milan. · Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan. · Statistical Unit, Regina Elena National Cancer Institute, Rome. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena · Pubmed 25538176
  • Melanoma Department, Istituto Nazionale Tumori 'Fondazione Pascale' Napoli, Italy. · Division of Pathology, Istituto Nazionale Tumori 'Fondazione Pascale' Napoli, Italy. · Division of Anesthesiology, Istituto Nazionale Tumori 'Fondazione Pascale' Napoli, Italy. · Pubmed 30190842
  • Christie NHS Foundation Trust, Manchester, UK. · Istituto Nazionale Tumori, Fondazione G Pascale, Napoli, Italy. · Karolinska Institutet, Stockholm, Sweden. · Clinica Universitaria de Navarra, Pamplona, Spain. · Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Institute of Cancer Sciences, Manchester M20 4BX, UK. Electronic address: · Pubmed 26433815
  • Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Naples, Italy. · Dipartimento di Chirurgia "P. Valdoni", Sapienza Università di Roma, Rome, Italy. · Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Catanzaro "Magna Graecia", Catanzaro, Italy. · Takis S.r.l., Rome, Italy. · Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Rome, Italy. · Istituto Pasteur Fondazione Cenci Bolognetti, Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Rome, Italy. · Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Azienda Ospedaliera S. Andrea, Rome, Italy. · Pubmed 26208478
  • Melanoma and Sarcoma Surgery Unit; Istituto Nazionale Tumori Fondazione "G. Pascale" ; Naples, Italy. · Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione "G. Pascale" ; Naples, Italy. · Statistical Unit; Regina Elena National Cancer Institute ; Rome, Italy. · Scientific Direction; Istituto Nazionale Tumori Fondazione "G. Pascale" ; Naples, Italy. · Pubmed 26155423
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Oncology and Medicine, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, 3970 Reservoir Rd NW, Washington, DC, 20057, USA. · Pubmed 26141621
  • Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Naples, Italy. · Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy. · Melanoma Unit, National Cancer Institute 'G. Pascale Foundation', Naples, Italy. · Dermatology Section, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy. · Department of Biological Science, University of Portsmouth, Portsmouth, UK. · Pubmed 25895097
  • European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy. · Istituto Oncologico Veneto, Padova, Italy. · Istituto Nazionale dei Tumori di Napoli, Italy. · Federazione Italiana delle Associazioni di Volontariato in Oncologia, Italy. · Pubmed 25729424
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori - Fondazione 'G. Pascale', Via Mariano Semmola, 80131, Naples, Italy, · Pubmed 25549844
  • Institute of Genetics and Biophysics -I.G.B. A. Buzzati-Traverso- CNR, Naples I-80131, Italy; Dipartimento di Scienze Biomediche, Università degli Studi di Catania, Catania I-95124, Italy. Electronic address: · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine (DTM), Clinical Center (CC), Center for Human Immunology (CHI), National Institutes of Health (NIH), Bethesda, MD, United States; Sidra Medical and Research Center, Doha, Qatar. · Institute of Genetics and Biophysics -I.G.B. A. Buzzati-Traverso- CNR, Naples I-80131, Italy. · Institute of Genetics and Biophysics -I.G.B. A. Buzzati-Traverso- CNR, Naples I-80131, Italy; Institute of Biosciences and BioResources-IBB, CNR, Naples I-8013, Italy. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine (DTM), Clinical Center (CC), Center for Human Immunology (CHI), National Institutes of Health (NIH), Bethesda, MD, United States. · Dipartimento di Scienze Biomediche, Università degli Studi di Catania, Catania I-95124, Italy. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples I-80131, Italy. · Pubmed 25444926
  • Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Department of Genetic Medicine, Weill Cornell Medical College in Qatar, PO Box 24144, Doha, Qatar; Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar. Electronic address: · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Department of Biochemistry, Biocenter, University of Wuerzburg, Wuerzburg 97074, Germany; Genelux Corporation, San Diego Science Center, San Diego 92109, USA. · Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Center of Excellence for Biomedical Research (CEBR), University of Genoa, Italy. · Department of Biology, Northern Michigan University, Marquette, MI, USA. · Department of Genetic Medicine, Weill Cornell Medical College in Qatar, PO Box 24144, Doha, Qatar. · Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA; Institute of Infectious and Tropical Diseases, University of Milan, L. Sacco Hospital, Milan, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale", Via G. Semmola, Naples, Italy. · Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Pubmed 25174651
  • Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Translational Molecular Pathology, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Departments of Pathology and Laboratory Medicine and Surgery, David Geffen School of Medicine at University of California Los Angeles (UCLA), John Wayne Cancer Institute, Santa Monica, CA, USA. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · University of Manchester/Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre and University of Melbourne, Victoria, Australia. · Department of Oncology-Pathology, The Karolinska Hospital, Stockholm, Sweden. · Centro de Investigación Médica Aplicada, and Clinica Universidad de Navarra, Pamplona, Navarra, Spain. · Department of Dermatology, Harvard Medical School, Boston, MA, USA. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Division of Molecular Oncology, Unit of Bio-Immunotherapy of Solid Tumors, San Raffaele Institute, Milan, Italy. · Vanderbilt University Medical Center, Nashville, TN, USA. · Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Essen, Germany. · Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Centre, Doha, Qatar. · INSERM, UMRS1138, Laboratory of Integrative Cancer Immunology, Université Paris Descartes, Sorbonne Paris Cité, Centre de Recherche des Cordeliers, Paris, France. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 26619946
2014
  • Department of Melanoma and Soft Tissue, Istituto Nazionale Tumori Fondazione "G, Pascale", Via Mariano Semmola, 80131 Naples, Italy. · Pubmed 25015684
  • Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Pubmed 24577788
  • From Royal Marsden Hospital, London (J.L.) · Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Azienda Ospedaliera Universitaria Senese, Siena (M. Maio), and Papa Giovanni XXIII Hospital, Bergamo (M. Mandalà) - all in Italy · Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite (L.T.), and Hôpital Saint André, Bordeaux (C.D.) - all in France · Princess Alexandra Hospital, Woolloongabba, QLD (V.A.), and Peter MacCallum Cancer Centre, Melbourne, VIC (G.A.M.) - both in Australia · National Institute of Oncology, Budapest, Hungary (G.L.) · N.N. Blokhin Russian Cancer Research Center, Moscow (L.D.), and Moscow City Oncology Hospital 62, Krasnogorsk (D.S.) - both in Russia · Hospital Universitario Virgen Macarena, Seville, Spain (L.C.-M.) · University of Tübingen, Tübingen, Germany (C.G.) · Genentech, South San Francisco, CA (M.A.S., I.C., N.C., S.P.H.) · and Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles (A.R.). · Pubmed 25265494
  • Melanoma Cancer Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata, 64, 35128 Padua, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G Pascale', Via Cappella dei Cangiani, 1, 80131 Naples, Italy. · Medical Oncology and Immunotherapy Unit, University Hospital of Siena, Istituto Toscano Tumori, Strada delle Scotte, 14, 53100 Siena, Italy. · 1] Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy [2] Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035-39, 00189 Rome, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy. · Divisione Melanoma, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141 Milan, Italy. · Oncology of Melanoma Unit, Istituto Europeo di Oncologia, Via Ripamonti, 435, 20141 Milan, Italy. · Department of Medical Oncology A, San Martino Hospital, National Institute for Cancer Research, L.go R. Benzi, 10, 16132 Genoa, Italy. · Dermatologic Clinic, Department of Medical Sciences, University of Torino, San Giovanni Battista di Torino, Via Cherasco, 23, 10126 Turin, Italy. · Division of Medical Oncology, Institute for Cancer Research and Treatment, IRCC, Piedmont Oncology Foundation, Strada Provinciale, 142, 10060 Candiolo, Italy. · Unit of Medical Oncology, Papa Giovanni XXIII Hospital, Piazza OMS-Organizzazione Mondiale della Sanità, 1, 24127 Bergamo, Italy. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133 Milan, Italy. · Pubmed 24619072
  • Royal Marsden Hospital NHS Foundation Trust, London, UK. Electronic address: · Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Dermatooncology Department, General University Hospital, Prague, Czech Republic. · Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · Universitair Ziekenhuis Brussel, Brussels, Belgium. · Service of Oncology-Hospital La Paz, Madrid, Spain. · Universität Tübingen-Hautklinik, Tübingen, Germany. · Melanoma Oncology Unit, Veneto Oncology Institute, Gattamelata, Padova, Italy. · Medical Oncology, University of Athens, Greece. · Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands. · Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · IRCCS San Martino Hospital-IST, Genoa, Italy. · University Hospital Schleswig-Holstein, Department of Dermatology, Kiel, Germany. · Cancer Clinical Trials Unit, Royal Adelaide Hospital, and Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia. · F Hoffmann-La Roche, Basel, Switzerland. · Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. Electronic address: · Pubmed 24582505
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione "G. Pascale"; Naples, Italy. · Statistical Unit; Regina Elena National Cancer Institute; Rome, Italy. · Radiotherapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale"; Naples, Italy. · Radiology Unit; Istituto Nazionale Tumori Fondazione "G. Pascale"; Naples, Italy. · National Research Council; Sassari, Italy. · Scientific Direction; Istituto Nazionale Tumori Fondazione "G. Pascale"; Naples, Italy. · Melanoma and Sarcoma Surgery Unit; Istituto Nazionale Tumori Fondazione "G. Pascale"; Naples, Italy. · Pubmed 25083318
  • European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy. · Istituto Nazionale dei Tumori di Napoli, Italy. · Istituto Oncologico Veneto, Padova, Italy. · Federazione Italiana delle Associazioni di Volontariato in Oncologia, Italy. · Pubmed 25075214
  • Istituto Nazionale Tumori Fondazione 'G, Pascale', Napoli, Italy. · Pubmed 24885479
  • UOS Epigenetica dei Tumori, IRCCS A.O.U. San Martino-IST, Genova, Italy. · UOS Epigenetica dei Tumori, IRCCS A.O.U. San Martino-IST, Genova, Italy; Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università degli Studi di Genova, Genova, Italy. · UOC Biologia cellulare, IRCCS A.O.U. San Martino-IST, Genova, Italy. · UOC Epidemiologia Clinica, IRCCS A.O.U. San Martino-IST, Genova, Italy. · Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università degli Studi di Genova, Genova, Italy. · Unità di Oncologia Medica e Terapie Innovative, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · UOC Oncologia Medica 2, IRCCS A.O.U. San Martino-IST, Genova, Italy. · UOS Epigenetica dei Tumori, IRCCS A.O.U. San Martino-IST, Genova, Italy. Electronic address: · Pubmed 24801647
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
  • Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy,1. · Pubmed 24484235
  • Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Melanoma Cancer Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy. · "Paolo Giaccone" Polyclinic University Hospital, Palermo, Italy. · Divisione Melanoma e Sarcomi Muscolo-Cutanei, Istituto Europeo di Oncologia IEO-IRCCS, Milan, Italy. · Unità di Ricerca Traslazionale sul Melanoma, Divisione di Oncologia Medica del Melanoma, Istituto Europeo di Oncologia IEO-IRCCS, Milan, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy; Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Italy. · Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy. · San Martino Hospital, National Institute for Cancer Research, Genoa, Italy. · University Hospital Pisa, "Gathered Hospitals of Santa Chiara", Pisa, Italy. · Department of Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 24100024
2013
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale," Naples, Italy. · Pubmed 22874771
  • Alexander M.M. Eggermont, Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, and Université Paris-Sud, Kremlin Bicêtre, Paris, France · Stefan Suciu, Larissa Polders, and Michel Praet, European Organisation for Research and Treatment of Cancer, Brussels, Belgium · Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland · Jeremy Marsden, University Hospital Birmingham, Birmingham · Philippa Corrie, Addenbrookes Hospital, Cambridge · Poulam M. Patel, University of Nottingham, Nottingham · Neville Davidson, Broomfield Hospital, Broomfield, United Kingdom · Mario Santinami, Istituto Nazionale dei Tumori, Milan · Paolo A. Ascierto, Istituto Nazionale Tumori Fondazione Pascale, Napoli · Lorenzo Borgognoni, Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence · Maria Grazia Bernengo, University Hospital Turin, Turin, Italy · Steinar Aamdal, Oslo University Hospital and Radium Hospital, Oslo, Norway · Wim H. Kruit, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands · Lars Bastholt, Odense University Hospital, Odense, Denmark · and Alan Spatz, McGill University and Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Pubmed 24019551
  • Paolo A. Ascierto, Ester Simeone, Instituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy · David Minor, California Pacific Center for Melanoma Research and Treatment, San Francisco · Antoni Ribas, Jonsson Comprehensive Cancer Center, University of California, Los Angeles · Omid Hamid, Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA · Anne O'Hagan, Niki Arya, Mary Guckert, Anne-Marie Martin, Jolly Mazumdar, Vicki L. Goodman, GlaxoSmithKline Oncology, Collegeville · Ravi Amaravadi, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA · Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX · Celeste Lebbe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris, Université Paris Diderot, Paris · Jean-Jacques Grob, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France · Dirk Schadendorf, University Hospital Essen, Essen · Tabea Wilhelm, Uwe Trefzer, Charité-Universitätsmedizin, Berlin, Germany · Richard F. Kefford, Georgina V. Long, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia. · Pubmed 23918947
  • National Tumor Institute, Foundation G Pascale, Naples, Italy. · Pubmed 23414587
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Department of Melanoma, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Pubmed 23497384
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione G Pascale, Napoli, Italy. · Pubmed 23460532
  • Istituto Nazionale Tumori, Fondazione "G, Pascale", Naples, Italy. · Pubmed 23731854
2012
  • Department of Melanoma, Istituto Nazionale Tumori Fondazione G, Pascale, Naples, Italy. · Pubmed 22554099
  • Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G, Pascale, Naples, Italy. · Pubmed 22640478
  • Department of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 22551296
2011
  • Department of Melanoma, Sarcoma, and Head and Neck Disease, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 21439082
2010
  • Unit of Medical Oncology and Innovative Therapy, National Tumor Institute, Naples, Italy. · Pubmed 20406483
  • Unit of Medical Oncology and Innovative Therapy and Melanoma Cooperative Group, National Tumor Institute, Naples, Italy. · Pubmed 20712892
  • National Cancer Institute, Naples, Italy. · Pubmed 20707921
2019
  • From the Royal Marsden NHS Foundation Trust, London (J.L.), and the College of Medicine, Swansea University, Swansea (J.W.) - both in the United Kingdom · the Oncology Institute of Veneto IRCCS, Padua (V.C.-S.), the European Institute of Oncology, IRCCS, Milan (P.F.F.), Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and the Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital, Siena (M.M.) - all in Italy · the University of Colorado Cancer Center, Aurora (R.G.) · Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille Hôpital Timone, Marseille (J.-J.G.), and Université de Paris, INSERM Unité 976, Assistance Publique-Hôpitaux de Paris Dermatology and Centres d'Investigation Clinique, Saint Louis Hospital, Paris (C.L.) - both in France · the Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · the University of Michigan, Ann Arbor (C.D.L.) · Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.) · the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.) · Universitäts Spital, Zurich, Switzerland (R.D.) · Cross Cancer Institute, Edmonton, AB (M.S.), and the Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada · Tasman Oncology Research, Southport, QLD (A.H.), the Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney, Sydney, NSW (M.S.C., G.V.L.), and the Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and the Peter MacCallum Cancer Centre, Melbourne, VIC (G.M.) - all in Australia · General University Hospital Gregorio Marañon and Centro de Investigación Biomédica en Red de Oncología, Madrid (I.M.-R.) · the Netherlands Cancer Institute, Amsterdam (J.H.) · the Leuven Cancer Institute, Department of General Medical Oncology, University Hospital Leuven, Leuven, Belgium (P.S.) · University of California San Diego Health-La Jolla Moores Cancer Center, La Jolla (G.A.D.) · the Department of Oncology, Odense University Hospital, Odense, Denmark (L.B.) · Bristol-Myers Squibb, Princeton, NJ (J.I.R., A.B., A.M.) · Dana-Farber Cancer Institute, Boston (F.S.H.) · and the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W.). · Pubmed 31562797
2018
  • From the Gustave Roussy Cancer Campus Grand Paris and University Paris-Saclay, Villejuif (A.M.M.E., C.R.), Hospices Civils de Lyon Cancer Institute, Cancer Research Center of Lyon, Lyon University, Lyon (S.D.), and Aix-Marseille University, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille (J.-J.G.) - all in France · Netherlands Cancer Institute-Antoni van Leeuwenhoek (C.U.B., A.C.J.A.) and VU University Medical Center (A.J.M.E.), Amsterdam, and Radboud University Medical Center Nijmegen, Nijmegen (R.K.) - all in the Netherlands · Azienda Ospedaliera Papa Giovanni XXIII, Bergamo (M. Mandala), Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples (P.A.A.), and Universita Degli Studi Di Siena-Policlinico le Scotte, Siena (M. Maio) - all in Italy · Melanoma Institute Australia, the University of Sydney, and Mater and Royal North Shore Hospitals (G.V.L.) and Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney (M.S.C.), Sydney, Princess Alexandra Hospital, University of Queensland, Brisbane (V.A.), Alfred Hospital (A.H.) and Peter MacCallum Cancer Centre (S. Sandhu), Melbourne, VIC, and Fiona Stanley Hospital-University of Western Australia-Edith Cowan University Perth, Perth (A.K.) - all in Australia · Cancer Research Center, Moscow (M.L.) · Royal Marsden Hospital, London (J.L.) · Hospital Clinic Universitari de Barcelona, Barcelona (S.P.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · University Hospital Essen, Essen and German Cancer Consortium, Heidelberg (D.S.), and the Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover (R.G.) - all in Germany · Washington University School of Medicine, St. Louis (L.H.-A.) · Centre Hospitalier de l'Université de Montréal (CHUM), Centre de Recherche du CHUM, Montreal (R.J.) · Christie NHS Foundation Trust, Manchester, United Kingdom (P.L.) · Merck, Kenilworth, NJ (N.I.) · and the European Organization for the Research and Treatment of Cancer Headquarters, Brussels (S.M., S. Suciu). · Pubmed 29658430
2017
  • From New York University Perlmutter Cancer Center, New York (J.W.) · Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M. Mandala), Medical Oncology, National Cancer Institute, Milan (M.D.V.), Oncology Institute of Veneto Istituti di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M. Maio), Ospedale Policlinico San Martino, Genoa (P.Q.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · National and Kapodistrian University of Athens, Athens (H.J.G.) · Hospital Clinic de Barcelona, Barcelona (A.M.A.), and General University Hospital Gregorio Marañón, Madrid (I.M.-R.) - both in Spain · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · Hospices Civils de Lyon, Pierre Bénite (S.D.), Aix-Marseille University, Hospital de la Timone, Marseille (J.-J.G.), Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse (N.M.), Université Lille, INSERM Unité 1189, CHU Lille, Lille (L.M.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint Louis, Université Paris Diderot, Paris (C.L.) - all in France · Oncology Center Sf. Nectarie, Craiova, Romania (M. Schenker) · Princess Margaret Cancer Centre, University of Toronto, Toronto (M.O.B.), and Cross Cancer Institute, Edmonton, AB (M. Smylie) - both in Canada · the Department of Oncology, University of Oxford, Oxford (M.R.M.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · Gallipoli Medical Research Foundation and University of Queensland, Queensland, VIC (V.A.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.) - all in Australia · University of Colorado, Denver (R.G.) · Winship Cancer Institute, Emory University School of Medicine, Atlanta (R.R.K.) · Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.) · University of Washington, Seattle (S.B.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Nagoya University Graduate School of Medicine, Nagoya (K.Y.), and the National Cancer Center Hospital, Tokyo (N.Y.) - both in Japan · Seoul National University Hospital, Seoul, South Korea (T.M.K.) · and Bristol-Myers Squibb, Princeton, NJ (V.P, J.S., A.Q.). · Pubmed 28891423
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.) · Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · University of Colorado, Denver (R.G.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · University of Michigan, Ann Arbor (C.D.L.) · the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.) · Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada · Universitäts Spital, Zurich, Switzerland (R.D.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia · Netherlands Cancer Institute, Amsterdam (J.H.) · University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.) · General University Hospital Gregorio Marañón, Madrid (I.M.-R.) · Northwestern University, Chicago (J.S.) · Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.) · and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
  • aDepartment of Medical Oncology, Royal North Shore Hospital bDepartment of Medical Oncology Melanoma Institute Australia cDepartment of Medical Oncology, The University of Sydney, Sydney, New South Wales, Australia dDepartment of Medical Oncology, Istituto Nazionale Tumori 'Fondazione Pascale', Naples, Campania, Italy. · Pubmed 28230715
2016
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France · the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy · University of Zurich Hospital, Zurich, Switzerland (R.D.) · Memorial Sloan Kettering Cancer Center, New York (J.D.W.) · Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark · the Angeles Clinic and Research Institute, Los Angeles (O.H.) · Oncology Specialists, Park Ridge, IL (J.M.R.) · Cross Cancer Institute, Edmonton, AB, Canada (M.S.) · H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.) · Broomfield Hospital, Chelmsford, United Kingdom (S.T.) · Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany · Dana-Farber Cancer Institute, Boston (F.S.H.) · Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.) · and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
2015
  • aDepartment of Dermatology, University Hospital Zürich, Zürich, Switzerland bDepartment of Dermatology, University Hospital Essen, Essen cDepartment of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany dIstituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy eRoyal Marsden NHS Foundation Trust, London, UK fAPHP Oncodermatology Unit, University Paris 7 Diderot U976, Paris, France. · Pubmed 26426764
  • O.U. Melanoma, Cancer Immunotherapy and Innovative Therapies, National Cancer Institute of Naples "G. Pascale" Foundation, Naples, Italy. · Pubmed 26175403
  • 1First Department of Medicine, Athens University Medical School, Athens, Greece; 2Division of Medical Oncology, Baskent University School of Medicine, Adana, Turkey; 3Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy; 4Department of Biotherapy, Blokhin Cancer Center, Moscow, Russia; 5Department of Dermatology, Medical University of Vienna, Vienna, Austria; 6Department of Dermatology, Institute Gustave Roussy, Villejuif Cedex, France; 7Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel; 8Department of Dermatologie, University of Kiel, Kiel, Germany; and 9Oncology Service, Hospital La Paz, Madrid, Spain. · Pubmed 24176884
  • From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.) · Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France · Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.) · Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.) · Department of Dermatology, University of Essen, Essen, Germany (D.S.) · University of Zürich Hospital, Zurich, Switzerland (R.D.) · Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie) · Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia · Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.) · Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.) · Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York · Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.) · Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc · Pubmed 26027431
  • aDivision of Melanoma, Cancer Immunotherapy and Innovative Therapies bDivision of Melanoma and Skin Cancer cDepartment of Diagnostic Imaging, Radiant and Metabolic Therapy, Division of Radiology dDivision of Radiotherapy, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 25622086
2014
  • Istituto Nazionale Tunori Fondazione 'G. Pascale', Naples, Italy. · Pubmed 24419498
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy. · Pubmed 24258976
  • Unit of Melanoma, Immunotherapy and Innovative Therapies, Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G. Pascale, Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24114495
  • Pathology Unit, Istituto Nazionale Tumori Fondazione, "G. Pascale", via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24993904
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS, Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 24695951
2013
  • National Cancer Institute-Fondazione Pascale, Naples, Italy. · Pubmed 23036080
  • Department of Melanoma, Istituto Nazionale Tumori Fondazione Pascale, Via Mariano Semmola, 80131, Naples, Italy. · Pubmed 23402397
  • Unit of Surgery "Melanoma - Soft Tissues - Head & Neck - Skin Cancers", Istituto Nazionale per lo Studio e la cura dei tumori "Fondazione G,Pascale" IRCCS, Naples, Italy. · Pubmed 24289268
  • Department Melanoma, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Pubmed 23317446
2012
  • Unit of Medical Oncology and Innovative Therapy, G Pascale Institute of National Tumor Foundation, Naples, Italy. · Pubmed 22993335
  • Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Pubmed 22524673
  • Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione, G, Pascale, Napoli, Italy. · Pubmed 22433222
  • Department of Surgery, National Cancer Institute, Via Mariano Semmola, Naples, Italy. · Pubmed 22800396
  • Pathology Unit, Istituto Nazionale Tumori Fondazione G, Pascale, via Mariano Semmola, 80131, Naples, Italy. · Pubmed 22583695
2011
  • Division of Cardiology, National Cancer Institute, Sen. Pascale Foundation, via Mariano Semmola, 80131 Naples, Italy. · Pubmed 21705351
National Institutes of Health
2018
  • From the Istituto Nazionale Tumori "Fondazione G. Pascale," Naples, Italy; Massachusetts General Hospital Cancer Center, Boston, MA; Center for Cancer Research, National Cancer Institute, Bethesda, MD. · Pubmed 30231371
Harvard University Boston
2018
  • From the Istituto Nazionale Tumori "Fondazione G. Pascale," Naples, Italy; Massachusetts General Hospital Cancer Center, Boston, MA; Center for Cancer Research, National Cancer Institute, Bethesda, MD. · Pubmed 30231371
Unspecified
2016
  • General Dermatology and Oncology Service, Ambroise-Paré Hospital, AP-HP, University of Versailles-Saint-Quentin-en-Yvelines, Boulogne, France · Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · National Institute for Tumors Foundation 'G. Pascale', Napoli. · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Department of Dermatology and Skin Cancers, La Timone APHM Hospital, Aix-Marseille University, Marseille, France. · Department of Biochemistry and Molecular Biology, Poznań University of Medical Sciences, Poznań, Poland. · Dermatology Clinic, Hôtel-Dieu Hospital, CHU Nantes, Nantes, France. · Department of Surgical Oncology, UTMD Anderson Cancer Center, Houston. · Moffitt Cancer Center, Tampa, USA. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Center and Institute of Oncology, Warsaw, Poland. · Melanoma and Soft Tissue Sarcoma Division, European Institute of Oncology, Milan, Italy. · Petrov Research Institute of Oncology, St Petersburg, Russian Federation. · Department of Dermatology, University of Heidelberg, Heidelberg, Germany. · Department of Dermatology, University Hospital of Brest, Brest, France. · GSK Vaccines, Rixensart, Belgium. · Pubmed 27502712
2015
Miscellaneous institutions in Naples, IT
2015
  • 1 Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori—Fondazione G. Pascale, Naples, Italy; · 2 Odense University Hospital, Odense, Denmark; · 3 Newcastle University, Newcastle, Australia; · 4 Instituto de Onco-logia Angel Rolfo, Buenos Aires, Argentina; · 5 Institut Gustave Roussy, Villejuif, France; · 6 University of Kiel, Kiel, Germany; · 7 Hospital La Paz, Madrid, Spain; · 8 Institut Gustave Roussy, Villejuif, France. · Pubmed 24185314
2013
  • Department of Melanoma, Sarcoma and Skin Cancer, Via Mariano Semmola, Naples 80131, Italy. · Pubmed 23379355
2012
Azienda Ospedaliera Universitaria Senese
2014
  • From Royal Marsden Hospital, London (J.L.) · Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Azienda Ospedaliera Universitaria Senese, Siena (M. Maio), and Papa Giovanni XXIII Hospital, Bergamo (M. Mandalà) - all in Italy · Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite (L.T.), and Hôpital Saint André, Bordeaux (C.D.) - all in France · Princess Alexandra Hospital, Woolloongabba, QLD (V.A.), and Peter MacCallum Cancer Centre, Melbourne, VIC (G.A.M.) - both in Australia · National Institute of Oncology, Budapest, Hungary (G.L.) · N.N. Blokhin Russian Cancer Research Center, Moscow (L.D.), and Moscow City Oncology Hospital 62, Krasnogorsk (D.S.) - both in Russia · Hospital Universitario Virgen Macarena, Seville, Spain (L.C.-M.) · University of Tübingen, Tübingen, Germany (C.G.) · Genentech, South San Francisco, CA (M.A.S., I.C., N.C., S.P.H.) · and Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles (A.R.). · Pubmed 25265494
2019
  • From the Royal Marsden NHS Foundation Trust, London (J.L.), and the College of Medicine, Swansea University, Swansea (J.W.) - both in the United Kingdom · the Oncology Institute of Veneto IRCCS, Padua (V.C.-S.), the European Institute of Oncology, IRCCS, Milan (P.F.F.), Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and the Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital, Siena (M.M.) - all in Italy · the University of Colorado Cancer Center, Aurora (R.G.) · Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille Hôpital Timone, Marseille (J.-J.G.), and Université de Paris, INSERM Unité 976, Assistance Publique-Hôpitaux de Paris Dermatology and Centres d'Investigation Clinique, Saint Louis Hospital, Paris (C.L.) - both in France · the Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · the University of Michigan, Ann Arbor (C.D.L.) · Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.) · the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.) · Universitäts Spital, Zurich, Switzerland (R.D.) · Cross Cancer Institute, Edmonton, AB (M.S.), and the Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada · Tasman Oncology Research, Southport, QLD (A.H.), the Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney, Sydney, NSW (M.S.C., G.V.L.), and the Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and the Peter MacCallum Cancer Centre, Melbourne, VIC (G.M.) - all in Australia · General University Hospital Gregorio Marañon and Centro de Investigación Biomédica en Red de Oncología, Madrid (I.M.-R.) · the Netherlands Cancer Institute, Amsterdam (J.H.) · the Leuven Cancer Institute, Department of General Medical Oncology, University Hospital Leuven, Leuven, Belgium (P.S.) · University of California San Diego Health-La Jolla Moores Cancer Center, La Jolla (G.A.D.) · the Department of Oncology, Odense University Hospital, Odense, Denmark (L.B.) · Bristol-Myers Squibb, Princeton, NJ (J.I.R., A.B., A.M.) · Dana-Farber Cancer Institute, Boston (F.S.H.) · and the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W.). · Pubmed 31562797
2018
  • From the Gustave Roussy Cancer Campus Grand Paris and University Paris-Saclay, Villejuif (A.M.M.E., C.R.), Hospices Civils de Lyon Cancer Institute, Cancer Research Center of Lyon, Lyon University, Lyon (S.D.), and Aix-Marseille University, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille (J.-J.G.) - all in France · Netherlands Cancer Institute-Antoni van Leeuwenhoek (C.U.B., A.C.J.A.) and VU University Medical Center (A.J.M.E.), Amsterdam, and Radboud University Medical Center Nijmegen, Nijmegen (R.K.) - all in the Netherlands · Azienda Ospedaliera Papa Giovanni XXIII, Bergamo (M. Mandala), Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples (P.A.A.), and Universita Degli Studi Di Siena-Policlinico le Scotte, Siena (M. Maio) - all in Italy · Melanoma Institute Australia, the University of Sydney, and Mater and Royal North Shore Hospitals (G.V.L.) and Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney (M.S.C.), Sydney, Princess Alexandra Hospital, University of Queensland, Brisbane (V.A.), Alfred Hospital (A.H.) and Peter MacCallum Cancer Centre (S. Sandhu), Melbourne, VIC, and Fiona Stanley Hospital-University of Western Australia-Edith Cowan University Perth, Perth (A.K.) - all in Australia · Cancer Research Center, Moscow (M.L.) · Royal Marsden Hospital, London (J.L.) · Hospital Clinic Universitari de Barcelona, Barcelona (S.P.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · University Hospital Essen, Essen and German Cancer Consortium, Heidelberg (D.S.), and the Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover (R.G.) - all in Germany · Washington University School of Medicine, St. Louis (L.H.-A.) · Centre Hospitalier de l'Université de Montréal (CHUM), Centre de Recherche du CHUM, Montreal (R.J.) · Christie NHS Foundation Trust, Manchester, United Kingdom (P.L.) · Merck, Kenilworth, NJ (N.I.) · and the European Organization for the Research and Treatment of Cancer Headquarters, Brussels (S.M., S. Suciu). · Pubmed 29658430
2017
  • From New York University Perlmutter Cancer Center, New York (J.W.) · Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M. Mandala), Medical Oncology, National Cancer Institute, Milan (M.D.V.), Oncology Institute of Veneto Istituti di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M. Maio), Ospedale Policlinico San Martino, Genoa (P.Q.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · National and Kapodistrian University of Athens, Athens (H.J.G.) · Hospital Clinic de Barcelona, Barcelona (A.M.A.), and General University Hospital Gregorio Marañón, Madrid (I.M.-R.) - both in Spain · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · Hospices Civils de Lyon, Pierre Bénite (S.D.), Aix-Marseille University, Hospital de la Timone, Marseille (J.-J.G.), Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse (N.M.), Université Lille, INSERM Unité 1189, CHU Lille, Lille (L.M.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint Louis, Université Paris Diderot, Paris (C.L.) - all in France · Oncology Center Sf. Nectarie, Craiova, Romania (M. Schenker) · Princess Margaret Cancer Centre, University of Toronto, Toronto (M.O.B.), and Cross Cancer Institute, Edmonton, AB (M. Smylie) - both in Canada · the Department of Oncology, University of Oxford, Oxford (M.R.M.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · Gallipoli Medical Research Foundation and University of Queensland, Queensland, VIC (V.A.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.) - all in Australia · University of Colorado, Denver (R.G.) · Winship Cancer Institute, Emory University School of Medicine, Atlanta (R.R.K.) · Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.) · University of Washington, Seattle (S.B.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Nagoya University Graduate School of Medicine, Nagoya (K.Y.), and the National Cancer Center Hospital, Tokyo (N.Y.) - both in Japan · Seoul National University Hospital, Seoul, South Korea (T.M.K.) · and Bristol-Myers Squibb, Princeton, NJ (V.P, J.S., A.Q.). · Pubmed 28891423
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.) · Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · University of Colorado, Denver (R.G.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · University of Michigan, Ann Arbor (C.D.L.) · the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.) · Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada · Universitäts Spital, Zurich, Switzerland (R.D.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia · Netherlands Cancer Institute, Amsterdam (J.H.) · University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.) · General University Hospital Gregorio Marañón, Madrid (I.M.-R.) · Northwestern University, Chicago (J.S.) · Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.) · and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
2016
  • From Gustave Roussy Cancer Campus Grand Paris, Villejuif (A.M.M.E., C.R.), Aix-Marseille University, Hôpital de La Timone, Marseille (J.-J.G.), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris (C.L.), University Lille, INSERM Unité-1189, Centre Hospitalier Universitaire (CHU) Lille, Service de Dermatologie, Lille (L.M.), and CHU Lyon, Lyon (L.T.) - all in France · the Oncology Institute of Veneto-Istituto di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Istituti Fisioterapici Ospitalieri, Rome (V.F.), University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), and the European Institute of Oncology, Milan (A.T.) - all in Italy · University of Zurich Hospital, Zurich, Switzerland (R.D.) · Memorial Sloan Kettering Cancer Center, New York (J.D.W.) · Aarhus University Hospital, Aarhus (H.S.), and Odense University Hospital, Odense (L.B.) - both in Denmark · the Angeles Clinic and Research Institute, Los Angeles (O.H.) · Oncology Specialists, Park Ridge, IL (J.M.R.) · Cross Cancer Institute, Edmonton, AB, Canada (M.S.) · H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.) · Broomfield Hospital, Chelmsford, United Kingdom (S.T.) · Universitätsklinikum Schleswig-Holstein, Kiel (A.H.), and University Hospital Heidelberg, Heidelberg (J.C.H.) - both in Germany · Dana-Farber Cancer Institute, Boston (F.S.H.) · Bristol-Myers Squibb, Princeton, NJ (C.T., V.P.) · and the European Organization for Research and Treatment of Cancer, Brussels (G.S., S.S.). · Pubmed 27717298
2015
  • From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.) · Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France · Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.) · Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.) · Department of Dermatology, University of Essen, Essen, Germany (D.S.) · University of Zürich Hospital, Zurich, Switzerland (R.D.) · Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie) · Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia · Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.) · Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.) · Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York · Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.) · Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc · Pubmed 26027431
2013
  • Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Tuscan Cancer Institute, Siena. · Pubmed 24067719
2012
  • Medical Oncology and Immunotherapy, Azienda Ospedaliera Universitaria Senese, Istituto Toscano Tumori, Siena, Italy. · Pubmed 22894884
  • Medical Oncology and Immunotherapy, Azienda Ospedaliera Universitaria Senese, Istituto Toscano Tumori, Strada delle Scotte, 53100, Siena, Italy. · Pubmed 23116062
Azienda Ospedaliera Papa Giovanni XXIII
2014
  • From Royal Marsden Hospital, London (J.L.) · Istituto Nazionale Tumori Fondazione G. Pascale, Naples (P.A.A.), Azienda Ospedaliera Universitaria Senese, Siena (M. Maio), and Papa Giovanni XXIII Hospital, Bergamo (M. Mandalà) - all in Italy · Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.), Centre Hospitalier Lyon Sud, Pierre-Bénite (L.T.), and Hôpital Saint André, Bordeaux (C.D.) - all in France · Princess Alexandra Hospital, Woolloongabba, QLD (V.A.), and Peter MacCallum Cancer Centre, Melbourne, VIC (G.A.M.) - both in Australia · National Institute of Oncology, Budapest, Hungary (G.L.) · N.N. Blokhin Russian Cancer Research Center, Moscow (L.D.), and Moscow City Oncology Hospital 62, Krasnogorsk (D.S.) - both in Russia · Hospital Universitario Virgen Macarena, Seville, Spain (L.C.-M.) · University of Tübingen, Tübingen, Germany (C.G.) · Genentech, South San Francisco, CA (M.A.S., I.C., N.C., S.P.H.) · and Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles (A.R.). · Pubmed 25265494
2018
  • From the Gustave Roussy Cancer Campus Grand Paris and University Paris-Saclay, Villejuif (A.M.M.E., C.R.), Hospices Civils de Lyon Cancer Institute, Cancer Research Center of Lyon, Lyon University, Lyon (S.D.), and Aix-Marseille University, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille (J.-J.G.) - all in France · Netherlands Cancer Institute-Antoni van Leeuwenhoek (C.U.B., A.C.J.A.) and VU University Medical Center (A.J.M.E.), Amsterdam, and Radboud University Medical Center Nijmegen, Nijmegen (R.K.) - all in the Netherlands · Azienda Ospedaliera Papa Giovanni XXIII, Bergamo (M. Mandala), Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples (P.A.A.), and Universita Degli Studi Di Siena-Policlinico le Scotte, Siena (M. Maio) - all in Italy · Melanoma Institute Australia, the University of Sydney, and Mater and Royal North Shore Hospitals (G.V.L.) and Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney (M.S.C.), Sydney, Princess Alexandra Hospital, University of Queensland, Brisbane (V.A.), Alfred Hospital (A.H.) and Peter MacCallum Cancer Centre (S. Sandhu), Melbourne, VIC, and Fiona Stanley Hospital-University of Western Australia-Edith Cowan University Perth, Perth (A.K.) - all in Australia · Cancer Research Center, Moscow (M.L.) · Royal Marsden Hospital, London (J.L.) · Hospital Clinic Universitari de Barcelona, Barcelona (S.P.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · University Hospital Essen, Essen and German Cancer Consortium, Heidelberg (D.S.), and the Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover (R.G.) - all in Germany · Washington University School of Medicine, St. Louis (L.H.-A.) · Centre Hospitalier de l'Université de Montréal (CHUM), Centre de Recherche du CHUM, Montreal (R.J.) · Christie NHS Foundation Trust, Manchester, United Kingdom (P.L.) · Merck, Kenilworth, NJ (N.I.) · and the European Organization for the Research and Treatment of Cancer Headquarters, Brussels (S.M., S. Suciu). · Pubmed 29658430
2017
  • From New York University Perlmutter Cancer Center, New York (J.W.) · Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M. Mandala), Medical Oncology, National Cancer Institute, Milan (M.D.V.), Oncology Institute of Veneto Istituti di Ricovero e Cura a Carattere Scientifico, Padua (V.C.-S.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M. Maio), Ospedale Policlinico San Martino, Genoa (P.Q.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · National and Kapodistrian University of Athens, Athens (H.J.G.) · Hospital Clinic de Barcelona, Barcelona (A.M.A.), and General University Hospital Gregorio Marañón, Madrid (I.M.-R.) - both in Spain · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · Hospices Civils de Lyon, Pierre Bénite (S.D.), Aix-Marseille University, Hospital de la Timone, Marseille (J.-J.G.), Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse (N.M.), Université Lille, INSERM Unité 1189, CHU Lille, Lille (L.M.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint Louis, Université Paris Diderot, Paris (C.L.) - all in France · Oncology Center Sf. Nectarie, Craiova, Romania (M. Schenker) · Princess Margaret Cancer Centre, University of Toronto, Toronto (M.O.B.), and Cross Cancer Institute, Edmonton, AB (M. Smylie) - both in Canada · the Department of Oncology, University of Oxford, Oxford (M.R.M.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · Gallipoli Medical Research Foundation and University of Queensland, Queensland, VIC (V.A.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.) - all in Australia · University of Colorado, Denver (R.G.) · Winship Cancer Institute, Emory University School of Medicine, Atlanta (R.R.K.) · Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.) · University of Washington, Seattle (S.B.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Nagoya University Graduate School of Medicine, Nagoya (K.Y.), and the National Cancer Center Hospital, Tokyo (N.Y.) - both in Japan · Seoul National University Hospital, Seoul, South Korea (T.M.K.) · and Bristol-Myers Squibb, Princeton, NJ (V.P, J.S., A.Q.). · Pubmed 28891423
30 Other Locations Show
Yearly article counts 8313138273025251645
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.